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Chapter 1:
General introduction
During the last decades, the replacement of missing teeth with implant-supported prostheses 
has become a widely accepted and routinely used treatment modality for the rehabilitation of 
fully and partially edentulous patients (Östman 2008). The underlying biological phenomenon 
of osseointegration was first described by the two research groups of Brânemark (Brânemark, 
et al. 1969) and Schroeder (Schroeder, et al. 1976, Schroeder, et al. 1978, Schroeder, et al. 
1981). Today, osseointegration is thought to be a biological reaction cascade dividable into 
three distinct phases. The first and most important healing phase, osteoconduction, relies on 
the recruitment and migration of osteogenic cells to the implant surface. The second healing 
phase, de novo bone formation, results in a mineralized interfacial matrix equivalent to that 
seen in the cement line in natural bone tissue. These two healing phases, osteoconduction 
and de novo bone formation, result in contact osteogenesis and given an appropriate implant 
surface, in bone bonding. The long term remodeling of the tissue, the third healing phase, is 
influenced by different stimuli, the most important being biomechanics of the developed 
healing site (Davies 2003). Accordingly, primary implant stability and lack of movements are 
considered main factors for successful osseointegration (Albrektsson, et al. 1981, Esposito, et 
al. 2007, Ottoni, et al. 2005). Originally, to minimize the implant failure risk for the first 
generation of osseointegrated implants which had a relatively smooth surface (Brânemark, et 
al. 1969), it has been recommended to keep the implants load-free during a healing period of 
three to four months in the mandible and six to eight months in the maxilla (Brânemark, et al. 
1977). Good long-term clinical outcomes have been reported when such implants were 
installed correspondingly in bone of high density and a two-stage procedure was used 
(Albrektsson and Sennerby 1991). In more challenging situations such as low bone densities, 
grafted bone as well as immediate or early loading, increased failure rates of implants with 
smooth surfaces have been reported (Becktor, et al. 2004, Friberg, et al. 1991, Glauser, et al. 
2001). On the contrary, improved implant stability as well as accelerated healing have been 
shown for modified implant surfaces (Albrektsson and Wennerberg 2004, Albrektsson and 
Wennerberg 2004, Wennerberg and Albrektsson 2009). Surface modifications of dental 
titanium implants are accomplished by roughening or by altering the chemical composition. 
Coating of dental titanium implants with calcium phosphate (CaP) ceramic is one of the used 
methods for changing the chemical surface composition (Le Guéhennec, et al. 2007). 
Consequently, CaP-coatings have been used to enhance implant stabilization and to maximize 
bone formation (Bloebaum, et al. 1991, Cooley, et al. 1992, Rivero, et al. 1988, Thomas and 
Cook 1985). Already more than a decade ago numerous studies have been published about 
the biological advantage of such coated implants (Caulier, et al. 1995, Caulier, et al. 1997, 
Caulier, et al. 1997, Jansen, et al. 1991). The study results demonstrated an increased 
mechanical interlocking and an increased percentage of bone contact for CaP surfaced 
implants, when compared with non-coated titanium implants. However, although promising 
effects of calcium phosphate coatings on bone-to-implant response are known for decades
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(Jansen, et al. 1999, Van Blitterswijk, et al. 1993), the clinical performance of these coatings 
remains controversial (Lee, et al. 2000, Schwartz-Arad, et al. 2005). Particularly, coating 
degradation might be related to supplementary crestal bone loss.
Plasma spraying is still the most commonly used method to coat CaP ceramics onto titanium 
implant surfaces. However, for conventional plasma spraying numerous powder 
characteristics and process parameters must be carefully controlled to consistently deposit 
high-quality coatings. This implies that only close control of a multitude of factors such as 
velocity of the plasma flame, powder particle size, and plasma temperature, can finally 
guarantee a minimum control of physical and chemical coating characteristics as adherence, 
thickness, porosity, crystallinity, and roughness. Consequently, relevant limitations still persist 
in conventionally plasma sprayed CaP coatings. To overcome these procedural challenges, 
novel microplasma spraying equipment (MSE) with technical advantages compared to the 
conventional equipment has been developed (Borisov, et al. 2002, Yushchenko, et al. 1995). 
The maximum power of the MSE gun is up to 2 kW, while conventional spraying operates at 
24-40 kW. Due to physical parameters of MSE, it is possible to spray finer particles and to 
apply textured coatings. Furthermore, because of the low heat power of the microplasma jet, 
overheating of the powder particles as well as excessive local overheating of the substrate is 
diminished. The latter gives an opportunity to produce coatings on components with small 
dimensions. Considering the small size of the microplasma equipment, the low level of noise 
(25-50 dB) compared to 80 -  120 dB for conventional plasma spraying equipment and hardly 
any dust, the equipment can operate under normal workroom conditions and is very easy to 
include in pre-existing clean rooms. Additionally, it is possible to reduce the size of sprayed 
spot diameter down to 1-5 mm, resulting in high spray efficiency, like for the spraying of oral 
implants. Therefore, the use of MSE might be a useful tool to coat dental implants. However, 
until now no in vivo experiments have been done to characterize biocompatibility, 
osteoconductivity as well as mechanical stability of such microplasma sprayed (MPS) CaP­
coatings. Moreover, data on bone and soft-tissue response under functional load of MPS 
coatings are lacking.
Beside plasma spraying other methods have been developed and are used to coat CaP 
ceramics onto titanium implant surfaces. Currently, the Nanotite surface ( 3i Implant 
Innovations, Palm Beach Gardens, USA) with a sol-gel deposited calcium phosphate nano 
particle modification of a minimally rough titanium alloy implant surface, is available for 
clinical use. Animal (Mendes et al. 2007, 2009) and human (Goené et al. 2007, Orsini et al. 
2007) data indicate, but do not finally proof an advantage of the surface composition of the 
Nanotite surface during osseointegration.
Hypothesizes
For the current research it was hypothesized that:
1. Micro- and conventionally CaP plasma sprayed titanium implants will evoke 
comparable effects at the bone-implant interface
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2. Micro- and conventionally plasma sprayed CaP coatings will perform similar 
regarding coating degradation
3. Surface chemical composition (e.g.: CaP coating) is a predominant factor in the bone 
deposition process
Research objectives
1. The central objective of this thesis was to perform appropriate in vivo experiments 
to characterize coating behavior, biocompatibility, osteoconductivity as well as 
mechanical stability and to obtain data on bone and soft-tissue response under 
functional load of MPS CaP coated oral implants. (Chapters 3, 4, 5 and 6)
2. It is already known for years that physically as well as chemically modified titanium 
implant surfaces are associated with improved implant stability and accelerated 
healing. However, as optimization of implant surfaces is a dynamic field in 
experimental and clinical Implant Dent an objective of this thesis was to review bone 
integration efficacy of experimental surface alterations as well as of recently 
developed and marketed surface modifications of oral implants (i.e.: OsseoSpeed, 
Astra Tech; SLActive, Straumann; TiUnite, NobelBiocare; Nanotite, 3i; Friadent plus, 
DENTSPLY Friadent). (Chapter 2)
3. A further objective of this thesis was to address chemical surface composition as a 
predominant factor in the bone deposition process. (Chapters 2, 3, 4, 5, 6 and 7)
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Chapter 2:
Effects of implant surface coatings and composition on bone integration A review of the 
literature
A. Introduction
Dental implants are surgically inserted into the jaw bones and are retained because of the 
intimacy of bone growth onto their surfaces. A phenomenon which is referred to as 
osseointegration (Brânemark et al. 1969, Schroeder et al. 1976, Brânemark et al. 1977). This 
biological fixation is considered to be a prerequisite for implant-supported prostheses and 
their long-term success (Le Guéhennec et al. 2007). During the past 40 years, prosthetic 
rehabilitation of completely or partially edentulous patients with implant-born removable or 
fixed dentures has developed into a practical and in principle predictable treatment option 
(Östman 2008). Regardless of high success rates shown by longitudinal studies, failures do 
occur (Montes et al. 2007). The cause of these failures is in large attributable to a failure in 
bone formation in support of osseointegration (Mendonça et al. 2008). Today more than 1300 
types of oral implants varying in form, material, dimension, interface geometry and surface 
properties are commercially available (Binon 2000). In a recent systematic review (Esposito et 
al. 2007b) the question was addressed whether there are surface modifications, implant 
shapes or particular materials that can indeed improve the clinical performance. Based on the 
available results of randomized controlled trials (RCTs), Esposito and co-workers found no 
evidence that any particular type of dental implant showed superior long-term success. 
However, because the RCTs included in the systematic review were performed with relative 
short follow-up periods, few patients and high risk of bias, Esposito and co-workers concluded 
that they finally do not know if there are implant characteristics or implant systems that are 
superior to others due to scarcity of reliable scientific research. Beside other parameters, 
implant surface characteristics are factors affecting the rate and extent of the implant bone 
response as well as the mechanical quality of the bone/implant interface (Le Guéhennec et al. 
2007, Monte, et al. 2007). In view of this, within the systematic review of Esposito et al. 
(2007b) there was only limited evidence showing that implants with relatively smooth 
(turned) surfaces are less prone to bone loss due to chronic infection (peri-implantitis) than 
implants with rougher surfaces. There was only a tendency for implants with a turned surface 
to show early failures more often than implants with roughened surfaces. Furthermore, there 
appeared to be no clinical significant differences when using a cylindrical or tapered 
immediate implant in post extraction sockets. Still, it should be highlighted that no RCT 
investigating the long term performance of implants made or coated with materials other 
than titanium was available for inclusion. Nevertheless, there is evidence for the 
improvement of implant-bone integration by surface modification (Albrektsson and 
Wennerberg 2004a, b). Therefore, optimization of the implant surface, is a dynamic field in 
experimental and clinical Implant Dent (Esposito et al. 2007a, Montes et al. 2007), which will 
finally result in new products.
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The aim of the present review was to evaluate the bone integration efficacy of recently 
developed and marketed oral implants (e.g. OsseoSpeed, Astra Tech; SLActive, Straumann; 
TiUnite, NobelBiocare; Nanotite, 3i; Friadent plus, DENTSPLY Friadent) as well as experimental 
surface alterations. Therefore, histomorphometric bone apposition data as well as data 
regarding mechanical stability testing, derived from animal experiments and human reports, 
were systematically reviewed.
B. Background
B.1. Osseointegration and implant surface characteristics
Immediately following implant placement, a series of events occur between the host and the 
implant surface. This sequence of events include the initial interaction between blood and the 
implant surface, where proteins and ligands are dynamically adsorbed onto and released from 
the implant surface as well as the inflammatory process, which is followed by initial bone 
formation (modeling) around the implant (Lemons 2004). Recently, Davies (Davies 2003, 
2007) proposed a concept that comprises the biological cascade of early peri-implant bone 
healing. In brief, while cortical bone healing relies on osteonal remodeling, peri-implant 
trabecular bone healing can be divided in three distinct phases. The first and most important 
healing phase, osteoconduction, relies on the recruitment and migration of osteogenic cells to 
the implant surface, through the residue of the peri-implant blood clot. Among the most 
important aspects of osteoconduction are the knock-on effects generated at the implant 
surface, by initiation of platelet activation, which results in direct osteogenic cell migration, as 
well as fibrin clot stabilization by physical interlocking of fibrin fibers with the implant surface 
promoting the directed ongrowth of bone forming cells onto the implant surface. Those cells 
that differentiate before reaching the implant surface will secrete matrix. As a result, they will 
stop migrating and will not reach the implant surface. Thus, osteoconduction will result in a 
bony spicule advancing towards the target surface. Osteogenic cells that migrate onto the 
implant surface will differentiate and form de novo bone by secreting first a proteinaceous 
matrix directly on the implant surface. This second healing phase, de novo bone formation, 
results in a mineralized interfacial matrix equivalent to that seen in the cement line in natural 
bone tissue. These two healing phases, osteoconduction and de novo bone formation, result 
in contact osteogenesis and given an appropriate implant surface, bone bonding. The third 
healing phase, bone remodeling, relies on slower processes. During several remodeling cycles, 
the bone surrounding the implant achieves its highest degree of organization and mechanical 
properties (Lemons 2004).
The rate, quantity and quality of bone response are related to implant surface properties, 
which means that the actual implant surface area being in direct contact with bone, the time 
frame for the establishment of the direct bone-to-implant contact, and the mechanical nature 
of the connection between bone and implant surface is influenced by the nature of the 
implant surface itself. In other words, chemical and physical surface properties as ionic 
composition, hydrophilicity and roughness are parameters that play a major role in implant-
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tissue interaction (Le Guéhennec et al. 2007). Therefore, distinctive alterations of implant 
surfaces may lead to different and unique chemical as well as physical surface properties, and 
might potentially lead to changes in the bone-to-implant reaction (Coelho, PG et al. 2009).
B.2. Implant surface features
B.2.1. Chemical composition
Depending on their bulk composition as well as on surface treatments, the chemical 
composition and charges on implant surfaces differ. It is well known, that composition and 
charges are critical for protein adsorption and cell attachment. For example, the surface 
chemical composition of titanium implants affects the hydrophilicity of the implant surface. 
Highly hydrophilic surfaces (Rupp et al. 2006) seem to be more desirable than hydrophobic 
ones because of their interactions with biological fluids, cells and tissues (Buser et al. 2004, 
Zhao et al. 2005). Recently, it was shown in an animal model that a hydrophilic SLA implant 
surface gave higher bone-to-implant contact than a regular SLA surface (Buser et al. 2004). 
However, it should be mentioned, that others (Carlsson et al. 1989, Wennerberg et al. 1991), 
reported contradictory results and failed to demonstrate an improved bone response using 
hydrophilic surfaced dental implants.
B.2.2. Calcium phosphate coating
Already for decades, titanium dental implants have been coated with calcium phosphates. It is 
well known, that following implantation, the release of calcium phosphate into the peri- 
implant region increases the saturation of body fluids and results in the precipitation of a 
biological apatite onto the surface of the implant (De Groot et al. 1998, Daculsi et al. 2003). 
This layer of biological apatite might contain endogenous proteins and serve as a matrix for 
osteogenic cell attachment and growth (Davies 2003). As the biological fixation of titanium 
implants to bone tissue is faster with a calcium phosphate coating than without (Morris et al. 
2000, Barrere et al. 2003), it seems rational to assume that the bone healing process around 
the implant is enhanced by the formation of the aforementioned biological apatite layer. 
Various methods have been developed and tested in order to coat metal implants, e.g.: 
plasma-spraying, sputter-deposition, sol-gel coating, electrophoretic deposition or 
biomimetic precipitation. Till now, plasma-spray coating, magnetron-sputtering and more 
recently sol-gel deposition of nano-sized calcium phosphate crystals have been used to coat 
titanium dental implants in clinical practice. It has to be emphasized that the clinical use of 
plasma-sprayed calcium phosphate coated dental implants is limited. One of the major 
concerns with plasma-sprayed coatings is the possible delamination of the coating from the 
surface of the titanium implant and failure at the implant/coating interface. It is thought, that 
the discrepancy in dissolution behavior between amorphous and crystalline calcium 
phosphate phases that make up the coating led to delamination, particle release and thus the 
clinical failure of implants (Wheeler 1996, Chang et al. 1999, Lee et al. 2000, Tinsley et al.
2001). It should be kept in mind that plasma-sprayed calcium phosphate coated implants are
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nevertheless highly successful in orthopedics. Despite their negative reputation in dental 
practice, a systematic review (Lee et al. 2000) did not show that long-term survival rates were 
inferior for plasma-sprayed calcium phosphate coated dental implants compared to other 
types of dental implant. The negative publications about plasma sprayed coated oral implants 
have resulted in the development of thin calcium phosphate coating techniques.
B.2.3. Surface roughness
It is well known that the surface roughness of implants affects the rate of osseointegration 
and biomechanical fixation (Le Guéhennec et al. 2007).Commonly, implant surface roughness 
is divided, depending on the dimension of the measured surface features in: macro-, micro-, 
and nano-roughness. Typically, these different roughness features are related to distinct 
effects during wound healing and osseointegration.
Macro roughness comprises features in the range of millimeters to tens of microns. This scale 
directly relates to implant geometry, with threaded screw and macro porous surface 
treatments. Evidence exists that primary implant fixation and long-term mechanical stability 
can be improved by an appropriate macro roughness. The underlying mechanism thereby is 
the mechanical interlocking between the macro rough features of the implant surface and the 
surrounding bone profile (Buser et al. 1991, Gotfredsen et al. 1995, Wennerberg et al. 1996). 
Micro roughness is defined as being in the range of 1-10 ^m. This range of roughness 
maximizes the interlocking between mineralized bone and implant surface (Wennerberg et al. 
1996, Wennerberg et al. 1998). In a theoretical approach, Hansen and Norton (Hansson and 
Norton 1999) described the interaction of bone with the implant surface and mathematically 
defined the role of surface roughness at the micron-scale within this hypothetical concept. 
They calculated that an optimized implant surface should be densely covered with pits of 
approximately 1.5 ^m depth and 3-5 ^m diameter. This theoretical determined surface 
geometry is supported by experimental data (Albrektsson and Wennerberg 2004a, b). Today, 
micro rough implant surfaces are accepted in the dental implant market (Albrektsson and 
Wennerberg 2004a, b). The suggestion that micron-level surface topography results in greater 
accrual of bone at the implant surface is supported by some clinical evidence (Cochran 1999, 
Shalabi et al. 2006). In this context, it should be mentioned that micro rough surfaces have 
been generally interpreted as biocompatible with limited ability to directly affect the initial 
fate of surrounding tissues, i.e. the ability to enhance bone formation or to prevent bone 
resorption (Mendonça et al. 2008). A variety of methods have been developed in order to 
create surface roughness in order to improve the bone behavior of dental implants. Methods 
use to create a certain surface roughness for titanium dental implants are for example 
titanium plasma-spraying, blasting with ceramic particles, acid-etching and anodization. These 
methods are in detail reviewed elsewhere (Le Guéhennec et al. 2007).
Current trends in clinical dental implant therapy include the use of surfaces provided with 
nanoscale topographies. Nanotechnology has been defined as "the creation of functional 
materials, devices and systems through control of matter on the nanometer length scale (1­
100 nm), and exploitation of novel phenomena and properties (physical, chemical, and
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biological) at that length scale" (National Aeronautics and Space Administration). 
Nanotechnology involves materials that have a nano-sized topography or are composed of 
nano-sized materials. These materials have a size range between 1 and 100 nm. Nanometer 
roughness plays an important role in the adsorption of proteins, adhesion of osteoblastic cells 
and thus the rate of osseointegration (Brett et al. 2004). However, reproducible surface 
roughness in the nanometer range is difficult to produce with chemical treatments. In 
addition, the optimal surface nano topography for selective adsorption of proteins leading to 
the adhesion of osteoblastic cells and rapid bone apposition is unknown (Le Guéhennec et al.
2007). Current approaches in the development of implant surfaces with nano features were 
recently reviewed (Mendonça et al. 2008).
B.3. Biocompatibility of implant surfaces
New implant surfaces or surface modifications should undergo in vitro and in vivo evaluation. 
The evaluation typically follows a hierarchical approach, where in vitro testing evolves to in 
vivo laboratory experiments, and then to clinical trials in humans (Lemons 2004). The 
hierarchical testing approach is especially useful in cases where surface modifications are 
compared with already known implant surfaces. That means, if a new implant surface does 
not show at least equivalent performance when tested in vitro and in animal models, clinical 
trials in humans should be avoided (Coelho et al. 2009).
In principle, cell culture studies attempt to get insight in cell morphology, adhesion, 
migration, proliferation, and differentiation on implant surfaces (Lemons 2004). Although in 
vitro cell culture evaluations have been shown to be useful for initial biological screening of 
novel biomaterials, results obtained in cell cultures cannot yet be fully correlated to in vivo 
performance (Groth et al. 1995). Cell cultures by no means represent the dynamic in vivo 
bone/implant surface environment (Coelho et al. 2009) and the merit of novel or altered 
implant surfaces can only be confirmed in animal models and subsequent clinical trials (Groth 
et al. 1995).
C. Search strategy
C.1. Search strategy "Recently developed and marketed implant surfaces"
C.1.1. Study design
As mentioned earlier, today more than 1300 types of oral implants varying in form, material, 
dimension, interface geometry and surface properties are commercially available (Binon 
2000). In view of this multitude of different oral implant systems, which represent a huge 
number of distinct implant surface modifications, it was decided for the current review to 
concentrate regarding "recently developed and marketed implant surfaces" on published 
evidence of surface modification from five commonly used implant systems within Europe, 
e.g. OsseoSpeed (Astra Tech), SLActive (Straumann), TiUnite(NobelBiocare), Nanotite( 3i) and 
Friadent plus (DENTSPLY Friadent).
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C.1.2. Outcome variables
The primary outcome variables were bone to implant contact percentage as the lengths of 
light microscopic direct bone to implant contact obtain in histological slides (BIC) as well as 
mechanical stability testing.
C.1.3. Inclusion criteria
Animal studies as well as human reports and human studies presenting bone to implant 
contact percentage (BIC) or data regarding mechanical testing (e.g. removal torque, [RTQ]) for 
implants supplied by Astra (OsseoSpeed), Straumann (SLActive), Nobel Biocare (TiUnite), 3i 
(Nanotite) or DENTSPLY/Friadent (Cell Plus), in pristine bone were included for analysis.
C.1.4. Study selection
A search in the database of the National Library of Medicine (http://www.ncbi.nlm.nih.gov) 
up to 01 December 2008 was carried out. Only publications in English were considered. The 
search was broadened to animals and humans. The search strategy applied was: ("dental 
implants"[MeSH Terms] OR ("dental"[All Fields] AND "implants"[All Fields]) OR "dental 
implants"[All Fields]) AND (("anatomy and histology"[Subheading] OR ("anatomy"[All Fields] 
AND "histology"[All Fields]) OR "anatomy and histology"[All Fields] OR "histology"[All Fields] 
OR "histology"[MeSH Terms]) OR (mechanical[All Fields] AND testing[All Fields])) 
Furthermore, the reference lists of related review articles, publications selected for inclusion 
in this review, and literature referenced by the specific companies were systematically 
screened.
C.1.5. Inclusion of studies
The search resulted in the identification of 3212 titles. These titles were initially screened by 
the two independent reviewers (Rüdiger Junker [RJ] and Maurice Thoneick [MT]) for possible 
inclusion, resulting in further consideration of 867 publications. Screening the abstracts led to 
71 full text articles. From these articles, 29 were selected for inclusion in the review. No 
additional publications from manual search were included (Fig. 1). Any disagreement between 
the reviewers was resolved by discussion. The two reviewers used a data extraction form (Fig. 
2) to extract data independently. Disagreement regarding data extraction was resolved by 
consensus.
C.2. Search strategy "Experimental surface alterations"
C.2.1. Study design
A systematic strategy for study selection was used. However, because of the multitude of new 
surface technologies, resulting in an infinity of distinct implant surface modifications, the 
authors of the current review decided to exemplary discuss animal data regarding mechanical 
testing and/or bone to implant contact for selected techniques and/or surface modifications
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(Pulsed laser deposition (PLD), Sputter coating, Ion beam assisted deposition (IBAD), 
Electrostatic spray deposition (ESD), Biomimetic deposition, Collagen and collagen mimetic 
peptides coated onto titanium implant surface, Collagen combined with chondroitin sulfate 
coated onto titanium implant surface, Collagen composite coating with calcium phosphate, 
and BMPs as well as non-BMP growth factors coated onto titanium implant surface).
C.2.2. Outcome variables
The primary outcome variables were bone to implant contact percentage as the lengths of 
light microscopic direct bone to implant contact obtain in histological slides (BIC) as well as 
mechanical stability testing.
C.2.3. Inclusion criteria
Animal studies presenting bone to implant contact percentage (BIC) or data regarding 
mechanical testing (e.g. removal torque, [RTQ]) for the above mentioned selected techniques 
and/or surface modifications were included for analysis.
C.2.4. Study selection
A search in the database of the National Library of Medicine (http://www.ncbi.nlm.nih.gov) 
up to 01 December 2008 was carried out. Only publications in English were considered. The 
search was restricted to animals. Initially, search was conducted in separate clusters. Clusters, 
search strategy applied and number of retrieved titles were:
Pulsed laser deposition (PLD):
(("lasers"[MeSH Terms] OR "lasers"[All Fields] OR ("pulsed"[All Fields] AND "laser"[All Fields]) 
OR "pulsed laser"[All Fields]) AND deposition[All Fields]) OR "pld"[All Fields])) AND ("dental 
implants"[MeSH Terms] OR ("dental"[All Fields] AND "implants"[All Fields]) OR "dental 
implants"[All Fields] OR ("dental"[All Fields] AND "implant"[All Fields]) OR "dental implant"[All 
Fields])
Sputter coating:
((sputter[All Fields] AND coated[All Fields]) OR sputter[All Fields]) AND ("dental 
implants"[MeSH Terms] OR ("dental"[All Fields] AND "implants"[All Fields]) OR "dental 
implants"[All Fields] OR ("dental"[All Fields] AND "implant"[All Fields]) OR "dental implant"[All 
Fields])
Ion beam assisted deposition (IBAD):
(("ions"[MeSH Terms] OR "ions"[All Fields] OR "ion"[All Fields]) AND beam[All Fields] AND 
assisted[All Fields] AND deposition[All Fields]) OR (("ions"[MeSH Terms] OR "ions"[All Fields] 
OR "ion"[All Fields]) AND beam[All Fields]) OR IBAD[All Fields]) AND ("dental implants"[MeSH 
Terms] OR ("dental"[All Fields] AND "implants"[All Fields]) OR "dental implants"[All Fields] OR 
("dental"[All Fields] AND "implant"[All Fields]) OR "dental implant"[All Fields])
Electrostatic spray deposition (ESD):
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((electrostatic[All Fields] AND spray[All Fields] AND deposition[All Fields]) OR ESSD[All Fields]) 
AND ("dental implants"[MeSH Terms] OR ("dental"[All Fields] AND "implants"[All Fields]) OR 
"dental implants"[All Fields] OR ("dental"[All Fields] AND "implant"[All Fields]) OR "dental 
implant"[All Fields])
Biomimetic deposition:
(("biomimetics"[MeSH Terms] OR "biomimetics"[All Fields] OR "biomimetic"[All Fields]) OR 
(simulated[All Fields] AND ("body fluids"[MeSH Terms] OR ("body"[All Fields] AND "fluids"[All 
Fields]) OR "body fluids"[All Fields] OR ("body"[All Fields] AND "fluid"[All Fields]) OR "body 
fluid"[All Fields])) OR SBF[All Fields]) AND ("dental implants"[MeSH Terms] OR ("dental"[All 
Fields] AND "implants"[All Fields]) OR "dental implants"[All Fields] OR ("dental"[All Fields] 
AND "implant"[All Fields]) OR "dental implant"[All Fields])
Biomolecules: Extracellular matrix peptide sequence or proteins coatings: RGD peptide 
sequence
(RGD[All Fields] OR RGD-loaded[All Fields] OR RGD-coated[All Fields]) AND ("dental 
implants"[MeSH Terms] OR ("dental"[All Fields] AND "implants"[All Fields]) OR "dental 
implants"[All Fields] OR ("dental"[All Fields] AND "implant"[All Fields]) OR "dental implant"[All 
Fields])
Biomolecules: Extracellular matrix peptide sequence or proteins coatings: Collagen and 
collagen mimetic peptides, Collagen combined with chondroitin sulfate, Collagen composite 
coating with calcium sulfate
(("collagen"[MeSH Terms] OR "collagen"[All Fields]) AND surface[All Fields] AND coating[All 
Fields]) OR (("collagen"[MeSH Terms] OR "collagen"[All Fields]) AND coating[All Fields])) AND 
("dental implants"[MeSH Terms] OR ("dental"[All Fields] AND "implants"[All Fields]) OR 
"dental implants"[All Fields] OR ("dental"[All Fields] AND "implant"[All Fields]) OR "dental 
implant"[All Fields])
Growth factor coatings:
(intercellular signaling peptides and proteins"[MeSH Terms] OR ("intercellular"[All Fields] AND 
"signaling"[All Fields] AND "peptides"[All Fields] AND "proteins"[All Fields]) OR "intercellular 
signaling peptides and proteins"[All Fields] OR ("growth"[All Fields] AND "factor"[All Fields]) 
OR "growth factor"[All Fields]) AND ("dental implants"[MeSH Terms] OR ("dental"[All Fields] 
AND "implants"[All Fields]) OR "dental implants"[All Fields] OR ("dental"[All Fields] AND 
"implant"[All Fields]) OR "dental implant"[All Fields])
Furthermore, the reference lists of related review articles and publications selected for 
inclusion in this review were systematically screened. Additionally, to include relevant 
literature in this review, one reviewer (Rüdiger Junker [RJ]) had discussions with experts in the 
field of experimental surface alterations.
C.2.5. Inclusion of studies
The search resulted in the identification of 356 titles. These titles were initially screened by 
the two independent reviewers (Rüdiger Junker [RJ] and Athanasios Dimakis [AD]) for possible 
inclusion, finally resulting in 35 full text articles for inclusion in the review. Sixteen additional
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publications from manual search were included (Fig. 3). Any disagreement between the 
reviewers was resolved by discussion. The two reviewers used a data extraction form (Fig. 2) 
to extract data independently. Disagreement regarding data extraction was resolved by 
consensus.
D. Recently developed and marketed implant surfaces
All publications fulfilling the inclusion criteria of this review are listed in Table 1.
D.1. OsseoSpeed (Astra)
D.1.1. Surface
Up to now, only a few nanoscale surface topography modifications have been used to 
enhance bone responses at clinical dental implants. The OsseoSpeed surface (Astra Tech AB, 
Mölndal, Sweden) possesses 50-100 nm structured features created by titanium oxide 
blasting followed by chemical modification of the surface by hydrofluoric acid treatment 
(Abron et al. 2001, Cooper et al. 2006).
D.1.2. Animal experiments
As mentioned above, the most important preclinical tests in order to evaluate the merit of 
novel or altered implant surfaces are animal experiments. Typically, in vivo tests of implants 
have histomorphometric and /or biomechanical components. The histomorphometric part 
usually evaluates static parameters such as amount of bone-to-implant contact, bone density, 
as well as amount and type of cellular content. The biomechanical testing component usually 
evaluates push-out force, pull-out force, or torque to implant failure of implants in bone 
(Coelho et al. 2009). In view of this, Ellingsen and co-workers (Ellingsen et al. 2004) found that 
titanium oxide blasted implant surfaces modified by hydrofluoric acid treatment were slightly 
smoother (Sa: 0.91 ^m) compared to only titanium oxide blasted titanium implant surfaces 
(Sa: 1.12). In a rabbit tibia model they showed that after 3 months removal torque values (85 
Ncm for hydrofluoric acid modifies surfaces versus 54 Ncm) and shear strength between bone 
and implants (23 Nmm2 for hydrofluoric acid modifies surfaces versus 15 Nmm2) were 
significantly higher for hydrofluoric acid modified surfaces. Histomorphometric evaluation 
demonstrated higher bone-to-implant contact for hydrofluoric acid modifies surfaces at 1 
month as well as at 3 months. Based on the biomechanical and histomorphometric data they 
concluded that the hydrofluoric acid treated titanium implants demonstrated a firmer bone 
anchorage than unmodified titanium implants, and that hydrofluoric acid treated titanium 
implants achieved greater bone integration than unmodified titanium implants after a shorter 
healing time.
Comparable results were found in a rat tibia model (Cooper et al. 2006). In this experiment, 
titanium oxide grit (75^m) blasted, machined implants (1.5 mm diameter x 2.0 mm long) 
made of c.p. titanium were compared with implants that were additionally hydrofluoric acid
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etched. The implants were randomly placed into the hind limbs of rats. After 21 days of 
implantation, significantly higher bone-to-implant contact percentages for hydrofluoric acid 
modified surfaces were observed compared to titanium oxide grit blasted titanium surfaces. 
Based on the histomorphometric data they concluded , that the hydrofluoric acid treated 
titanium resulted in osteoconduction at the metallic implant/bone interface, and that more 
bone can be formed in a reduced healing period at the chemically modified surface of 
topographically enhanced c.p. titanium implants.
In a mandibular wound chamber model in dogs, Berglundh et al. (Berglundh et al. 2007) 
evaluated early stages of osseointegration for the OsseoSpeed versus the TiOblast implant 
surface. In the partially edentulous mandible of mongrel dogs, the two different implant types 
were placed. Four weeks after the first implant surgery, the installation procedure was 
repeated in the opposite side of the mandible. Two weeks later the animals were sacrificed. 
Histomorphometry revealed that after 2 weeks of healing the amount of new bone that 
formed in the wound chambers at sites where the internal walls of the wound chamber were 
provided with a fluoride modified surface (OsseoSpeed) was statistically significant higher 
compared to no fluoride modified surface sites (TiOblast). Such a difference was not found 
after 6 weeks of submerged healing. A similar significant difference was found for bone-to- 
implant contact within the macro-threaded portions of the implants. Within this area, after 2 
weeks of submerged healing the mean bone-to-implant contact for the OsseoSpeed surface 
was 56% versus 43 % for the TiOblast surface. Also in this area, such a difference was not 
found after 6 weeks of healing. The authors concluded that the fluoride modification of the 
TiOblast surface provided conditions that enhanced the rate of early bone formation and 
osseointegration.
Similar results were obtained in another mandibular dog model (Abrahamsson et al. 2008). In 
this experiment, bone healing in wide marginal defects at implants with either having an 
OsseoSpeed or a TiOblast surface were studied. After 2 weeks the bone-to-implant contact 
within the defect area was 56% for the OsseoSpeed surface and 34% for the TiOblast 
surface. No significant difference was found after 6 weeks of submerged healing 
(OsseoSpeed: 64% versus TiOblast: 45%). Also, in this experiment it was concluded that the 
fluoride modification of the TiOblast surface promotes bone formation and osseointegration. 
In summary, in different animal models the histomorphometric data showed more bone-to- 
implant contact at early time points after implantation (Ellingsen et al. 2004, Cooper et al.
2006, Berglundh et al. 2007, Abrahamsson et al. 2008) and in one animal model the 
biomechanical evaluation after 3 months of healing showed more implant stability for the 
fluoride modification of the TiOblast surface compared to the only titanium oxide grit blasted 
TiOblast surface (Ellingsen et al. 2004).
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D.2. SLActive (Straumann)
D.2.1. Surface
The SLActive dental implant surface (Institute Straumann, Waldenburg, Switzerland) is a 
further development of the SLA surface. The SLA surface is in principle produced by coarse 
grit-blasting with 0.25-0.50 mm corundum grit at 5 bar followed by acid etching (Martin et al.
1995, Zhao et al. 2005).Such a standard titanium oxide surface exhibits low surface energy 
because of adsorbed hydrocarbons and carbonates from ambient air (Zhao et al. 2005). In 
addition to the SLA surface, the SLActive surface is rinsed under nitrogen protection to 
prevent exposure to air and then stored in a sealed tube containing isotonic NaCl solution 
(Zhao et al. 2005). Buser et al. (2004) characterized the SLActive surface in comparison to the 
SLA surface. No differences in surface topography were found. For surface wettability a 
statistically significant difference was observed. Dynamic contact angle (DCA) measurements 
indicated that the SLA surface was hydrophobic (DCA = 138.8° ± 4.2°), while the SLActive 
surface was hydrophilic (DCA = 0°). Additionally, the chemical composition between the 
surface types varied. The SLActive surface had increased oxygen and titanium concentrations 
(O: 55.0 at% ± 2.0 at%; Ti: 26.5 at% ± 0.9 at%) in comparison with the SLA surface (O: 44.2 at% 
± 1.9 at%; Ti: 18.4 at% ± 01.6at%). Conversely, the SLActive surface demonstrated reduced 
carbon concentration (C: 18.4 at% ± 2.7 at%) compared to the standard SLA surface (C: 37.3 
at% ± 3.4 at%). Osteoblasts grown on such modified surfaces exhibited a more differentiated 
phenotype characterized by increased alkaline phosphatase activity and osteocalcin 
production and generated an osteogenic microenvironment through higher production of 
PGE2 and TGF-ß1 (Zhao, et al. 2005).
D.2.2. Animal experiments
The interfacial biomechanical properties of the SLActive implant surface was compared to the 
SLA surface in an animal experiment by Ferguson et al. (Ferguson et al. 2006). In the well 
established maxillary miniature pig model (Buser et al. 1999, Li D et al. 2002) removal torque 
testing was performed after 2, 4, and 8 weeks of bone healing. Due to the fact that a split 
mouth design was used, removal torque values and interfacial stiffness were statistically 
compared in a pair-wise fashion. The removal torque values were on average 8-21% higher 
for SLActive surfaces than for SLA surfaces. These differences reached statistical significance. 
Additionally, the interfacial stiffness values, which were calculated on basis of the torque- 
rotation curve, were on average 9-14% higher for SLActive compared to SLA. Also these 
differences reached statistical significance. Both the healing period and the implant surface 
type were significant factors determining the biomechanical performance of the implants 
within this experiment. It was concluded that the SLActive surface achieves better bone 
anchorage during early stages of bone healing than the SLA surface, and that the chemical 
modification of the standard SLA surface likely enhances bone apposition and that this has a 
beneficial effect on the interfacial shear strength.
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In the already above mentioned maxillary miniature pig model, Buser et al (2004) evaluated 
also bone apposition on SLActive compared to SLA surfaced implants. After 2 weeks of healing 
mean bone-to-implant contact for SLActive surfaces was 49% compared to 29% for standard 
SLA surfaces. The bone apposition percentages at 4 weeks were 82% for SLActive and 67% for 
SLA. At 2 and 4weeks the differences between the two types of surfaces were statistically 
significant. After 8 weeks of implantation the corresponding values amounted to 78% for 
SLActive and 75% for SLA. This difference was not statistically significant. It was concluded 
that the SLActive surface promoted enhanced bone apposition during early stages of bone 
regeneration.
In a dog model, Schwarz (2007c) investigated the initial and early tissue reactions to SLActive 
and SLA surfaces. According to a randomization protocol, the different surfaces types were 
placed in the maxilla and the mandible of four fox hounds. For the SLActive surface bone-to- 
implant contact can be assessed as around 35% (day 1), 35% (day 4), 55% (day 8), and 70% 
(day 14). The corresponding values for the SLA surface are around 35% (day 1), 35% (day 4), 
40% (day 8), and 55% (day 14). Bone-to-implant contact tended to be higher for the SLActive 
surface at 8 and 14. Similar data were found for bone density.
In another experiment, Schwarz et al. (2007a) evaluated bone regeneration in dehiscence- 
type defects at SLActive and SLA implants as installed in the maxilla and mandible of beagle 
dogs. After 2 weeks of implantation, bone contact amounted to 74% for the SLActive and to 
56% for the SLA surface. The difference was statistically significant. After 12 weeks of healing 
the corresponding values, 84% (SLActive) and 76% (SLA) were not statistically significant 
different. The bone apposition pattern was even more apparent in the dehiscence defect 
areas. Within central portions of the defect areas bone-to-implant contact after 2 weeks of 
healing was 27% for the SLActive and 0% for the SLA surface. After 12 weeks of healing the 
corresponding values were 80% (SLActive) and 5% (SLA). The data of this experiment support 
the observation that the SLActive surface promotes enhanced bone apposition during early 
stages of bone regeneration.
The effect of the SLActive surface on early stages of bone apposition is also supported by a 
further experiment in the dog model by the study group of Schwarz and Becker (Schwarz, et 
al. 2007b). Screw-type titanium implants with SLActive or SLA endosseous surfaces with 
differently structured transmucosal surfaces were implanted in the maxillae and mandibles of 
beagle dogs. After a non-submerged healing period of 1, 4, 7, 14, or 28 days the animals were 
sacrificed. At day 7 and 14 bone-to-implant contact for SLActive surfaces was, in the maxilla as 
well as in the mandible, statistically significant higher compared to the SLA surfaces. At day 
28 bone-to-implant contact was significant higher for maxillary SLActive surfaced implants. 
Also the group of Cochran (Bornstein et al. 2008) evaluated bone apposition to SLActive and 
SLA surfaces in a dog model. In fox hounds each side of the mandible received six randomly 
assigned dental implants alternating between the standard SLA and the SLActive surface. Two 
dogs were sacrificed after 2 weeks and 3 dogs after 4 weeks of healing. After 2 weeks the 
mean percentage of newly formed bone in contact with the SLActive surface was 28% 
compared to 22% for the SLA surface. This difference was statistically significant (p<0.05).
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The bone-to-implant contact after 4 weeks was similar for the different surfaces, i.e. 38% for 
SLActive and 38% for SLA.
Additionally, a recent study by Schwarz et al. (2008) indicated that SLActive surfaces enhance 
bone apposition during early stages of wound healing. They evaluated bone regeneration in 
dehiscence-type defects around non-submerged and submerged titanium implants with 
SLActive and SLA surfaces. Standardized buccal dehiscence defects were surgically created 
following implant site preparation in the maxillae and mandibles of beagle dogs. After 1, 2, 4, 
and 8 weeks the animals were sacrificed. At 2, 4, and 8 weeks of implantation, significantly 
higher bone-to-implant contact was observed for the SLActive surfaces for both maxillary and 
mandibular implants.
In summary, in one animal experiment the biomechanical evaluation indicated more implant 
stability for the SLActive surface during early phases of bone regeneration. 
Histomorphometric evaluation in six animal experiments showed more bone-to-implant 
contact for the SLActive compared to the SLA surface at early time points.
D.3. TiUnite (Nobel Biocare)
D.3.1. Surface
The TiUnite implant surface (Nobel Biocare Holding AG, Zürich, Switzerland) is manufactured 
by anodic oxidation, representing an electrochemical anodization process used to modify 
machined surfaces. It has been shown that this electrochemical anodization process increases 
the surface micro texture and changes the surface chemistry (Sul et al. 2002b, Sul et al. 2002c, 
Sul et al. 2006). In vivo experiments in tibias of rabbits (Sul et al. 2002d) indicated, that 
electrochemical oxidation (Sul et al. 2001) of titanium implants can lead to titanium oxide 
properties as oxide thickness, micro pore configurations, and crystal structures, with 
statistically significant higher removal torque values after 6 weeks of healing compared to the 
not chemically modified, machined surface. Detailed information regarding surface chemistry, 
morphology, oxide thickness, pore characteristics and roughness of commercially available 
TiUnite surfaced implants are recently published (Sul et al. 2006). Chemically the TiUnite 
surface mainly consists of TiO2 and P < 10.9 at%, as well as contaminants as C < 24at%, Na < 4 
at%, and N < 1.5 at%, with traces of S. The surface is composed of a duplex oxide structure 
with an outer porous film with micro pores and an inner barrier film without micro pores. The 
pore/pit size was < 4 ^m. The oxide thickness is heterogeneous. The outer porous film varies 
between 0.9 and 5.0 ^m. The inner barrier film is 5.7 ^m at the first, 5.9 ^m at the third, and 
9.3 ^m at the fifth thread. The crystal structure is composed of anatase and rutile phases. The 
roughness is measured with a Sa value of 1.35 ^m. Because the implant surface contains 
phosphorous ions, it looks like that phosphoric acid has been used as an electrolyte. It is 
speculated that this might indicate that the TiUnite surface lacks bioactivity (Sul et al. 2002a). 
Albrektsson and Wennerberg (2004a) supplemented the description of the TiUnite surface by 
reporting, that it had a relatively thin oxide layer (a few hundred nanometers) and was
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minimally rough (Sa. 0.5 -  1.0 ^m) in the upper region, whereas the apical region displayed an 
oxide thickness in the range of more than 10 ^m and a roughness (Sa) of more than 2 ^m.
D.3.2. Animal experiments
The interfacial biomechanical properties of the TiUnite implant surface were compared to the 
Osseotite surface in an animal experiment by Sul et al.(Sul et al. 2006). In the rabbit tibia 
model, TiUnite surfaced implants were unscrewed with removal torque (RTQ) devices after 
healing periods of 3 and 6 weeks. The mean removal torque of TiUnite implants showed only 
at 6 weeks a significantly higher RTQ value than Osseotite implants. This mean RTQ value for 
TiUnite surfaced implants was further evaluated by Hall and co-workers (Hall et al. 2005). In 
an experiment in rabbits, they investigated the influence of 110^m (S1) and 200 ^m (S3) wide 
and 70 ^m deep grooves positioned at a thread flank of oxidized titanium implants regarding 
implant stability and bone formation. The implants were placed in the femoral condyle and 
the tibial metaphysis. After a healing period of 6 weeks, the mean RTQ value for the S1 
implants were 30.4 Ncm for the tibia and 50.6 Ncm for the femur. The corresponding values 
for the S3 implants were 32.3 Ncm for the tibia and 59.2 Ncm for the femur.
Furthermore, tibial implants that were not subjected to RTQ tests were histomorphometrical 
analyzed. The corresponding bone-to-implant contact percentages were 20% for S1 and 19% 
for S3 implants. Moreover, Burgos et al. (2008) studied in a rabbit model early events of bone 
integration of titanium implants with oxidized (TiUnite) and turned surfaces. 
Histomorphometry was performed after 7, 14, and 28 days of healing. Bone contact 
percentages for TiUnite surfaces were about 20% ( 7 days), 23% ( 14 days), and 46% ( 28 
days). For the machined surface the values were about 15% ( 7 days), 11% ( 14 days), and 26% 
( 28 days). It was concluded that osseointegration of an implant with an oxidized surface 
follows a different path than osseointegration of turned implants. Bone formation occurred 
directly on the moderately rough oxidized surface, while turned titanium surfaces were 
integrated by the ingrowth of bone from the adjacent bone marrow and bone tissue 
To assess osseous healing of TiUnite surfaced implants, the research group of Zechner and 
Watzek (Zechner, et al. 2003) performed an experiment in miniature pigs. Immediately after 
surgical removal of all mandibular premolars, three implants with different surfaces 
(machined, hydroxylapatite (HA) coated, and the TiUnite surface) were inserted in each 
mandibular quadrant. The experimental animals were subdivided into three observation 
groups of four animals each. The first group was sacrificed after 3 weeks, the second after 6 
weeks, and the third after 12 weeks. Bone-to-implant contact values for machined implants 
were more than 50% below those seen for TiUnite surfaced implants at all time points 
evaluated. After 6 and 12 weeks this differences were found to be statistically significant. The 
authors concluded that (1) the bone-to-implant contact percentages seen at TiUnite surfaced 
implants suggests that this surface can provide anchorage in the compromised host bed 
comparable as obtained with HA coated implants, and (2) the results obtained after 12 weeks 
of unloaded healing may be of particular importance for implant prognosis in patients with 
compromised bone.
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Xiropaidis et al. (2005) compared in a dog model bone-to-implant contact at a relatively 
smooth, highly crystalline calcium phosphate coating with that at TiUnite surfaced implants. 
Twelve weeks after extraction of mandibular premolar and molar teeth, two calcium 
phosphate coated as well as two TiUnite surfaced implants were inserted. After eight weeks 
of implantation, mean bone-to-implant contact for calcium phosphate coated implants was 
57% and for TiUnite surfaced implants 71% mean bone-to-implant contact percentage. The 
difference was statistically significant. It was concluded that the TiUnite surface exhibits 
osteoconductive properties exceeding that of the calcium phosphate surface.
Another study was performed by Al-Nawas et al. (2008). They tested six different types of 
implant macro and micro structure to assess favorable conditions for osseointegration with 
respect to optimum bone-to-implant contact in a loaded dog model,. The different implant 
types were: Brânemark MK III machined (minimally rough control), Brânemark MK III and MK 
IV with TiUnite surface (moderately rough), ZL Duraplant Ticer anodically oxidized implants 
(moderately rough), SLA surfaced Straumann ITI implants (moderately rough), and TPS coated 
Straumann ITI implants (rough control). All implants, one of each type, were inserted into the 
mandible and maxilla at randomized positions in the premolar region, resulting in six implants 
in the mandible and six in the maxilla, adding up to a total number of 196 implants. After a 
healing period of 8 weeks, the implants were loaded for 3 months before the animals were 
sacrificed. The median bone-to-implant contact percentages were 55% for Brânemark MK III 
machined, 65% for Brânemark MK III with TiUnite surface, 60% for Brânemark MK IV with 
TiUnite surface, 57% ZL Duraplant Ticer anodically oxidized implants, 60% for SLA surfaced 
Straumann ITI implants, and 60% for TPS coated Straumann ITI implants. It is stated, that 
there was no statistically significant difference between the groups. However, the turned 
Brânemark MK III surface showed the widest statistical spread of values. They concluded that 
(1) the macrostructure of implants seems to play a minor role in the histological outcome, 
and (2) the different moderately rough surfaces induce only minor differences in bone 
response.
In a monkey model (Huang et al. 2005) local bone formation and osseointegration in type IV 
bone at TiUnite surfaced implants was evaluated. Therefore, three TiUnite surfaced implants 
were installed in the posterior maxilla of 8 monkeys (Macaca Fascicularis). Sixteen weeks after 
implantation, a mean bone-to-implant contact percentage of 74% was found. There was a 
significant variability in bone-to-implant contact, both between animals and between sites of 
the same animal. According to the authors, the study results suggest that the TiUnite surface 
possesses a considerable osteoconductive potential promoting a high level of implant 
osseointegration in type IV bone in the posterior maxilla.
D.3.3. Human data
Ivanoff et al. (2003) evaluated human bone response to two commercially available implant 
surfaces. Twenty patients received one screw-type turned and one TiUnite surfaced micro 
implant each. After a mean healing period of 6.6 months in the maxilla and 3.5 months in the 
mandible, the micro implants together with surrounding tissue were removed with a trephine
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bur. The mean bone-to-implant contact percentages for implants retrieved from the maxilla 
were 29% for TiUnite surfaced implants, and 11% for machined implants. For mandibular 
implants the corresponding values were 37% for TiUnite surfaced implants and 15% for 
machined implants. The differences were statistically significant.
Bone response to TiUnite surfaced implants subjected to immediate or early loading was 
studied by Rocci et al. (2003). Five patients participated in this study; each had consulted for 
implant treatment in the posterior mandible and subsequently volunteered to have extra 
implants inserted for the purpose of histologic research. Nine TiUnite surfaced titanium 
implants were placed, predominantly in quality type III and IV bone, and retrieved after 5 to 9 
months in function. Two implants had been loaded the same day, whereas seven implants 
were loaded after 2 months of healing. Eight of the implants were able to be used for 
histology. The morphometric measurements showed a mean bone-to-implant contact of 84 % 
for all implants, 93 % for the two immediate loaded implants, and 81 % for the six evaluated 
implants loaded after 2 months. There were no apparent differences in any respect between 
straight or tapered implants, nor were there any differences seen for immediately (n=2) and 
early (n=6) loaded implants. Therefore, it was concluded that implant healing can occur 
around TiUnite surfaced implants placed in the posterior mandible and subjected to loading 
immediately following surgery or after 2 months of healing.
Romanos et al. (2005) reported a case of a 60 year old male patient. The patient, a heavy 
smoker (= 60 cigarettes per day), received 11 TiUnite surfaced implants in his completely 
edentulous maxilla. The implants were loaded immediately. The most distal implant located in 
the left tuberosity was, due to psychological reasons, retrieved with a trephine after 6 months 
of loading. This implant showed 60% bone-to-implant contact.
In summary, one animal experiment (Sul et al. 2006), done in a low bone quantity model, 
indicated higher implant stability of TiUnite surfaced implants after 6 weeks of healing when 
compared to Osseotite surfaced implants. Additionally, histomorphometric evaluation in two 
different animal models (Al-Nawas et al. 2008, Burgos et al. 2008) suggested that the TiUnite 
surface possessed osteoconductive potential above that of machined surfaces. This 
suggestion was confirmed in a study in humans (Ivanoff et al. 2003). Moreover, the 
compatibility of the TiUnite surface with an early loading protocol as shown in one animal 
experiment (Al-Nawas et al. 2008) was additionally confirmed for immediate as well as early 
loading in a human study (Rocci et al. 2003).
D.4. Nanotite (3i)
D.4.1. Surface
Next to the OsseoSpeed surface with nanoscale topography, the Nanotite surface ( 3i Implant 
Innovations, Palm Beach Gardens, USA) with a calcium phosphate nano particle modification 
of a minimally rough titanium alloy implant surface, is currently available for clinical use. The 
surface has been described as being created by a particulate sol-gel deposition method using 
discrete crystalline deposition (DCD) of calcium phosphate (CaP) (nominal crystal size 20 -  100
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nm) (Mendes, et al. 2009)) with a surface coverage of approximately 50% (Gubbi and Towse
2007, Mendes et al. 2009). The suggested nano feature size of the tightly adherent adsorbed 
CaP/DCD crystal is 20-100 nm (Mendes et al. 2009).
D.4.2. Animal experiments
In a rat model (femur), Mendes and colleagues (Mendes, et al. 2007) compared the 
mechanical interface behavior of discrete crystalline deposition (DCD) modified dual acid- 
etched (DAE) commercially pure titanium or titanium alloy implants with non-modified 
surfaces. Nine days after implantation the tensile test showed a significantly higher mean 
tensile force value in comparison to the non-DCD groups. They concluded that the treatment 
of titanium and titanium alloy implant surfaces with discrete crystalline deposits renders 
them bone-bonding. In addition, they hypothesized that the increase in complexity of the 
resultant surface is the driving force for the bonding mechanism, rather than the calcium 
phosphate chemistry.
In the same animal model (rat, femur), the same group (Mendes et al. 2009) implanted 
miniature bone ingrowths chambers fabricated from commercially pure titanium (c.p. Ti) or 
titanium alloy (Ti6Ai4V), either with a modified dual acid-etched (DAE) or a discrete crystalline 
deposition (DCD) modified dual acid-etched(DAE) surface. After 9 days of implantation, the 
amount of bone-to-implant contact was for the DCD groups statistically significant higher 
than for the non DCD groups. No statistical significant difference existed between titanium- 
DCD and titanium alloy-DCD or titanium-DAE and titanium alloy-DAE . The titanium alloy-DCD 
presented with the highest mean bone-to-implant contact and titanium-DAE with the lowest. 
The authors concluded that the deposition of discrete calcium phosphate nanocrystals on 
micro topographically complex titanium surfaces significantly enhanced osteoconduction.
D.4.3. Human data
Human histomorphometric data from prospective, randomized, controlled, double-blind 
studies are very limited. Orsini et al. (Orsini et al. 2007) enrolled 15 patients (mean age: 56.9 
years) with partial or full edentulism, who had elected to receive dental implants to restore 
their dentition in a study. One custom made 2x10 mm implant with a discrete crystalline 
deposition (DCD) modified dual acid-etched(DAE) surface an one implant with only a DAE 
surface were placed in the posterior maxilla of the 15 patients. After a mean healing time of 
8±1 weeks, implants and surrounding hard and soft tissue were retrieved by trephine. The 
mean bone-to-implant contact for the DCD-DAE surfaces was 32% and for the DAE surfaces 
19%. This difference was statistically significant. The authors concluded that the DCD 
treatment increased the osteoconduction of the implant surface during the first two months 
after implant placement. Further, they suggested that DCD surface modification can lead to a 
shorter healing period after implant placement, providing earlier fixation as well as 
minimizing micromotion, thus allowing earlier loading protocols and restoration of function 
for implants placed in areas with low-density bone.
37
The results of Goené et al. (Goené et al. 2007) point in the same direction. In a prospective, 
randomized, controlled trial in humans; nine pairs of implants , with either DCD modified DAE 
surfaces or the DAE surfaces, were placed in the posterior area of maxillae. Three pairs were 
retrieved by trephine with surrounding soft and hard tissue after 4 weeks of healing, five after 
8 weeks, and one pair after 12 weeks. After 4 weeks, no significant difference between DCD- 
DAE and DAE implants was reported. After 8 to 12 weeks the mean bone-to-implant contact 
percentages were 45% for DCD and 18% for DAE. It was concluded that DCD modification 
appeared to have a significant effect on the development of new bone after implant 
placement. As Orsini et al. (2007), Goené and colleagues suggest that this may have 
significant clinical importance for areas with low bone quantity.
In summary, two animal (Mendes et al. 2007, 2009) as well as two human experiments 
(Goené et al. 2007, Orsini et al. 2007) indicated increased implant stability and bone-to- 
implant contact for the discrete crystalline deposition (DCD) modified dual acid-etched (DAE) 
surface compared with the DAE surface. The published data indicate, but do not finally proof 
an advantage of the nano roughness of the Nanotite surface during early phases of 
osseointegration in areas with low bone quantity.
D.5. Friadent plus (DENTSPLY Friadent)
D.5.1. Surface
The Friadent plus implant surface (DENTSPLY Friadent, Mannheim, Germany) is manufactured 
by large grit blasting (354-500 ^m) and acid etching in hydrochloric acid/sulfuric 
acid/hydrofluoric acid/oxalic acid and finally neutralized with a proprietary process of 
DENTSPLY Friadent (Rupp et al. 2004). This chemical process leads to commercially available 
implants with a regular micro roughness with pores in the micrometer dimension overlying a 
macro-roughness structure caused by the grit blasting (Papalexiou et al. 2004). The micro 
pores are irregularly rounded, steep sized, with flat or sharp edges, approximately 3-5 ^m in 
diameter and 2-3 ^m in depth. Within these micro pores even smaller micro pores of less 
than 0.5-1 ^m diameter are located (Sammons et al. 2005). The Ra value for the commercially 
available Friadent plus surface is 2.75 ^m (SD: 0.46 ^m) (Sammons et al. 2005). The surface 
roughness is associated with increased wettability. Rupp et al. (Rupp et al. 2004) showed that 
the Friadent plus surface is initially hydrophobic as indicated by a mean dynamic contact 
angle (DCA) of 140°, but on second contact with water, this changes to an extremely 
hydrophilic behavior (DCA = 0°).
D.5.2. Animal experiments
Novaes (Novaes Jr et al. 2004) analyzed the influence of implant microstructure on the bone 
response of immediate implants placed into infected sites. In mongrel dogs periodontitis was 
established around the first to fourth mandibular premolars. These premolars were surgically 
removed and three Frialit-2 stepped cylinder implants were placed immediately. The animals
were sacrificed 12 weeks after implant placement. The mean bone-to-implant contact
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percentage for grit blasted/acid etched surfaces was 53% and for titanium plasma sprayed 
(TPS) surface 43%. The difference between the means was not statistically significant. The 
data for the grit blasted/acid etched implant surfaces showed that eleven implants had 50% 
to 90% bone-to-implant contact and that no implant had less than 20%, while in for TPS 
surfaced implants only seven implants showed 50% to 90% bone-to-implant contact and two 
implants had less than 20%. Therefore, the authors suggested that grit blasted/acid etched 
surfaced implants had a slightly better performance compared to TPS surfaced implants. This 
slight difference in performance is supported by another experiment of the same group 
(Papalexiou et al. 2004). As in the previous study, periodontal disease was induced during 12 
weeks bilateral in the premolar area of mongrel dogs. The teeth were extracted and 
immediate implants were placed. Each dog received six implants: three with a grit 
blasted/acid etched and three with a TPS surface. During the healing period, fluorescent bone 
markers were injected at different time points in order to study bone regeneration around 
the implants. The animals were sacrificed 12 weeks after implant placement. Between 3 days 
and 8 weeks, covariance analysis showed that the increase in percentage of newly formed 
bone was statistically significant greater for grit blasted/acid etched surfaces compared to TPS 
surfaces. However, there was no statistically significant difference between both groups of 
surfaces.
D.5.3. Human data
Recently, Iezzi and colleagues (Iezzi et al. 2005) presented bone-to-implant contact 
percentages of submerged implants inserted in posterior areas of human jaws and retrieved 
for different causes after healing periods varying from 6 weeks to 12 months. One Friadent 
plus surfaced Xive implant inserted in type D3 to D4 bone was retrieved after 6 weeks from 
the posterior mandible. The bone-to-implant contact percentage was 96%. Another Friadent 
plus surfaced Xive implant inserted in type D3 to D4 bone was retrieved after 7 weeks from 
the posterior mandible. The bone-to-implant contact percentage was 55%. The same type of 
implant inserted in preexisting type D4 bone was retrieved after 8 weeks from the posterior 
maxilla and showed 68% bone-to-implant contact. Furthermore, Xive DPS surfaced implants 
were retrieved. The Friadent DPS (deep profile surface) is large grit blasted and acid etched 
(hydrochloric acid/hydrofluoric acid/nitric acid) with a mean Ra value of 2.94 ^m (SD: 0.18 
^m) (Rupp et al. 2004). The major difference between the Friadent plus and DPS surface is 
micro porosity. Micro porosity is characteristic for the Friadent plus surface and not found on 
DPS surfaces (Rupp et al. 2004). One Friadent DPS surfaced Xive implant inserted in type D3 to 
D4 bone was retrieved after 6 months from the posterior mandible. The bone-to-implant 
contact percentage was 51%. Another one was retrieved after 12 months from the posterior 
maxilla. The bone-to-implant contact percentage was 30%. These differences regarding bone- 
to-implant contact might indicate an advantage of the micro rough Friadent plus surface, but 
as these are only case reports a definite conclusion cannot be made.
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The same group (Degidi et al. 2005) reported 71% bone-to-implant contact for a Friadent plus 
surfaced Xive implant. This implant was inserted in mandibular D4 bone and retrieved after 2 
months of immediate, nonfunctional loading due to psychological reasons.
In summary, in two animal studies no additional effect of surface micro roughness regarding 
bone-to-implant contact (Novaes Jr et al. 2004) or amount of bone (Papalexiou et al. 2004) 
could be observed. Furthermore, the favorable bone-to-implant contact percentages for the 
micro rough Friadent plus surfaced implants in the publications of Iezzi et al. (2005) and 
Degidi et al. (2005) have to be seen in the light of a case report by Romanos and co-workers 
(Romanos et al. 2005).
E. Experimental surface alterations
Main objectives for engineering new dental implant surfaces are to improve the clinical 
performance in areas with low bone quantity or quality, to predict the clinical outcome of 
immediate or early loading protocols, and to stimulate vertical and horizontal bone growth in 
order to permit implant placement in sites that lack sufficient height and width of the residual 
alveolar ridge. Efforts have focused on the development of new surface technologies and 
surface characteristics. Because of the multitude of new surface technologies, resulting in an 
infinite number of distinct implant surface modifications, the authors of the current review 
decided to exemplary discuss animal data regarding mechanical testing and/or bone-to- 
implant contact for selected techniques and/or surface modifications. All publications 
fulfilling the inclusion criteria of this review are listed in Table 2. Only, the manuscripts that 
are indeed exemplary for the investigated surface alteration are discussed. For example, in 
some of the studies various experimental surface parameters are mixed and/or investigated 
in the same study, which excludes a proper conclusion about the effect of a specific surface 
alteration.
E.1. "New techniques" to deposit calcium phosphate coatings onto titanium implant 
surfaces
Calcium phosphate (CaP) ceramics are known for their bioactive properties. Generally, 
bioactive materials interact with surrounding bone, resulting in the formation of a chemical 
bond to this tissue ("bone-bonding"). This phenomenon of bioactivity is determined mainly by 
chemical factors - such as the crystal phase and molecular structure of the material - as well 
as physical factors, such as surface roughness and porosity. From a commercial point of view, 
the most successful method to apply CaP coatings to titanium implants has been the plasma 
spraying technique. Although the osteoconductive and bone-bonding behavior of plasma- 
sprayed coatings is confirmed by numerous studies, serious concerns related to plasma 
spraying -like poor control of chemical and physical coating parameters- are still not solved. 
Therefore, researchers have been investigating alternative or complementary techniques to 
deposit CaP coatings onto titanium implant surfaces.(De Jonge et al. 2008)
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Because of the huge number of new CaP coating techniques, we decided to discuss only 
animal data regarding mechanical testing and/or bone-to-implant contact for pulsed laser 
deposition (PLD), sputter coating, ion beam assisted deposition (IBAD), electrostatic spray 
deposition (ESD), and biomimetic deposition.
E.1.1. Pulsed laser deposition (PLD)
E.1.1.1. Technique
Pulsed laser deposition (PLD) is a physical vapor deposition technique and was widely used 
during the last decade to deposit thin films of materials of technological interest. In principle, 
PLD technology is based on the irradiation of a solid target by a focalized pulsed laser beam 
resulting in a gaseous cloud. This cloud, a plasma composed of electrons, atoms, ions, 
molecules, clusters and, in some cases, droplets and target fragments, expands, either in 
vacuum or in a gaseous environment, and deposits on a substrate giving rise to a film. The 
particles have a high kinetic energy allowing them to interact effectively with a reactive gas, if 
present within the deposition chamber. They also have great mobility on the deposition 
substrate, avoiding the necessity for high substrate temperature. In the interaction between 
the target and the laser beam many different thermal and electronic mechanisms are 
involved, but in general the composition of the gaseous phase is often very different from 
that found in thermal equilibrium vaporization allowing the deposition of materials with a 
complex stoichiometry (Brama et al. 2007).
E.1.1.2. Experiments with PLD calcium phosphate coatings
Although, in vitro experiments indicated that PLD might be a suitable technique to coat 
titanium implants with thin calcium phosphate films (Cléries et al. 2000a, b; Arias et al. 2003, 
Kim et al. 2005, Hashimoto et al. 2008), only a very limited number of peer-reviewed 
publications is available dealing with in vivo studies. However, the available studies indicate 
that PLD CaP coated implants resulted in a favorable bone response compared with non­
coated implants (Dostalova et al. 2001, Peraire et al. 2006).
E.1.2. Sputter coating
E.1.2.1. Technique
Sputtering is a process whereby atoms or molecules of a material are ejected in a vacuum 
chamber by bombardment of high energy ions. The thereby dislodged particles deposit on a 
substrate placed within the vacuum chamber. Several sputter techniques are described, 
whereby radiofrequency (RF) magnetron sputtering is largely used to deposit thin films of 
calcium phosphate coatings on titanium (experimental) implants.
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E.1.2.2. Animal experiments
The experiments of Vercaigne et al. (2000a, b), Mohammadi et al. (2003, 2004) and Xiropaidis 
et al. (2005) provide a good example of the effect of calcium phosphate sputter coated 
titanium implants.
Vercaigne et al. (2000b) installed titanium oxide (TiO2) grit blasted implants provided with RF 
magnetron sputtered, amorphous/crystalline calcium phosphate coatings of different 
thickness (0.1 ^m [CaP 0.1], 1 ^m [CaP 1], 4^m [CaP 4]; Ra: 1.3 ^m- 2.1 ^m) in the trabecular 
bone of the femoral condyle of goats and compared mechanical anchorage as well as bone- 
implant response . After 6 and 12 weeks of healing, no statistical difference for fracture load 
was observed between the various implant surfaces. Further, at 6 weeks, bone-to-implant 
contact percentages were 51% for uncoated surfaces, 63% for CaP 0.1, 78% for CaP 1, and 
65% for CaP 4. After 12 weeks, the corresponding values were 49% for uncoated surfaces, 
53% for CaP 0.1, 76% for CaP 1, and 83% for CaP 4. Compared with the uncoated, grit 
blasted surface, the mean bone-to-implant contact percentages for CaP 1 and CaP 4 were 
statistically higher after 6 as well as after 12 weeks.
A similar improving effect of crystalline sputtered HA coatings on the implant-to-bone 
response was observed by Mohammadi et al. in rabbit studies (2003, 2004).
These beneficial results are in contrast to Xiropaidis et al. (2005), who compared in a 
mandibular dog model bone-to-implant contact at relatively smooth, highly crystalline, RF 
magnetron sputtered calcium phosphate coated surfaces with that at TiUnite surfaced 
implants. After eight weeks of healing, mean bone-to-implant contact percentages were 57% 
for calcium phosphate coated implants and 71% for the TiUnite surface. The difference was 
statistically significant.
E.1.3. Ion beam assisted deposition (IBAD)
E.1.3.1. Technique
Ion beam assisted deposition (IBAD) is, beside RF magnetron sputtering and pulsed laser 
deposition, a third vacuum deposition technique to deposit thin ceramic coatings on metals 
(Lacefield 1998). Typically, IBDA involves one or two ion beam sources that impinge a 
bioceramic target to produce an elemental cloud towards the surface of a substrate. This 
condition results in calcium phosphate coatings normally ranging from a few angstroms to 
several micrometers thick (Coelho and Lemons 2009).
E.1.3.2. Animal experiments
The data as published by Jung, Park, and Coelho (Jung et al. 2001, Park Y et al. 2005, Coelho 
and Lemons 2009, Coelho PC et al. 2009 b) are very appropriate to demonstrate the state of 
engineering as regards in vivo testing of thin IBAD calcium phosphate coated titanium implant 
surfaces.
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In a rabbit tibia model, Park et al. (2005) compared mechanical anchorage as well as bone-to- 
implant contact of aluminum oxide grit blasted c.p. titanium implants (group 1; Ra: 5.8 ^m) 
with IBAD calcium phosphate coated implants (group 2; coating thickness: 1 ^m; Ra: 5.7 ^m). 
After 6 weeks of healing, mean removal torque was 38 Ncm for group 1 and 44 Ncm for 
group 2, mean bone-to-implant contact percentages were 59 % for group 1 and 69 % for 
group 2. Mean removal torque and mean bone-to-implant contact percentages were 
statistically higher for the IBAD group.
In the same model, Jung et al. (2001) compared mechanical anchorage as well as bone-to- 
implant contact of aluminum oxide grit blasted titanium implants (blasted surfaces; Ra: 5.8 
^m) with machined (machined surfaces; Ra: 1.13 ^m) and with machined and additionally 
IBAD calcium phosphate coated implants (IBAD surfaces; coating thickness: 1 ^m; Ra: 1.04 
^m). After 12 weeks of healing, no significant differences in removal torque and bone-to- 
implant contact were observed.
Also Coelho et al. (2009 b) compared in a dog tibia model the mechanical stability as well as 
bone-to-implant contact of alumina blasted/ acid etched titanium alloy implants (blasted/acid 
etched surfaces; Ra: 0.66 ^m with IBAD calcium phosphate coated implants (IBAD surfaces; 
coating thickness: 20-50 nm; Ra: 0.54 ^m). They did not observe significant differences in 
bone behavior between the various implant surfaces after 4 weeks of implantation. On the 
other hand, they demonstrated that after a healing period of 5 weeks (Coelho and Lemons 
2009) that IBAD calcium phosphate coatings with a thickness of 300 to 500 nm presented 
significantly higher torque to fracture values compared with 30-50 nm IBAD calcium 
phosphate coated as well as with uncoated implants.
E.1.4. Electrostatic spray deposition (ESD)
E.1.4.1. Technique
The basic principle of ESD as a technique for applying calcium phosphate coatings onto 
titanium implant surfaces is the generation of an aerosol out of organic solvents containing 
calcium and phosphate ions. Under the influence of a high voltage the aerosol is directed 
towards a heated substrate. Evaporation of the solvent results in the intended calcium 
phosphate coating on the substrate. Major advantages of this technique include the control 
over the chemical composition and over the morphological properties of the calcium 
phosphate coating (Leeuwenburgh et al. 2003).
E.1.4.2. Animal experiments
The experimental results of Manders et al. and Siebers et al. (Manders et al. 2006, Siebers et 
al. 2007) are suitable to describe the state of engineering as regards in vivo testing of ESD 
calcium phosphate coated titanium implant surfaces.
In the trabecular bone of the femoral condyle of goats, Manders et al. (2006) compared the 
bone-to-implant for aluminum oxide grit blasted titanium implants (Ti; Ra: 1-1.5 ^m)
deposited with a plasma sprayed hydroxyapatite coating (HAPS; coating thickness: 50-60 ^m)
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and an ESD calcium phosphate coating (ESD; coating thickness: 1.5-2 ^m). In addition, the 
implants were manufactured in such a way that a 1 or 2 mm gap existed between the implant 
surface and surrounding bone. For 1 mm as well as for 2mm gaps, mean bone-to-implant 
contact percentages were statistically significant higher for ESD compared with Ti, but 
statistically significant lower for ESD compared with HAPS after 12 weeks of healing.
In a similar goat model, Siebers et al. (2007) compared bone-to-implant contact on titanium 
plasma spray coated titanium implants (Ti; TPS coating thickness: 50 ^m; Ra: 5.5 ^m) with 
three different, ESD calcium phosphate coated implants (ESD1: heat treatment 400°C, 
amorphous CaP; CaP coating thickness:2 ^m; Ra: 5.7 ^m; ESD2: heat treatment 500°C, 
crystalline carbonate apatite; CaP coating thickness:2 ^m; Ra: 5.7 ^m; ESD3: heat treatment 
700°C, crystalline carbonated hydroxylapatite; CaP coating thickness:2 ^m; Ra: 5.7 ^m). After 
12 weeks of healing, mean bone-to-implant contact percentages were 48% for Ti, 66% for 
ESD1, 55% for ESD2, and 71% for ESD3. The difference between Ti and ESD3 was statistically 
significant. Therefore, the authors concluded that crystalline carbonated hydroxylapatite ESD 
coated implants positively influenced the biological performance compared with titanium 
plasma sprayed titanium implants (Ra: 5.5 ^m).
E.1.5. Biomimetic deposition
E.1.5.1. Technique
Biomimetic deposition is a method whereby a biologically active bone-like apatite layer is 
formed on a substrate surface by immersion of the substrate in simulated body fluid (SBF) 
under physiological conditions of temperature (37°C) and pH (7.4) (Kokubo et al. 1990, Liu et 
al. 2001, Kokubo and Takadama 2006). Main benefits of this deposition technique are the 
possibility to include drugs and growth factors into the CaP coating, while complex implant 
geometries can be coated using this soaking procedure. Accelerated biomimetic strategies 
have been developed by employing metastable SBF-solutions with a fivefold higher 
concentration of SBF after supersaturation with carbon dioxide gas (Barrere et al. 1999) or 
dissolution of sodium hydrogen carbonate salts (Li P 2003). In both cases, gradual release of 
CO2 gas is accompanied by release of hydroxyl anions according to the reaction HCO3" ^  OH" 
+ CO2, thereby increasing the solution pH and triggering the accelerated deposition of 
biomimetic apatite crystals onto the substrate surface.
E.1.5.2. Animal experiments
The results published by Zagury et al. (2007) and by Liu et al. (2007b) were chosen to show 
the state of engineering with regard to in vivo testing of biomimetic calcium phosphate 
coated titanium implant surfaces.
In the maxilla of miniature pigs, Liu et al. (2007b) compared bone-to-implant contact on sand­
blasted, acid etched titanium implant surfaces (Ti) with biomimetic calcium phosphate coated 
implant surfaces (biomimetic CaP: coating thickness: 54.7 ^m [SD:8.73 ^m]). Animals were
sacrificed after 1, 2, and 3 weeks of healing. Mean bone-to-implant contact percentages were
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for Ti 5% after 1 week, 31% after 2 weeks, and 39% after 3 weeks. The corresponding values 
for biomimetic CaP coated implants were 16% after 1 week, 49% after 2 weeks, and 76% after 
3 weeks. The differences between Ti and biomimetic CaP were not statistically significant. 
Zagury et al. (2007) compared in a tibia rabbit model bone-to -implant contact on titanium 
alloy implant surfaces (Ti alloy) with biomimetic calcium phosphate coated surfaces 
(biomimetic CaP). Animals were sacrificed after three months of healing. Mean bone-to- 
implant contact percentages were 63% for Ti alloy and 67% for biomimetic CaP coated 
implants. The differences between Ti alloy and biomimetic CaP were not statistically 
significant.
E.2. Biomolecules coated onto titanium implant surface
E.2.1. Extracellular matrix peptide sequences or proteins coated onto titanium implant 
surfaces
The fundamental role of the extracellular matrix (ECM) for osteoblast function is the starting 
point to functionalize titanium implant surfaces with native or synthetic molecules based on 
peptides, proteins , and growths factors found therein (Bernhardt et al. 2005, De Jonge et al. 
2008). Cell to ECM contact is mediated by cell adhesion receptors, e.g. integrins. Integrins 
bind to specific amino acid sequences , in particular to the arginin-glycin-aspartic (RGD) 
sequence found not only in type I collagen, but also in fibronectin, vitronectin, osteopontin, 
and bone sialoprotein. Additionally to cell attachment, ECM plays an active role in regulating 
cellular processes influencing migration, proliferation, morphological change, gene expression 
and cell survival by intracellular signaling (De Jonge et al. 2008). Furthermore, as ECM is highly 
diverse for different tissues or stages of development, other components may be of interest 
due to their function in specific situations. Such a situation is fracture healing, where initially 
type III collagen is expressed, forming a scaffold for the migration of osteoprogenitor cells as 
well as capillary ingrowth and is only later replaced by type I collagen (Bernhardt et al. 2005). 
Additionally, ECM proteogylcans and their glycosaminoglycans, like chondroitin sulfate, are 
able to bind cytokines and growth factors (Rammelt et al. 2007).
Therefore, the biological acceptance and function of titanium implants might be improved by 
modifying their surfaces with ECM components, e.g. the RGD peptide sequence, type I 
collagen, type III collagen, or chondroitin sulfate.
In addition, as bone is composed of an organic matrix (90% collagenous proteins), 
strengthened by an inorganic calcium phosphate phase (carbonated hydroxyapatite), 
research has focused on the development of bio-inspired composite coatings that resemble 
the unique nano-composite structure bone tissue, thereby offering an added value over 
coatings consisting of merely organic or inorganic components. Composite coatings made of 
both collagen and calcium phosphate have therefore generated a great deal of interest for 
implant surface modification (De Jonge et al. 2008).
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Again it should be mentioned that because of the multitude of studies, it was decided to 
discuss only some representative animal data regarding mechanical testing and/or bone-to- 
implant contact.
E.2.1.1. Amino acid sequence arginine-glycine-aspartic (RGD) - Animal experiments
To illustrate the in vivo osteoconductive potential of the RGD peptide sequence as coating for 
titanium implants, the publications of Bernhardt, Schliephake and Rammelt (Bernhardt et al. 
2005, Schliephake et al. 2005b, Rammelt et al. 2006) were selected.
In a goat femur wound chamber model, Bernhardt et al. (2005) compared bone-to-implant 
contact on uncoated titanium implant surfaces with RGD peptide coated surfaces. After 5 and 
12 weeks of healing, no significant effect of RGD coating on mean bone-to-implant contact 
percentages were observed.
These results contradict the findings of Schliephake et al.( 2005b) and Rammelt et al.( 2006).
In an intramedullary model in the tibia of rats, Rammelt et al. (2006) compared bone-to- 
implant contact on uncoated titanium implant surfaces (Ti) with additionally RGD peptide 
coated surfaces (Ti/RGD). After 28 days of healing the mean bone-to-implant contact 
percentage for Ti/RGD was 84 % and for Ti 4 %. Mean bone-to-implant contact percentage 
was statistically higher for Ti/RGD. Schliephake et al. (2005b) compared in the mandible of 
dogs machined titanium implant surfaces (Ti) with RGD coated implant surfaces. RGD coatings 
were achieved either with low RGD concentrations (100 ^mol/ml) ["RGD low"] or with high 
RGD concentrations (1000 ^mol/ml) ["RGD high"]. After one month of healing, bone-to- 
implant contact was significantly higher for "RGD high" compared to Ti. After three months of 
healing, bone-to-implant contact was significantly higher for "RGD high" and for "RGD low" 
compared to Ti.
E.2.1.2. Collagen and collagen mimetic peptides - Animal experiments
The in vivo osteoconductive potential of type I collagen, type III collagen , and collagen 
mimetic peptide sequences as coating for titanium implants was investigated in the 
publications of Reyes, Bernhardt, Schliephake, and Rammelt (Bernhardt et al. 2005, 
Schliephake et al. 2005a, b, Rammelt et al. 2004, 2006, 2007, Reyes et al. 2007).
In the proximal tibial metaphysis of rats, Reyes et al. (2007) compared the mechanical 
anchorage as well as bone-to-implant contact of machined c.p. titanium implant surfaces (Ti) 
with either bovine type I collagen (Col I) or glycine-phenylalanine-hydroxyproline-glycine- 
glutamate-arginine (GFOGER; a collagen mimetic peptide sequence) coated implant surfaces. 
After 4 weeks of healing, mean pull-out forces were around 35N for GFOGER, 20N for Col I, 
and 35 N for Ti. GFOGER was statistically higher compared to Col I or Ti, but the values for Col 
I were not statistically higher compared to Ti. Mean bone-to-implant contact percentages 
were 75 % for GFOGER, 58% for Col I, and 43 % for Ti. GFOGER was statistically higher 
compared to Col I or Ti and Col I was statistically higher compared to Ti. The authors
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concluded that both coatings (GFOGER and Col I) enhanced bone repair and implant 
integration.
In line with these results are the published data of Rammelt et al. as well as Schliephake et al. 
(Schliephake et al. 2005a, b, Rammelt, et al. 2007). In the sheep tibia model, Rammelt et al. 
found after 6 weeks of healing no significant difference in extraction torque between titanium 
and type I collagen coated surfaces. In both dog studies of Schliephake, bone-to-implant 
contact to machined titanium implants (Ti) was compared with type I collagen (Col I) coated 
implants in the mandible of dogs. After three months of healing, in both experiments bone- 
to-implant contact was significantly higher for Col I compared to Ti.
These significant differences are contradicted by Bernhardt et al. and Rammelt et al. 
(Rammelt et al. 2004, 2006, Bernhardt et al. 2005). In their rat and goat studies, no significant 
effect of collagen type I and type II coating in implant-bone response was observed.
E.2.1.3. Collagen combined with chondroitin sulfate - Animal experiments
The in vivo osteoconductive potential of type I collagen combined with chondroitin sulfate as 
coating for titanium implants has been described in the publications of Rammelt (Rammelt et 
al. 2006, 2007).
In the sheep tibia model, Rammelt et al. (2007) found after 6 weeks of healing no significant 
differences in extraction torque between titanium, type I collagen, and type I collagen/ 
chondroitin sulfate coated surfaces However, despite this non significant difference in 
mechanical anchorage, they (Rammelt et al. 2006) found in the tibia of rats after 28 days of 
healing significantly more bone-to-implant contact for titanium surfaces coated with type I 
collagen and chondroitin sulfate (84 %) compared to uncoated titanium implant surfaces (64 
%). Such a difference was not seen between titanium surfaces coated with type I collagen 
and uncoated titanium implant surfaces
E.2.1.4. Collagen composite coating with calcium phosphate - Animal experiments
In the mandible of dogs, Schliephake et al. (2003) compared bone-to-implant contact 
between titanium alloy implants with a polished surface (Ti), collagen coated (Col), 
mineralized (hydroxylapatite) collagen coated (Col/HA), sequentially hydroxylapatite-collagen 
coated (Col/seq HA), and hydroxylapatite coated titanium surfaces (HA). Animals were 
sacrificed after one and three months of healing. No significant differences in mean bone-to- 
implant contact between the various implant surfaces were observed in cortical as well as 
cancellous bone after one and three months of implantation.
E.2.2. Growth factor coatings
Growth factors are signaling proteins, which promote replication, differentiation, protein 
synthesis and/or migration of appropriate cell types. In case of endosseous titanium implants, 
an enhanced proliferation and differentiation of undifferentiated mesenchymal cells, 
osteoprogenitor cells , and preosteoblasts into osteoblasts may enhance bone healing
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(Chappard et al. 1999). Therefore, the rational to coat titanium implants with locally acting 
growth factors is the assumption that the release of these growth factors might improve the 
remodeling process at the bone-implant interface leading to enhanced bone response (De 
Jonge et al. 2008).
E.2.2.1. BMPs
A particular class of growth factors, bone morphogenetic proteins (BMPs) has shown 
considerable potential to stimulate bone formation both in extraskeletal sites (Yamazaki et al.
1996, Yoshida et al. 1998) and in defect models in different species (Zellin and Linde 1997, 
Teixeira and Urist 1998). BMPs originate from the transforming growth factor-ß family and 
include at least 18 different proteins (Reddi 1995). As BMP-2 possesses high osteoinductive 
potential (Laub et al. 2001), it was supposed to be an interesting candidate growth factor to 
coat titanium implants. While BMP-2 is more commonly used, also BMP-4 is considered as 
candidate growth factor that might improve the remodeling process at the bone-implant 
interface (Stadlinger et al. 2008).
Besides promoting bone formation, BMPs stimulate recruitment, proliferation and 
differentiation of osteoclasts as well (Chen et al. 2004). Hence, they may promote the 
resorption of newly formed bone almost as soon as it has been laid down (Liu et al. 2007a) 
onto a titanium implant surface. Consequently, it should be kept in mind that the net volume 
of bone deposited may be lower in the presence than in the absence of BMPs. Additionally, 
the applied dose of the drug is critical, since an overdosage can trigger the production of 
intrinsic BMP-inhibitors, such as noggin (Rosen 2006). Therefore, it might be possible that 
BMPs, in contrast to the desired enhancement of bone regeneration at the bone-implant 
interface may possibly impair the osteoconductivity of the implant surface (Liu et al. 2007b).
E.2.2.1.1. Animal experiments
In the critical-size, supra-alveolar, peri-implant defect dog model, Wikesjö et al. (2008a) 
examined the ability of recombinant human BMP-2 (rhBMP-2) coated onto a titanium porous 
oxide implant surface to stimulate local bone formation including osseointegration and 
vertical augmentation of the alveolar ridge. Animals received either implants coated with 0.75 
mg/ml, 1.5 mg/ml , or 3 mg/ml rhBMP-2, or uncoated control implants. After 8 weeks of 
healing, a significantly higher mean vertical bone regeneration was observed for rhBMP-2 
coated surfaces. On the other hand, the mean bone-to-implant contact was statistically 
significant higher for uncoated surfaces. It was also noticed that the regenerated bone 
appeared immature and without cortex formation compared with that observed for implants 
coated with lower rhBMP-2 doses. In addition, exhibited expansive seroma formation was 
observed, which extended into the resident bone and displaced the implants. This advanced 
seroma formation prevented even meaningful histological preparation in two animals. 
Furthermore, all implants coated with rhBMP-2 at 3.0 mg/ml exhibited extensive peri-implant
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bone remodeling extending up or beyond 300 ^m from the implant surface including 
remodeling of the buccal crestal plate.
Therefore, the authors concluded that rhBMP-2 coated onto titanium porous surfaces 
induced clinically relevant local bone formation including vertical augmentation of the 
alveolar ridge and osseointegration and that higher concentrations of rhBMP-2 were 
associated with problematic effects.
These results of Wikesjö et al. regarding vertical bone augmentation are confirmed by Freilich 
et al. (2008). They compared in a murine calvaria model vertical bone growth around titanium 
ring implants. Four groups were evaluated: uncoated titanium surfaces (Ti), titanium surfaces 
coated with 20 ^g non-glycosylated rhBMP-2 (Ti-ng/rhBMP-2), titanium surfaces coated with 
hydroxylapatite (HA), and HA surfaces additionally coated with 20 ^g non-glycosylated 
rhBMP-2 (HA-ng/rhBMP-2). After 21 days of healing, a negligible formation of new 
supracalvarial bone was found around Ti and HA. Statistically significant more bone was found 
around Ti-ng/rhBMP-2 and HA-ng/rhBMP-2. Additionally, the application of ng/rhBMP-2 
significantly increased the percentage of bone-to-implant contact on both the inferior, 
calvarial side of the implant and the superior aspect of both the Ti and HA-coated ring 
implants.
Besides vertical bone augmentation/regeneration in the above cited critical-size, supra­
alveolar defect model, Wikesjö et al. (2008b) studied in an orthotopic, mandibular dog model, 
whether rhBMP-2 adsorbed onto a titanium porous oxide (TPO) implant surface might 
enhance or accelerate local bone formation and support osseointegration in type II bone. 
Three groups were evaluated: uncoated titanium porous oxide surfaces (TPO), TPO absorbed 
with 0.2 mg/ml rhBMP-2 (TPO/rhBMP-2/0.2), TPO absorbed with 4.0 mg/ml rhBMP-2 
(TPO/rhBMP-2/4.0). After 8 weeks of healing, bone-to-implant contact was 43% for 
TPO/rhBMP-2/0.2, versus 72% for TPO, as well as 35% for TPO/rhBMP-2/4.0, versus 68% for 
TPO. Bone-to-implant contact percentages were statistically significant higher for TPO 
compared to TPO/rhBMP-2/0.2 as well as compared to TPO/rhBMP-2/4.0. Finally, it was 
concluded by the authors that rhBMP-2 coated onto TPO implant surfaces initiated dose- 
dependent peri-implant bone remodeling resulting in the formation of normal, physiologic 
bone and clinically relevant osseointegration within 8 weeks.
These effects of rhBMP-2 were substantiated for type IV bone in the posterior maxilla of 
monkeys (Wikesjö et al. 2008c). Sixteen weeks after healing the mean bone-to-implant 
contact percentages were 43% for TPO surfaces coated with 2.0 mg/ml rhBMP-2 
(TPO/rhBMP-2/2.0) and 37% for TPO surfaces coated with 0.2 mg/ml rhBMP-2 (TPO/rhBMP- 
2/0.2), versus 74% and 75% for the corresponding uncoated TPO control surfaces. Mean 
bone-to-implant contact was statistically significant higher for uncoated TPO surfaces versus 
TPO/rhBMP-2/2.0 as well as versus TPO/rhBMP-2/0.2.
Additionally, it should be mentioned that the rhBMP-2 coated implants exhibited a 
characteristic bone-to-implant contact pattern without major differences between rhBMP-2 
concentrations. The surrounding bone projected into the root of the threads forming pinpoint 
bone-to-implant contacts. Areas of broader bone-to-implant contact were also observed. In
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contrast, the predominant observation for the control implants was a thin layer of bone 
covering most of the implant threads, resulting in a higher bone-to-implant contact. The 
authors concluded that rhBMP-2 coated TPO surfaces enhanced /accelerated local bone 
formation in type IV bone in a dose dependent fashion in non-human primates resulting in 
significant osseointegration. Furthermore, they concluded that rhBMP-2 induced de novo 
bone formation did not reach the level of osseointegration observed in native bone within the 
sixteen week interval.
In line with these results are the findings of Schliephake et al. and Liu et al. (Schliephake et al. 
2005a, Liu et al. 2007b).
In the mandible of dogs, Schliephake et al.( 2005a), evaluated bone-to-implant contact to 
machined titanium implants coated with type I collagen (Col I) versus collagen I, chondroitin 
sulphate and BMP-2 (BMP-2). After three months of healing, bone-to-implant contact was not 
significantly higher for BPM-2 compared to Col I. Therefore, they concluded that addition of 
BMP-2 did not increase peri-implant bone formation. Liu et al. (2007b) assessed in the 
maxillae of miniature pigs the effects of BMP-2 and its mode of delivery on the 
osteoconductivity of dental implants. Six different types of surfaces were evaluated: uncoated 
titanium surfaces (Ti), BMP-2 adsorbed to Ti (Ti/BMP-2), biomimetic calcium phosphate 
coated surfaces (CaP), BMP-2 adsorbed to CaP(CaP/BMP-2 ads), BMP-2 incorporated into CaP 
(CaP/BMP-2 inc), as well as BMP-2 adsorbed to and incorporated into CaP (CaP/BMP-2 
ads+inc). After one to three weeks of healing, bone-interface coverage was highest for CaP, 
followed by (CaP/BMP-2 ads+inc) and (CaP/BMP-2 inc). The lowest amount of bone-to- 
implant contact was observed for Ti/BMP-2. The authors concluded that the 
osteoconductivity of functionalized implant surfaces was seriously impaired when BMP-2 was 
present as a superficially adsorbed depot upon calcium phosphate coated or uncoated 
surfaces.
These results are slightly contrasted by Becker et al. (2006). In the mandible and the tibia of 
dogs, bone formation onto sand blasted, acid etches titanium surfaces (C), chromo-sulfuric 
acid surface-enhanced (CSA), and rhBMP-2 biocoated CSA [BMP-A: noncovalently immobilized 
rhBMP-2 (596 ng/cm2), BMP-B: covalently immobilized rhBMP-2 (819 ng/cm2)] was 
investigated. After 4 weeks of healing, histomorphometric analysis revealed for implants 
inserted into mandibles and tibiae that bone-to-implant contact values appeared to be 
highest for the BMP-B group, followed by BMP-A, CSA, and C.
Stadlinger et al. (2008) investigated the effect of another bone morphogenetic protein 
(rhBMP-4). In the mandible of miniature pigs they compared osseointegration of type I 
collagen coated (Col), type I collagen and chondroitin sulphate coated (Col/Cs), with type I 
collagen plus chondroitin sulphate and additionally rhBMP-4 coated titanium implants 
(Col/Cs/rhBMP-4). After six months of healing, histometric evaluation showed the highest 
percentage of bone-to-implant contact for Col/Cs at 40%, followed by Col at 30%. The lowest 
percentage was obtained for Col/Cs/rhBMP-4 at 27%. Col/Cs showed statistically significantly 
higher bone-to-implant contact percentages when compared to Col/Cs/rhBMP-4. Compared
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to Col, there was no statistically significant difference. It was concluded that a low amount of 
rhBMP-4 had a detrimental effect on bone formation compared to Col/Cs.
E.2.2.2. Non-BMP growth factors
Besides BMPs, other growth factors loaded onto titanium implant surfaces were tested in 
animals as potential agents to enhance osseointegration (De Jonge et al. 2008). Examples are: 
growth hormone (GH) (Blom et al. 1998), platelet derived growth factor (PDGF) combined 
with insulin like growth factor -1 (IGF-1) (Stefani, et al. 2000), platelet released growth factors 
(PRGF) (Fuerst et al. 2003), transforming growth factor-ß2 (TGF- ß2) (De Ranieri et al. 2005), 
plasma rich in growth factors (PRGF) (Anitua 2006), fibroblast growth factor -human 
fibronectin fragment fusion protein (FGF-hFNIII) (Park J et al. 2006).
E.2.2.2.1. Animal experiments
Blom et al. (1998) found after 6 weeks of healing in a goat model that rhGH coatings inhibited 
bone ingrowth and bone-to-implant contact.
In the medullary cavity of the femur of rats, De Ranieri et al. (2005) compared mechanical 
anchorage as well as bone-to-implant contact of hydroxyapatite/tricalcium phosphate coated 
titanium implant surfaces (HA/TCP) with rhTGF- ß2 coated surfaces (rhTGF- ß2). After 28 days 
of healing, implants coated with 10 ^g rhTGF- ß2 showed a trend (not significant) of increased 
fixation strength and a statistically significant increase in bone-to-implant contact.
In a rabbit tibia model, Park et al. (2006) compared mechanical anchorage as well as bone-to- 
implant contact of anodized, machined c.p. titanium implant surfaces (group 1) with FGF- 
hFNIII coated surfaces (group 2). After 12 weeks of healing, significantly higher mean removal 
torque values and mean bone-to-implant contact percentages were found for group 2 
implants.
Recently, Anitua (2006) compared in the tibiae and radii of goats bone-to-implant contact of 
titanium implant surfaces (Ti) with human plasma rich growth factors coated titanium 
implants (PRGF). After 8 weeks of healing, mean bone-to-implant contact percentages were 
22% for Ti, and 51%% for PRGF. Titanium implants surfaces with PRGF demonstrated 
significantly higher bone-to-implant contact percentages. This significant difference is in 
contrast to earlier findings of Fuerst et al. (2003). After 4 and 8 weeks of healing, they found 
in the mandibles of miniature pigs no significant difference between PRGF coated versus 
uncoated titanium implants. On the other hand, Stefani et al. (2000) found after 3 weeks of 
healing in a mandibular dog model a statistically significant difference between 
rhPDGF/rhIGF-1 coated versus uncoated titanium implants. However, such a significance was 
not found after 8 and 12 weeks of healing.
F. Concluding remarks
In summary, the various available studies show that the applied implant surface roughening 
procedures not only create surface roughness, but also result in modification of the surface
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chemistry. Although, there is sufficient proof in animal as well as human studies that implant 
surface modification induces a safe and predictable implant-to-bone response, it is not clear 
whether this effect is caused due to the surface roughness or the related change in surface 
composition.
Further, the animal studies dealing with various thin film CaP coating technologies confirmed 
that this approach possesses the potential to solve the problems as associated with thick CaP 
coatings. Nevertheless, there is no definitive proof of an advantageous effect on bone- 
implant healing. For example, there is a lack of human studies, in which the success rate of 
thin CaP coated implants is compared with just surface roughened implants.
Also, it should be mentioned that in addition to thin film technology other techniques as 
electrophoretic deposition, hot isostatic pressing, sol-gel deposition, and electrolytic 
deposition can be used for CaP deposition. As each clinical application may demand specific 
requirements, the availability of a wide range of coating techniques might be useful to select 
the most appropriate deposition method for each specific implant application.
A similar remark can be made about the use of extracellular matrix peptide sequences or 
proteins (growth factors) coated onto titanium implant surfaces. No unequivocal evidence is 
present, but there is a tendency to suggest a positive effect of such coatings on bone implant 
response. On the other hand, it has to be emphasized that the results as obtained with using 
BMP-2 coatings are confusing. The current findings indicate that BMP-2 and BMP-4 might 
impede the magnitude of implant-to-bone response (Schliephake et al. 2005a, Liu et al. 
2007b, Stadlinger et al. 2008, Wikesjö et al. 2008 b, c) and are not favorable at all for final 
implant fixation.
In the light of the current review, it has to be noticed that there is an increasing trend to 
install oral implants on more challenging cases, especially in elderly patients with poor wound 
healing due to e.g. diabetes, other metabolic malconditions, osteoporosis, radiation therapy, 
etc. As a consequence, there is a need to establish surfaces that will lead to a predictive 
improvement of implant-to-bone response. Evidently, the currently available methods to 
modify implant surface composition show potential to control the biological activity of the 
implant surface. Still additional animal as well as human studies are needed to provide more 
insight into the bone response as evoked and to generate a predicted bone response.
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Appendix
Recently developed and marketed implant Manuscripts included from  system atic search in PubM ed and
surfaces discussed in review
Astra 1: Ellingsen et al. 2004 
2: Cooper et al. 2006 
3: Berglundh et al. 2007 
4: Abrahamsson et al. 2008
Straumann 1: Buser et al. 2004 
2: Ferguson et al. 2006 
3: Schwarz et al. 2007a 
4: Schwarz et al. 2007b 
5: Schwarz et al. 2007c 
6: Bornstein, et al. 2008 
7: Schwarz et al. 2008
Nobel 1: Ivanoff et al. 2003 
2: Rocci et al. 2003 
3: Zechner et al. 2003 
4: Hall et al. 2005 
5: Huang et al. 2005 
6: Romanos et al. 2005 
7: Xiropaidis et al. 2005 
8: Sul et al. 2006 
9: Al-Nawas et al. 2008 
10: Burgos et al. 2008
3i 1: Goené et al. 2007 
2: Mendes et al. 2007 
3: Orsini et al. 2007 
4: Mendes et al. 2009
DENTSPLY Friadent 1: Novaes Jr et al. 2004 
2: Papalexiou et al. 2004 
3: Degidi et al. 2005 
4: Iezzi et al. 2005
Table 1: Recently developed and m arketed im plant surfaces
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Experimental surface alterations 
(incl. number o f total number of 
identified titles)
Manuscripts included  
from  system atic search in 
PubM ed
Manuscripts 
included from  hand  
search
Manuscripts as 
exemplary discussed in 
review
Pulsed laser deposition (PLD) 
(5 titles)
1: Dostälovä T et 
al. (2001)
1: Peraire C et 
al.(2006)
1: Dostälovä T et 
al. (2001)
2: Peraire C et 
al.(2006)
Sputter coating  
(16 titles)
1: Cooley et al.
(1992)
2: Hayakawa et 
al. (2000)
3: Hulshoff et al.
(1996)
4: Hulshoff et al.
(1997)
5: Vercaigne et 
al. (2000a)
6: Vercaigne et 
al. (2000b)
1: Mohammadi 
et al. (2003) 
2: Mohammadi 
et al. (2004) 
3: Xiropaidis et 
al. (2005)
1: Vercaigne et 
al. (2000a)
2: Vercaigne et 
al. (2000b)
3: Mohammadi 
et al. (2003) 
4: Mohammadi 
et al. (2004) 
5: Xiropaidis et 
al. (2005)
Ion beam assisted deposition 
(IBAD)
(14 titles)
1: Hayakawa et 
al. (2002)
2: Jung et al. 
(2001)
3: Park et al. 
(2005)
1: Coelho and 
Lemons 
(2009)
2: Coelho et al. 
(2009b)
1: Jung et al. 
(2001)
2: Park et al.
(2005)
3: Coelho and 
Lemons 
(2009)
4: Coelho et al. 
(2009b)
Electrostatic spray deposition 
(ESD)
(4 titles)
1: Manders et al. 
(2006)
2: Siebers et al. 
(2007)
1: Manders et 
al. (2006)
2: Siebers et al. 
(2007)
Biomimetic deposition 
(32 titles)
1: Liu et al.
(2007)
2: Le Guehennec 
et al. (2008)
3: Schliephake et 
al. (2006)
4: Zagury et al. 
(2007)
1: Liu et al.
(2007)
2: Zagury et al. 
(2007)
Biomolecules: RGD peptide
sequence
(20 titles)
1: Germanier et 
al. (2006)
2: Jung et al.
(2007)
3: Park et al.
(2007)
4: Petrie et al.
(2008)
5: Schliephake et 
al. (2005b)
6: Schliephake et 
al. (2002)
7: Stadlinger et 
al. (2004)
1: Bernhardt et 
al. (2005)
2: Rammelt et 
al. (2007)
1: Schliephake 
et al. (2005b) 
2: Bernhardt et 
al. (2005)
3: Rammelt et 
al. (2007)
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Experimental surface Manuscripts included Manuscripts included Manuscripts as
alterations (incl. number o f from  system atic search in from  hand search exemplary discussed in
total number o f identified PubM ed review
titles)
Biomolecules: collagen 1: Reyes et al. 1: Bernhardt et 1: Reyes et al.
(20 titles) (2007) al. (2005) (2007)
2: Schliephake et 2: Rammelt et 2: Schliephake
al. (2002) al. (2004) et al.
3: Schliephake et 3: Rammelt et (2005a)
al. (2005a) al. (2006) 3: Schliephake
4: Schliephake et 4: Rammelt et et al.
al. (2005b) al. (2007) (2005b)
5: Schliephake et 5: Schliephake 4: Bernhardt et
al. (2006) et al. (2003) al. (2005)
6: Stadlinger et al. 5: Rammelt et
(2008) al. (2004)
6: Rammelt et 
al. (2006)
7: Rammelt et 
al. (2007)
8: Schliephake 
et al. (2003)
Growth factor coatings 1: Anitua (2006) 1: Blom et al. 1: Anitua
(263 titles) 2: Becker et al. (1998) (2006)
(2006) 2: De Ranieri et 2: Becker et al.
3: Franke al. (2005) (2006)
Stenport et al. 3: Freilich et al. 3: Liu et al.
(2003) (2008) (2007)
4: Liu et al. (2007) 4: Fuerst et al. 4: Park et al.
5: Park et al. (2003) (2006)
(2006) 5: Stefani et al. 5: Schliephake
6: Schliephake et (2000) et al.
al. (2005a) (2005a)
7: Stadlinger et al. 6: Stadlinger et
(2008) al. (2008)
8: W ikesjö et al. 7: W ikesjö et
(2008a) al. (2008a)
9: Wikesjö et al. 8: W ikesjö et
(2008b) al. (2008b)
10: Wikesjö et al. 9: W ikesjö et
(2008c) al. (2008c) 
10: Blom et al.
(1998)
11: De Ranieri 
et al. 
(2005)
12: Freilich et 
al. (2008) 
13: Fuerst et al.
(2003)
14: Stefani et 
al. (2000)
Table 2: Experimental surface alterations
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Chapter 3:
Bone-supportive behavior of microplasma-sprayed CaP-coated implants: mechanical and 
histological outcome in the goat
Introduction
During the last decades, the replacement of missing teeth with implant-supported prostheses 
has become a widely accepted and routinely used treatment modality for the rehabilitation of 
partially and fully edentulous patients. The underlying biological phenomenon of 
osseointegration was first described by the two research groups of Brânemark (Brânemark et 
al. 1969) and Schroeder (Schroeder et al. 1976, Schroeder et al. 1978, Schroeder et al. 1981). 
Today, osseointegration is thought to be a biological reaction cascade dividable into three 
distinct phases. The first and most important healing phase, osteoconduction, relies on the 
recruitment and migration of osteogenic cells to the implant surface. The second healing 
phase, de novo bone formation, results in a mineralized interfacial matrix equivalent to that 
seen in the cement line in natural bone tissue. These two healing phases, osteoconduction 
and de novo bone formation, result in contact osteogenesis and given an appropriate implant 
surface, in bone bonding. The long term remodeling of the tissue, the third healing phase, is 
influenced by different stimuli, the most important being biomechanics of the developed 
healing site (Davies 2003).
It is generally accepted that calcium phosphate ceramics (CaP ceramics) are appropriate 
implant materials to initiate bone bonding (Geesink et al. 1988, Jansen et al. 1999). However, 
as bulk material, CaP ceramics are intrinsically weak compared to other implant materials, like 
titanium and its alloys. Therefore, CaP ceramics are applied as coatings on mechanically 
strong implant materials in load bearing implant applications in order to combine the 
mechanical strength of metals with the excellent biological properties of CaP ceramics (De 
Groot et al. 1987, Lacefield 1993). Accordingly, numerous studies have been published about 
the biological advantage of such coated implants (Jansen et al. 1991, Caulier et al. 1995, 
Hulshoff et al. 1996, Caulier et al. 1997a, Caulier et al. 1997b). The study results 
demonstrated an increased mechanical interlocking and an increased percentage of bone 
contact for CaP surfaced implants, when compared with non-coated titanium implants.
Plasma spraying is the most common method used for applying synthetic hydroxylapatite 
(CaP ceramic) coatings onto biomedical devices, but for conventional plasma spraying 
numerous powder characteristics and process parameters must be carefully controlled to 
consistently deposit high-quality coatings. Because of the very high temperatures of the 
plasma, the thermo dynamical instability of CaP ceramics at such temperatures plays an 
important role in the final properties of the deposited coating. Ideally, only a thin outer layer 
of each powder particle gets into the molten plastic state which unavoidably undergoes phase 
transitions. This plastic state is necessary to ensure dense and adhesive coatings, but should 
comprise a negligible volume fraction of the CaP particle. Only by choosing an optimum 
relation between particle size (a molten layer of given thickness on a large particle occupies a
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smaller relative volume than on a smaller one), type of gas (the heat content of a plasma, and 
thus the ability to increase the temperature of a particle, depends strongly on the gas used), 
speed of the plasma (the longer a particle resides in a plasma, the higher its temperature), 
and cooling process of the coated surface, coatings with the desired CaP phase (mixture) and 
crystallinity (Cook et al. 1988, Wolke et al. 1992) are obtained. Deposition-dependent 
variations may result in alterations of CaP coating properties such as adherence and 
dissolution behavior. For example, coatings with a higher crystallinity show less dissolution in 
comparison with more amorphous coatings (LeGeros et al. 1992, Klein et al. 1994). Thus, a lot 
of parameters (such as thermal input, speed, particle size and temperatures, etc.) have to be 
closely monitored in order to guarantee a minimum control of roughness, porosity, 
adherence, thickness, CaP internal structure, etc. Consequently, relevant limitations still 
persist in conventionally plasma sprayed CaP coated implants.
Currently, a novel microplasma spraying equipment (MSE) with technical advantages 
compared to the conventional equipment has been developed (Yushchenko et al. 1995, 
Borisov et al 2002). The maximum power of the MSE gun is up to 2 kW, while conventional 
spraying operates at 24-40 kW. Because of the physical parameters of MSE it is possible to 
spray finer particles, as well as to apply textured hydroxylapatite surfaces. Furthermore, due 
to the low heat power of the microplasma jet, overheating of the powder particles, as well as 
excessive local overheating of the substrate is diminished. The latter gives an opportunity to 
produce coatings on components with small dimensions. Seeing the small size of the 
Microplasma equipment, the low level of noise (25-50 dB) compared to 80 -  120 dB for 
conventional plasma spraying equipment and hardly any dust, the equipment can operate 
under conditions of normal workrooms and is very easy to include in pre-existing clean 
rooms. Additionally, it is possible to reduce the size of sprayed spot diameter down to 1-5 
mm, resulting in high spray efficiency, especially in the case of spraying for dental implants. 
Until now, no in vivo experiments have been done to characterize biological effects, such as 
biocompatibility, functional stability, as well as osteoconductivity of such microplasma spray 
coatings.
Therefore, the aim of this study was to examine the bone biological effect for different micro 
plasma sprayed CaP coated implants as compared to conventionally plasma sprayed CaP 
coated implants, when inserted in artificial bone cavities in the femoral condyle of goats.
Our hypothesis was that micro plasma sprayed CaP coatings do evoke the same positive 
biological effects as conventionally plasma sprayed CaP coatings.
Material and Methods
Implant
In total ninety-six screw type titanium implants were manufactured with a diameter of 3.3 
mm and a length of 10 mm (manufacturer BTI, Spain). The implants were divided in four 
groups; non-coated, acid etched standard BTI implants with an average roughness (Ra) of 0.29 
^m [SD: 0.02 ^mj; conventionally plasma spray coated implants (HACAM: crystallinity 65%,
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average roughness (Ra) of 4.37 ^m [SD: 0.13 ^mj); as well as two experimental micro plasma 
spray (MPS) coated implants (MPS A: crystallinity 67%, average roughness (Ra) of 4.78 ^m 
[SD: 0.24 ^mj; MPS B: crystallinity 80%, average roughness (Ra) of 4.23 ^m [SD: 0.37 ^m] ). All 
coatings were applied using the microplasma spray facilities of the RWTH Aachen (Germany). 
Physicochemical analysis, using X-ray diffraction (XRD, Philips, Eindhoven, The Netherlands) 
confirmed the apatite nature of the coatings used.
Before use, all implants were sterilized by autoclaving (for 15 minutes at 121° C ).
Animal model and implantation procedure
In total, twenty-four healthy mature (2-4 years of age) female Saanen goats, weighing about 
60 kg were used in this study. Twelve goats were used for mechanical testing and twelve 
goats were used for histomorphometrical assessment. Before surgery blood samples of the 
goats were taken to ensure that the animals were caprine arthritis encephalitis free. The 
animals were housed in a stable. National guidelines for the care and use of laboratory 
animals were observed.
The operation was performed under general anesthesia. The anesthesia was induced by an 
intravenous injection of pentobarbital and maintained by ethrane 2-3% through a constant 
volume ventilator, administered through an orotracheal tube. The goats were connected to a 
heart monitor.
To reduce the risk of peri-operative infection, the goats were treated according to the 
following doses of antibiotics:
• During the operation: Albipen® 15 % (Intervet BV, Boxmeer, The Netherlands), 3 
ml/50 kg s.c.
• One day after the operation: Albipen® LA, 7.5 ml/50 kg s.c.
• Three days after the operation: Albipen®LA, 7.5 ml/50 kg s.c.
All implants were placed into the trabecular bone of the femoral condyles. Therefore, the 
animal was immobilized on its back and the hind limbs were shaved, washed and disinfected 
with povidone-iodine.
Subsequently, a longitudinal incision was made on the medial surface of the left and right 
femoral condyle. After exposure of the medial condyle, two 1.6 mm pilot holes were drilled. 
The holes were gradually widened with drills of increasing size till a final diameter of 2.5 mm 
was reached. The bone preparation was performed with a gentle surgical technique, using 
low rotational drill speeds (max. 450 r.p.m.) and continuous external saline cooling. In this 
way two holes were made in the medial condyle (distance between the holes at least 1 cm). 
After preparation the holes were irrigated and then packed with sterile cotton gauze to stop 
bleeding. Each femur had two implant sites, resulting in four femoral trabecular bone implant 
sites in each goat, i.e. location A, right superior; location B: right inferior; location C, left 
superior; and location D, left inferior. Implants were inserted by hand. To compensate for 
differences in bone quality and load characteristics among implantation sites, the different
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implant types were placed according to a balanced split plot design. After crestal insertion of 
the implants (i.e. implant shoulder on level with the outer cortical bone surface), the soft 
tissues were closed in separate layers using resorbable vicryl 3-0 sutures (Ethicon, Somerville, 
NJ, USA).
The predetermined implantation periods for mechanical testing as well as for 
histomorphometrical evaluation were either 6 or 12 weeks (n=6 for mechanical as well as 
histological evaluation for each implantation time). At the end of each experimental endpoint, 
twelve goats were sacrificed by an overdose of Nembutal® and implants with surrounding 
tissue were excised.
Mechanical testing and SEM
To determine the bone-bonding strength of the implants, mechanical analysis was performed. 
After sacrificing the goats, the femurs of the goats were stored and transported on ice at a 
temperature of approximately 4°C. Using a diamond saw, the femurs were sectioned in three 
pieces, each containing one implant. Of these pieces containing the implants, the bone 
overgrowth was removed and the cover screws were exposed and removed. Subsequently, 
the bone specimen were embedded in a mould with gypsum. A specially designed device was 
used to fix the specimens in a tensile bench (Hulshoff JEG, et al. 1997). This device enables the 
application of a perpendicular force (at a constant displacement speed of 0.5mm/min) on a 
lever fixed in the center of the implant. The force was applied at a distance of 1.5 cm of the 
diameter of the implants. The force at the point of implant failure was registered and the test 
was stopped immediately afterwards, to not completely fracture the interface. All samples 
were tested freshly. Following the torque measurements, the specimens were fixed and 
dehydrated by a series of ethanol and embedded in methylmethacrylate. After 
polymerization the samples were hemisectioned perpendicularly on the longitudinal axis of 
the implants. After polishing, the implants were examined with a SEM (Jeol, SEM6310, Tokyo, 
Japan) in the backscatter mode to determine the fracture plane of the mechanically tested 
implants.
Histological procedures and histomorphometrical evaluation
After sacrifice, the femoral condyles of the goats were excised immediately and excess tissue 
was removed. Then, using a diamond saw, the retrieved condyles were divided in smaller 
specimens, suitable for histological processing. Finally, each specimen contained one implant 
with surrounding bone. Subsequently, the specimens for histological evaluation were fixed in 
formaldehyde 4%, dehydrated in ethanol and embedded in methylmethacrylate (MMA). After 
polymerization, thin (10 |am) non-decalcified sections were prepared parallel to the long axis 
of the implant with a modified diamond blade sawing microtome technique (Leica, SP1600, 
Nussboch, Germany). All sections were stained with basic fuchsin and methylene blue and 
were examined with a light microscope (Leica MZ 12, Leica BV, Rijswijk, The Netherlands). In
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addition, digital image analysis software (Leica Qwin Pro, Leica Microsystems Imaging 
Solutions, Cambridge, UK) was used for histomorphometrical measurements.
The following quantitative parameters were assessed:
A. Percentage of bone contact at the interface: Measurements were 
performed along the entire length of the implant. The amount of bone 
contact was defined as the percentage of implant length at which there is 
direct bone-to-implant contact without intervening soft tissue layers.
B. Marginal bone apposition: Measurements were performed at the interface 
between implant shoulder and the first implant thread. The amount of bone 
contact was defined as the percentage of length at which there is direct 
bone-to-implant contact without intervening soft tissue layers.
C. Amount of bone: The amount of bone was determined in proximity of the 
middle part of the implant. The bone mass was measured in rectangular 
regions inside and outside the screw thread. The amount of bone was 
quantified in ^m2 (Vercaigne S, et al. 1998).
All quantitative measurements were performed for 3 different sections per implant, at both 
sides of the implant. Results are presented based on the average of these measurements. All 
parameters were scored separately by two independent researchers.
Statistical analysis
To statistically evaluate failure load, bone-to-implant contact percentages, marginal bone 
apposition as well as the amount of bone measurements, the GraphPad Instat version 3.05 
for Windows 95/NT (GraphPad Software, San Diego, California, USA) was used. At first, data 
for the two implantation periods were analyzed by One-way Analysis of Variance (ANOVA) 
combined with Tukey-Kramer Multiple Comparison Test as post hoc test. In case that the 
Bartelett statistic indicated a significant difference among standard deviations additionally 
the nonparametric Kruskal-Wallis Tests were performed to validate the p-values found using 
ANOVA.
Results
Physicochemical analysis
Figure 1a shows the XRD pattern of a commercially available plasma sprayed coating 
(HACAM), which indicates an amorphous/crystalline phase. The four strongest lines in this 
XRD pattern are 002, 211, 112 and 300 reflections corresponding with 25.8°, 31.8°, 32.2° and 
33.0° 2-Theta. Figure 1b shows the XRD pattern of a microplasma sprayed coating (MPS A). It 
can be seen that this coating is comparable to the HACAM coating. Figure 1c shows the X-ray 
diffraction of a microplasma sprayed coating (MPS B). This X-ray diffraction shows a 
preferential (00£) orientation of the crystal planes, and the four reflections 002, 021, 112 and 
202 correspond to 25.8°, 28.1°, 32.2° and 34.0° 2-Theta, which is similar to tooth enamel.
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Macroscopic evaluation
During the experimental period, all goats remained in good health. At sacrifice, no 
macroscopic signs of inflammation or adverse tissue reaction were apparent around the 
implant sites. All implants could be easily located.
Mechanical testing
The failure load for the different implant types and both implantation periods is given in Table 
1. At 6 weeks, the CaP ceramic coated implants showed statistically significant (p<0.001) 
higher torque values compared to the non-coated implants. At 12 weeks, MPS-A and MPS-B 
coated implants showed statistically significant (p<0.01) higher torque values compared to 
the non-coated implants. No significant differences existed between the various types of CaP 
coatings.
SEM
The non-coated implants at six as well as twelve weeks showed a fracture plane in the 
titanium-bone interface (Figure 17). The fracture plane of the CaP ceramic coated implants at 
six as well as twelve weeks was found to be situated inside the coating or at the interface 
between coating and bone or between coating and titanium surface. The coating could 
always clearly be observed (Figures 18-20). Moreover, irrespective of type of coating 
displaced CaP particles were found embedded in bone in the vicinity of the implant surface. 
Apparently, these particles were not related to foreign body reaction or osteolysis (Figure 18).
Light microscopic evaluation
Light microscopic evaluation of the implants showed an uneventful healing of all implants 
without any sign of inflammatory response. All implants were inserted for their major part in 
trabecular bone (Figures 2 and 3). Finally, 5 uncoated, 4 HACAM-, 4 MPS-A- and 5 MPS-B 
coated implants at 6 weeks as well as 5 uncoated, 4HACAM-, 4 MPS-A- and 4 MPS-B coated 
implants at 12 weeks were available for assessment.
Non-coated implants:
At six and twelve weeks, none of the non-coated implants showed an adverse bone reaction. 
However, trabecular bone ingrowth into the screw threads was limited and seemed to be 
quantitatively less compared with the coated implants (Figures 4 and 5). During time, the 
amount of newly formed bone increased.
Coated implants
At six and twelve weeks, an intimate bone contact with cortical and trabecular bone could be 
observed for all coated implants. New bone formation had occurred on the implant surface 
without any intervening soft tissue layer (Figures 6-9). In the trabecular bone compartment, 
the bone present at the implant surface had a tentacle-like appearance. The bone attached to
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one point, mostly at the top of the screw thread, and was growing as a layer over the implant 
surface along the screw thread (Figures 7 and 8). New bone formation was also observed at 
the apical bottom of the implants. In this area, the drill hole was oversized compared to the 
implant diameter. However, the created space became always filled with newly deposited 
bone. Furthermore, it appeared that the different CaP coatings reduced in thickness during 
implantation, but this reduction was not uniform. At some places the entire coating thickness 
was maintained, while at other sites only a thin layer or no coating at all was left. The 
reduction of coating thickness did not interfere with bone contact (Figures 7 and 8). No 
multinucleated cells could be observed. Irregardless of type of coating displaced CaP particles 
were found embedded in bone in the vicinity of the implant surface. Obviously, these 
particles were not related to foreign body reaction or osteolysis.
No major differences existed between six and twelve weeks of implantation for all coated 
implants. At twelve weeks, only the remodeling and compaction of the lamellar bone-implant 
interface had proceeded
Histomorphometrical evaluation
Bone contact percentage
All bone apposition data for the various implant surfaces are given in figures 10 and 11. At 6 
weeks the uncoated implants had a mean bone contact of 39.3% (SD: 15.3%), HACAM coated 
implants had 77.4% (SD: 14.5%), MPS-A coated implants had 77.1% (SD: 13.5%), and MPS-B 
coated implants had 77.7% (SD: 8.4%). At 12 weeks the uncoated implants had a mean bone 
contact of 57.9% (SD: 16.2%), HACAM coated implants had 92.5% (SD: 2.2%), MPS-A coated 
implants had 83.3% (SD: 7.8%), and MPS-B coated implants had 85.7% (SD: 5.7%). Statistical 
analysis at 6 weeks revealed significant differences between uncoated and CaP coated 
implants (p<0.01) and at 12 weeks significant differences between uncoated and HACAM 
coated implants (p<0.01). The differences among CaP coated implants were not significant.
Marginal bone apposition
At the marginal cortical bone level the presence of a peri-implant space was only observed 
around the non-coated implants (Figure 12). Around the coated implants, the marginal bone 
was almost at the same level with the top of the implants and no sign of crestal bone 
resorption was observed (Figure 13).
All marginal bone apposition data (Figure 14), i.e. bone contact percentage between implant 
shoulder and the first thread for the various implant surfaces are given in figures 15 and 16. 
At 6 weeks the uncoated implants had a mean marginal bone contact of 76.5% (SD: 25.5%), 
HACAM coated implants had 99.8% (SD: 0.4%), MPS-A coated implants had 96.7% (SD: 7.4%), 
and MPS-B coated implants had 86.4% (SD: 15.5%). At 12 weeks the uncoated implants had a 
mean bone contact of 46.1% (SD: 42.1%), HACAM coated implants had 96.8% (SD: 6.4%), 
MPS-A coated implants had 93.0% (SD: 14.0%), and MPS-B coated implants had 99.7% (SD:
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0.5%). The statistical analysis revealed significant differences between uncoated and MPS-B 
coated implant surfaces at 12 weeks (p<0.05).
Amount of bone
The amount of bone data for the various implant surfaces and the different analyzed regions 
of interest (roi) with distances of 0-500 ^m (roi 500), 500-1000 ^m (roi 1000), and 1000-1500 
^m (roi 1500) around the implant surface are given in Table 2. Comparison of roi 500, 1000, 
1500 of the different surfaces and time points revealed statistically significant differences 
(p<0.05) only for MPS A (roi 1500) compared to uncoated implant surfaces (roi 500) at 6 
weeks.
Discussion
The aim of the current study was to determine whether CaP coatings deposited with the 
newly developed microplasmaspray technique induced a similar bone response as coatings 
deposited with a conventional plasmaspray technique. The results of the study confirmed that 
both techniques produce CaP coatings with comparable effects regarding biocompatibility, 
functional stability, as well as osteoconductivity
In the present study, measurements of bone-to-implant contact showed significantly more 
bone apposition to CaP coated implants than to non-coated implants. This is in agreement 
with earlier observations in goat models for trabecular bone (Caulier et al. 1995, Caulier et al. 
1997b, Hulshoff and Jansen 1997). Furthermore, our findings do corroborate with results of 
other investigators as obtained in different animal models (Carr et al. 1997, Gottlander et al.
1997, Zechner et al. 2003, Weinlaender et al. 2006). For example, Gottlander et al. 
(Gottlander et al. 1997) found significant more bone contact to plasma-sprayed 
hydroxylapatite coated implants compared to non-coated controls after 4 weeks as well as 
after 6 months of healing in the femur of rabbits. However, it should be mentioned that 
others failed to show such an effect (Evans et al. 1996, London et al. 2002). On the other 
hand, it cannot be excluded that the significant difference between uncoated and CaP coated 
implants in the present study is partially explained by their dissimilarity in surface roughness. 
It is well known that surface roughness affects bone apposition onto titanium implants (Le 
Guéhennec et al. 2007). For example, Albrektsson and Wennerberg (Albrektsson and 
Wennerberg 2004) assume that implant surfaces with a roughness up to 0.4 ^m possess a 
potential risk for proper osseointegration, whereas micro roughness between 0.5 ^m and 8.5 
^m has a positive effect on bone apposition (Shalabi et al. 2006).
After 6 and 12 weeks of healing the amount of bone in the vicinity (0-500 ^m) of the various 
implant surfaces was overall not significantly different from more distant regions (500-1500 
^m). This is in contrast to earlier findings (Corten et al. 1997, Vercaigne et al. 1998). In a 
similar goat model, Corten et al. (Corten et al. 1997) found in close proximity to non-coated 
titanium implants (0-635 ^m) significantly more bone mineral density than in more distant 
regions. This can be partially explained by the different evaluation methods used. Corten et 
al. (Corten et al. 1997) applied Dual Energy X-ray Absorptiometry (DEXA) to assess the
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complete bone block as derived, while in the present study a digital analysis software was 
operated to calculate the light microscopical sections. For DEXA it is known (Markel, et al. 
1993) that pixels at the implant-bone interface may include both implant and bone, resulting 
in an average. When the segmentation algorithm is used to eliminate the metallic implant, 
these averaged pixels may not be excluded, resulting in an increased bone mineral density 
reading adjacent to the implant surface. This is not the case for the used histological analysis 
software. Furthermore, dissimilarity in implant geometry might partially explain the 
contrasting findings. Corten et al. (Corten et al. 1997) inserted cylindrical shaped implants in 
femoral condyles. This will result in a completely different breakdown of forces during 
loading, which can have a significant effect on bone response. Also Vercaigne et al. (Vercaigne 
et al. 1998) found in a similar goat model significantly more bone mass in the vicinity (0-500 
^m) of beam shaped implants than in more distant regions. This discrepancy with our study 
can be explained by continuous micromovement of their less incorporated implants which 
may stimulate surrounding bone resulting in increased bone mass (Vercaigne et al. 1998). 
Apparently, surface roughness and chemistry had in the present study no effect on bone 
mass.
To obtain information about the strength of the bone-implant interface, mechanical 
evaluation of retrieved implants must be performed. For threaded implants, the most 
appropriate technique is torque testing. A tensile bench, which allows the application and 
maintenance of an exact reproducible perpendicular force on the implant (Hulshoff et al. 
1997), was used in the current study to obtain mechanical failure values.. However, as reverse 
torque testing primarily places shear forces on root-form implants around its cross section, it 
is important to keep in mind that this method of loading may not directly relate to events 
during long-term clinical application (Jividen and Misch 2000). Additionally, after torque 
testing a thorough analysis of the fractured interface is required to determine whether the 
torque failure is indeed caused by failure of the bone implant interface. The CaP ceramic 
coated implants showed at 6 and 12 weeks higher failure load values compared to non­
coated implants, while no difference was found between the various CaP coated implants. 
Evidently, this difference can be explained by the higher bone-to-implant contact for the CaP 
coated implants compared with the non-coated ones. On the other hand, an effect of the 
difference in surface roughness between the non-coated and coated implants cannot be 
excluded (Johansson and Albrektsson 1987, Wennerberg et al. 1996, Cordioli et al. 2000, Le 
Guéhennec et al. 2007, Shalabi et al. 2007). For example, Vercaigne et al. (Vercaigne et al. 
2000b) observed no difference in a similar designed study in which CaP coated and non­
coated implants with similar surface roughness were used. Further, our finding that the 
fracture lines for CaP coated implants were predominantly located within the coating and not 
at the bone-implant interface is in accordance with earlier observations and can be explained 
by the occurrence of bone bonding at the surface, which is mechanically stronger than the 
adhesive forces within the thick CaP coating. (Vercaigne et al. 2000b). This observation 
suggests also that we did not measure bone to implant bonding but failure load of the coating 
itself. Obviously, the mechanical properties of conventionally and microplasma sprayed CaP
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coatings did not differ. Furthermore, it should be kept in mind that bonding strength data are 
only true for a single experiment as performed under strictly specific conditions and that 
comparison with other studies should be done with caution.
At 6 and 12 weeks after implantation, irrespective of the type of coating, a non-uniform 
reduction in coating thickness was observed. This agrees with earlier findings (Dhert et al. 
1991, Jansen et al. 1993, Klein et al. 1994, Caulier et al. 1995, Caulier et al. 1997, Caulier et al. 
1997a, Caulier et al. 1997b, Vercaigne et al. 1998). As already discussed in previous 
publications (Caulier et al. 1995, Caulier et al. 1997a, Jansen et al. 1999), the reason and 
consequences of this coating loss are still not understood. It is known that the degradation of 
the coating is not related to the presence of multinucleated or inflammatory cells, fibrous 
tissue and/or bone tissue. Probably the reduction of coating thickness is due to the 
dissolution of the amorphous phase between the remaining crystalline coating particles. In 
light of this, it seems worth to be mentioned that coating degradation seems not to be 
related to implant failure mechanisms (Piatelli et al. 1998). Furthermore, for all types of 
coatings, delaminated or loosened CaP particles were found embedded in bone in close 
vicinity of the implant surface. Apparently, embedded CaP particles did not cause a foreign 
body response or osteolysis (Gottlander et al. 1997), which corroborates with other findings 
(Gottlander and Albrektsson 1992, Frayssinet et al. 1995).
In the present study, after 6 weeks of healing 39% bone-to-implant contact were found for 
non-coated implants. This is within the range of others (Ellingsen et al. 2004, Bornstein et al.
2008), but low compared to studies within similar animal models (Vercaigne et al. 2000a, 
Nikolidakis et al. 2006). Thus, dissimilarity can be explained by differences in surface 
roughness of the used implants (Albrektsson and Wennerberg 2004, Shalabi et al. 2006). On 
the other hand, our 12 weeks data compare very well with other findings in different animal 
models (Caulier et al. 1995, Vercaigne et al. 2000a, Novaes Jr et al. 2004, Berglundh et al. 
2007). Further, non-coated implants were found to have less bone-to-implant contact 
between implant shoulder and the first implant thread, where peri-implant spaces were 
observed to be filled with fibrous tissue. Such findings were reported earlier (Caulier et al. 
1997b, Caulier et al. 1997c) and might be explained by osteoconductivity of CaP coatings. 
However, it has to be noticed that this difference reached statistical significance only for 
uncoated versus MPS-B coated implants at 12 weeks.
Conclusion
This study is the first to present in vivo results of micro plasma sprayed coatings. On the basis 
of our observations, we assume that conventionally plasma spray coated implants, as well as 
micro plasma spray coated implants have a comparable effect on adjacent bone response.
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Appendix
Implants N
6 weeks
Failure load
Mean (± SD) 
[Ncm]
N
12 weeks
Failure load
Mean (± SD) 
[Ncm]
Uncoated 6 43 (19.5) 6 76 (13.4)
HA-CAM 6 128 (22.1)* 6 135 (9.6)
MPS A 6 137 (7.8)* 6 140 (0.4)**
MPS B 6 135 (8.5)* 6 140 (0.4)**
Table 1: Failure load at 6 and 12 weeks 
N = number of implants analyzed
* statistically significant different (p<0.001 ) from uncoated at 6 weeks 
** statistically significant different (p<0.01) from uncoated at 12 weeks
roi Uncoated 
Mean 
[ ^m2]
(± SD)
HACAM 
Mean [^mfl 
(± SD)
MPS A 
Mean [^m2] 
(± SD)
MPS B 
Mean 
I^m2]
(± SD)
6 weeks 500 76.6 (11.3)* 74.7 (10) 59.8 (13.7) 65.4
(14.4)
12 weeks 500 80.1 76.2 (2.3) 76.9 (4.5) 71.6
(4.1) (16.8)
6 weeks 1000 73 68.8 (13.3) 57.2 (11.9) 62.1
(9.3) (13)
12 weeks 1000 74.3 73.4 (6.5) 74.6 (1.1) 68.9
(8) (17.7)
6 weeks 1500 64.9 (10.3) 59.5 (13.7) 49.2(10.2)* 55.3
(13)
12 weeks 1500 65.3 67.4 (7.8) 66.9 (0.8) 64.3
(8) (17.5)
Table 2: Amount of bone for the various implant surfaces and the different regions of interest 
roi = region of interest
p<0.05 (MPS-A versus uncoated implant surface at 6 weeks)
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Figure 1: The X-ray diffraction patterns of (a) conventionally plasma sprayed coating (HACAM), showing a oriented 
amorphous/crystalline structure, (b) microplasma sprayed coating (MPS-A), showing a oriented 
amorphous/crystalline coating, (c) microplasma sprayed coating (MPS-B), showing a preferential (001) oriented 
amorphous crystalline coating.
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Figure 3: HACAM 1x
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Figure 4: Ti 5x
Figure 5: Ti 10x
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Figure 6: HACAM 10x
Figure 7: MPS A 5x
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Figure 8: MPS A 10x
Figure 9: MPS B 10x
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Figure 10: Bone contact percentage at 6 weeks
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Figure 10: Bone contact percentage at 6 weeks
Figure 11: Bone contact percentage at 12 weeks
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Figure 11: Bone contact percentage at 12 weeks
89
90
Figure 14: Schematic drawing to illustrate marginal bone apposition measurement as linear bone contact percentage 
between implant shoulder and the first implant thread.
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Figure 15:
Bone contact percentage between împant shoulder and first thread 
at 6 weeks
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Figure 15: Bone contact percentage between implant shoulder and first thread at 6 weeks
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Figure 16:
Bone contact percentage between împant shoulder and first thread 
at 12 weeks
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Figure 16: Bone contact percentage between implant shoulder and first thread at 12 weeks
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Figure 17: SEM-uncoated surface
Figure 18: SEM-HACAM surface
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Figure 19: SEM-MPS A surface
Figure 20: MPS B surface
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Chapter 4:
Bone reaction adjacent to microplasma sprayed CaP-coated oral implants subjected to 
occlusal load; an experimental study in the dog. Part I: Short-term results
Introduction
During the past 40 years, prosthetic rehabilitation of completely or partially edentulous 
patients with implant-born removable or fixed dentures has developed into a practical and in 
principle predictable treatment option (Östman 2008). Dental implants are surgically inserted 
into the jaw bones and are retained due to adaptation with the surrounding bone tissue. This 
phenomenon is referred to as osseointegration(Brânemark, et al. 1969). Primary implant 
stability and lack of movements are considered main factors for successful osseointegration 
(Albrektsson, et al. 1981, Esposito, et al. 2007, Ottoni, et al. 2005). In the presence of 
movement a soft tissue interface can develop, which can cause implant failure (Brunski, et al. 
1979). To minimize the risk of soft tissue encapsulation, it has been originally recommended 
to keep the implants load-free during a healing period of three to four months in the 
mandible and six to eight months in the maxilla (Brânemark, et al. 1977) . However, since the 
first longitudinal clinical trial was published suggesting that implants could be loaded 
immediately or early in the mandibles of selected patients (Schnitman, et al. 1990), this 
traditional protocol has been questioned and numerous clinical studies have reported on the 
outcome of early and immediate loading of implants in various clinical situations. In their 
recent systematic review on interventions for replacing missing teeth, Esposito and co­
workers (Esposito, et al. 2007) conclude that it is in practice possible to load dental implants 
immediately or early after their placement in selected patients.
The first generation of osseointegrated implants had a relatively smooth (machined, turned) 
surface (Brânemark, et al. 1969). Good long-term clinical outcomes have been reported when 
such implants were installed in bone of high density and a two-stage procedure was used 
(Albrektsson and Sennerby 1991). In more challenging situations such as low bone densities, 
grafted bone, and immediate loading, increased failure rates of implants with smooth 
surfaces have been reported (Becktor, et al. 2004, Friberg, et al. 1991, Glauser, et al. 2001). In 
contrast, improved implant stability as well as accelerated healing have been shown for 
modified implant surfaces (Albrektsson and Wennerberg 2004, Albrektsson and Wennerberg 
2004, Junker, et al. 2009, Wennerberg and Albrektsson 2009). Surface modifications of dental 
titanium implants are accomplished by roughening or by altering the chemical composition. 
Various methods have been developed in order to create rough surfaces, e.g. titanium plasma 
spraying, grit-blasting, acid etching, and anodization. Coating of dental titanium implants 
with calciumphosphate (CaP) ceramic is the most frequently used method for changing the 
chemical surface composition (Le Guéhennec, et al. 2007). Several techniques have been 
developed and are used to coat CaP ceramics onto titanium implant surfaces, but plasma 
spraying is still the most commonly used method. However, for conventional plasma spraying 
numerous powder characteristics and process parameters must be carefully controlled to
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consistently deposit high-quality coatings. This implies that only close control of a multitude 
of factors such as velocity of the plasma flame, powder particle size, and plasma 
temperature, can finally guarantee a minimum control of physical and chemical coating 
characteristics as adherence, thickness, porosity, crystallinity, and roughness. Consequently, 
relevant limitations still persist in conventionally plasma sprayed CaP coatings. To overcome 
these procedural challenges, a novel microplasma spraying equipment (MSE) with technical 
advantages compared to the conventional equipment has been developed (Borisov, et al. 
2002, Yushchenko, et al. 1995). The maximum power of the MSE gun is up to 2 kW, while 
conventional spraying operates at 24-40 kW. Due to physical parameters of MSE, it is possible 
to spray finer particles and to apply textured coatings. Furthermore, because of the low heat 
power of the microplasma jet, overheating of the powder particles as well as excessive local 
overheating of the substrate is diminished. The latter gives an opportunity to produce 
coatings on components with small dimensions. Considering the small size of the 
microplasma equipment, the low level of noise (25-50 dB) compared to 80 -  120 dB for 
conventional plasma spraying equipment and hardly any dust, the equipment can operate 
under normal workroom conditions and is very easy to include in pre-existing clean rooms. 
Additionally, it is possible to reduce the size of sprayed spot diameter down to 1-5 mm, 
resulting in high spray efficiency, like for the spraying of oral implants.
An animal experiment confirmed recently that micro plasma spraying produces CaP coatings 
comparable to conventional plasma spraying in terms of bone biocompatibility. Moreover, 
bone apposition as well as mechanical stability were significantly enhanced as compared with 
non-coated titanium surfaces (Junker, et al. 2010). However, until now no data on bone tissue 
reaction under functional load are available.
Therefore, the aim of the present investigation was to examine the effect of occlusal loading 
of microplasma sprayed CaP ceramic coated implants on bone-implant integration.
It was hypothesized that functional loading of microplasma as well as conventionally plasma 
sprayed CaP ceramic coated implants results in a comparable effect at the bone-implant 
interface.
Material and Methods 
Implants
In total forty-eight screw type, acid-etched titanium implants (Ra: 0.29 ^m) were used with a 
diameter of 3.3 mm and a length of 10 mm (manufacturer: BTI, Vitoria, Spain). The implants 
were divided in four groups; , conventional CaP plasma sprayed implants (HACAM: 
crystallinity 65%, Ra: 4.37 ^m, adhesion strength > 55 MPa), micro CaP plasma sprayed 
implants (MPS: crystallinity 67%, Ra: 4.78 ^m, adhesion strength 13 MPa), implants that were 
provided only for their lower apical half with a MPS CaP coating (aMPS) and non-coated 
implants (non-coated), which served as controls. The conventional plasma-sprayed CaP 
coating was provided by CAM Bioceramics, Leiden, The Netherlands, while the MPS coatings 
were applied using the microplasma spray facilities of the RWTH Aachen (Germany).
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Physicochemical analysis was performed by using X-ray diffraction (XRD, Philips, Eindhoven, 
The Netherlands).
Before use, all implants were sterilized by autoclaving (for 15 minutes at 121 ° C ).
Study design
The study was performed in a mandibular dog model.
Animal model and implantation procedure
The experiment was performed using 6 healthy 4-5 year old Beagle dogs weighing about 10 
kg. The study was conform national guidelines for care and use of laboratory animals and 
approved by the ethical committee for animal research of The Radboud University Nijmegen 
Medical Center. The study design is depicted in Figure 1. Prior to the surgical procedures, the 
animals were premedicated with a combination of Droperidol® (Prostrakan, Galahiels, United 
Kingdom) and Fentanyl® (Hameln Pharmaceutical GmbH, Hameln, Germany) (0.2 ml/kg) . 
Subsequently, they were anaesthetized with an intra-venous injection of 30 mg/kg 
Thiopental® (Hospira Enterprises B.V., Hoofddorp, The Netherlands). After intubation, 
anesthesia was maintained with Isoflurane® (Rhodia Organique Fine Limited, Avonmouth, 
Bristol, England). The oral mucosa and dentition was cleaned with chlorhexidine digluconate 
1% in water. Thereafter, local anaeasthesia was given by injection of Lidocaine® (Fresenius 
Kabi, Den Bosch, The Netherlands). After surgery, the animals were medicated with 1 ml 
Albipen® 15% (Intervet BV, Boxmeer, The Netherlands) and a maintenance dose of 1 ml 
Albipen® LA (Intervet BV, Boxmeer, The Netherlands) the 2nd and 4th day postoperatively. The 
dogs received a normal diet after surgery. For weekly cleaning (oral hygiene) the dogs were 
sedated with a combination of Ketamine® (Eurovet, Bladel, The Netherlands) and Xylazine® 
(Astra Zenica, Zoetermeer, The Netherlands). In a first surgical session (Week 0), the second, 
third and fourth mandibular premolars were extracted bilaterally in each dog.
After a healing period of three months (Week 12), an incision was made at the bone crest and 
a full thickness mucoperiostal flap was raised both to the buccal- and to the lingual side of the 
alveolar ridge. Using a low-speed drill, a graded series of burs and continuous physiological 
saline irrigation, four implant sites per mandibular half were prepared. The self-tapping 
implants were subsequently inserted in their designated positions using a randomization 
scheme. Finally, the wound was closed using resorbable sutures.
After a healing period of 6 weeks (Week 18), a re-entry operation was performed at one side 
of the jaw (alternating the left or right side). The cover screws of the implants were removed 
and the implants were provided with gold standard structures, mimicking tooth crowns to 
allow occlusal loading of the implants (Picture 1). In each dog the contra lateral side served as 
control and received no further treatment. Subsequently, the animals were allowed to chew 
with the implants. The implants were brushed twice weekly with Hibitane® (Regent Medical, 
Irlam, United Kingdom) 0.2% chlorhexidine gel.
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Six weeks after loading (Week 24), the dogs were sacrificed. After premedication with a 
combination of Droperidol® (Prostrakan, Galahiels, United Kingdom)and Fentanyl® (Hameln 
Pharmaceutical GmbH, Hameln, Germany) they were brought under general anesthesia using 
30 mg/kg Thiopental® (Hospira Enterprises B.V., Hoofddorp, The Netherlands). After some 
minutes a lethal dose of Thiopental® (Hospira Enterprises B.V., Hoofddorp, The Netherlands) 
was injected intravenously. The vascular system was perfused with physiologic saline, 
followed by 4% neutral formaldehyde as a fixative.
Histological procedures and histomorphometrical evaluation
After perfusion, the mandibles of the dogs were dissected and following excess tissue 
removal immersed with 4% neutral formaldehyde for another 2 weeks. Then, using a 
diamond saw, the mandibles were sectioned in smaller blocks, suitable for histological 
processing. Finally, each block contained one implant with surrounding bone. Subsequently, 
the specimens for histological evaluation were dehydrated in ethanol and embedded in 
methylmethacrylate (MMA). After polymerization in MMA, thin (10 |am) non-decalcified 
sections were prepared in a bucco-lingual direction parallel to the long axis of the implant 
using a modified diamond blade sawing microtome technique (Leica, SP1600, Nussboch, 
Germany). All sections were stained with basic fuchsin and methylene blue and were 
examined with a light microscope (Zeiss - Axio Imager Z1 automated microscope with 
AxioCam MRc5 digital camera and AxioVision V6.3.2. acquisition software, Göttingen, 
Germany). In addition, digital image analysis software (Leica Qwin Pro, Leica Microsystems 
Imaging Solutions, Cambridge, UK) was used for histomorphometrical measurements.
The following parameters were assessed:
A. Percentage of mineralized bone contact at the interface 
Measurements for coating-to-implant contact were performed:
1. along the coronal half of the implant (from middle of the top of the most 
coronal, first implant thread to the middle of the top of the 4th thread; 
illustration 1) for HACAM and MPS ;
2. along the apical half (from middle of the top of the 4th implant thread to the 
middle of the top of the 8th thread; illustration 1) for HACAM, MPS and 
aMPS;
3. along the entire length of the implant (from middle of the top of the most 
coronal, first implant thread to the middle of the top of the 8th thread; 
illustration 1) for HACAM and MPS;
B. Amount of mineralized bone in the proximity (0-1500 ^m) of the implant surface 
Measurements were performed:
1. along the coronal half of the implant (from middle of the top of the most 
coronal, first implant thread to the middle of the top of the 4th thread; 
illustration 1);
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2. along the apical half (from middle of the top of the 4th implant thread to the 
middle of the top of the 8th thread; illustration 1);
3. along the entire length of the implant (from middle of the top of the most 
coronal, first implant thread to the middle of the top of the 8th thread; 
illustration 1);
The amount of bone contact was defined as the percentage of implant length at 
which there was direct bone-to-implant contact without intervening soft tissue 
layers.
C. Coating degradation
Coating degradation was analyzed by measuring the length of the implant surface 
areas that were not covered with CaP coating any more. Finally, coating degradation 
for the various areas of interest (i.e. coronal, apical, entire implant length) was 
expressed as the percentage of the corresponding implant surface that was no longer 
covered with CaP coating.
All quantitative measurements were performed for three different sections per implant, at 
both sides of the implant. Results were presented based on the average of these 
measurements. All parameters were scored separately by two independent researchers.
Statistical analysis
For statistical analysis SPSS 16.0 (SPSS Inc., Chicago, USA) was used. To evaluate effects of the 
different surface types on bone healing and coating degradation One-Way ANOVA with Tukey 
Post Hoc Multiple Comparison Test at a significance level of 0.05 was used. Differences 
between unloaded and functional loaded implants were analyzed using Independent- 
Samples T test. P-values <0.05 were considered significant.
Results
Physicochemical analysis
Figure 2 shows the XRD pattern of a commercially available plasma sprayed CaP coating 
(HACAM), which indicates an amorphous/crystalline phase. The four strongest lines in this 
XRD pattern are 002, 211, 112 and 300 reflections corresponding with 25.8°, 31.8°, 32.2° and 
33.0° 2-Theta, which are indicative for hydroxyapatite. It can be seen that the XRD pattern of 
the microplasma sprayed coating (MPS) 
is comparable to that of HACAM.
Macroscopic evaluation
During the experimental period, all dogs remained in good health. However, during removal 
of the cover screws in order to install the superstructures, several implants were found to be 
not integrated in the alveolar bone. In one dog, even all implants failed. Finally, 3 not- 
loaded/non-coated implants (from dogs 2, 5 and 9), 3 not-loaded/HACAM implants (from
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dogs 2, 5 and 9), 3 not-loaded/MPS implants (from dogs 2, 5 and 9), 3 not-loaded/aMPS 
implants (from dogs 2, 5 and 9), 4 loaded/non-coated implants (from dogs 2, 5, 9 and 12), 4 
loaded/HACAM (dogs 2, 5, 9 and 12), 3 loaded/MPS implants (from dogs 2,9 and 11) and 3 
loaded/aMPS implants (from dogs 2, 9 and 11) could be included in the study. During the six 
week loading period, no additional implants were lost. All maintained implants showed 
clinically a healthy gingival response without any sign of pocket formation, recessions or bone 
resorption. At sacrifice, no macroscopic signs of inflammation or adverse tissue reaction were 
apparent around the implant sites. All submerged implants could be easily located.
Light microscopic evaluation
Light microscopic evaluation of the implants showed an uneventful healing of all harvested 
implants. In none of the specimens, signs of an inflammatory response were seen.
Conventional- and MPS CaP coated implants
An intimate contact with cortical and trabecular bone was observed for non- and functional- 
loaded conventional- as well as MPS CaP coated implants. New bone formation had occurred 
at the implant surface without the occurrence of an intervening fibrous tissue layer. The 
pattern of bone apposition was not affected by the loading condition. Generally, non-loaded 
as well as loaded implants with both types of coating were surrounded by dense bone 
(Pictures 2 and 3). In trabecular bone compartments, the bone present at the implant surface 
had a tentacle-like appearance, which involved that the bone was adhering to the implant 
surface and subsequently had grown over the implant surface (Pictures 4 and 5). New bone 
formation was also observed at the apical bottom of the implants. In this area, the drill hole 
was oversized compared to the implant diameter, but the created space became always filled 
with newly deposited bone. The appearance of the CaP coating as left after 12 weeks of 
implantation was not very uniform. In some areas the thickness was maintained for both 
conventional and MPS CaP coatings, while at other sites only a thin layer or no CaP coating at 
all was left. Reduction of CaP coating thickness did never interfere with bone-to-implant 
contact. Furthermore, CaP particles were found embedded in bone in the vicinity of the 
implant surface. No multinucleated cells could be observed (Pictures 6-1, 6-2, 6-3, 7, 8-1, 8-2 
and 8-3).
Apical MPS CaP coated and non-coated implants
Also, the apically MPS CaP coated and non-coated control implants showed no adverse bone 
reaction. However in about 40% of the specimen (two non-coated, one apical MPS), 
functional loading appeared to reduce bone apposition onto the coronal part of both implant 
groups. This phenomenon seemed to be more pronounced for the non-coated than for apical 
coated implants (Pictures 9 and 10). Similar to conventional- and MPS CaP coatings, apical 
coated and non-coated implants were surrounded by dense bone (Pictures 9 and 10). New 
bone formation was also observed in the oversized apical bottom of the implants.
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Histomorphometrical evaluation
Bone contact percentage
Bone-to-implant contact data for the different implant groups and loading conditions are 
given in Table 1. Bone apposition in the areas of interest appeared to be higher for the non­
loaded non-coated implants compared with the conventional plasma-sprayed CaP coatings, 
while for the loaded non-coated implants bone contact seemed to be lower compared with 
all CaP-coated implant groups. However, statically testing indicated that no significant 
differences existed neither for non-loaded nor for functionally-loaded implants (Oneway- 
ANOVA, p>0.05, Table 1-1). Furthermore, no statistically significant difference was found in 
the distinct areas of interest when comparing bone-to-implant contact for a certain implant 
surface type in non-loaded or functionally-loaded conditions (T-test, p>0.05, Table 1-1). 
However, it should be mentioned that functional loading of non-coated implants was 
associated with a tendency of less bone apposition in the coronal half of the implant surface 
(p=0.058, Table 1-1). Additionally, for apical MPS CaP coated implants statistical analysis 
revealed irrespective of the loading conditions no significant different bone apposition onto 
the apical coated compared to the non-coated coronal part (T-test, p>0.9 for unloaded and 
p>0.1 for functionally loaded, Table 1-2).
Amount of bone
Amount of bone was measured for distinct areas and regions of interest. The different regions 
of interest (roi) had distances of 0-500 ^m (roi 500), 500-1000 ^m (roi 1000), and 1000-1500 
^m (roi 1500) to the implant surfaces. Amount of bone data for the different implant groups 
and loading conditions are given in Table 2-1.
Neither for non-loaded nor for functionally loaded implants, significant differences existed in 
the amount of bone (Oneway-ANOVA, p>0.05, Table 2-1). Moreover, no statistically 
significant difference was found in the distinct areas and regions of interest when comparing 
amount of bone for a certain implant surface type in non-loaded or functionally loaded 
conditions (T-test, p>0.05, Table 2-1). Additionally, for apical MPS CaP coated implants 
statistical analysis revealed irrespective of the loading conditions no significant different bone 
volume in the vicinity (roi 500) of the apical coated compared to the non-coated coronal part 
(T-test, p>0.7 for non-loaded and p>0.2 for functionally loaded, Table 2-2).
Coating degradation
Coating degradation data for the different implant groups and loading conditions are given in 
Table 3-1. Statistical testing indicated significant more apical coating degradation on loaded 
HACAM compared to loaded aMPS implants (Oneway-ANOVA, Tukeys Post Hoc Test, p<0.05, 
Table 3-1). Furthermore, loading of HACAM was, for the apical implant part as well as for the 
entire implant length, associated with significantly more coating degradation as compared to 
the not loaded situation (T-test, p<0.05, Table 3-1). Additionally, for HACAM as well as MPS 
statistical analysis revealed irrespective of the loading conditions no significant different
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coating degradation at the apical compared to the coronal part (T-test, HACAM: p>0.9 for not 
loaded and p>0.1 for functionally loaded, MPS: p>0.7 for not loaded and p>0.9 for 
functionally loaded, Table 3-2).
Discussion
The aim of the present investigation was to examine the effect of functional loading on bone- 
implant integration of microplasma sprayed CaP ceramic coated implants. It was 
hypothesized that functional loading of microplasma as well as conventionally plasma spray 
coated implants results in comparable effects at the bone-implant interface.
For the various implant surfaces tested, functional loading was neither for bone-to-implant 
contact nor for amount of bone associated with statistically significant differences. Hence the 
null hypothesis of similar functional loading effects at the bone-implant interface of 
microplasma as well as conventionally plasma sprayed CaP ceramic coated implants is not 
rejected.
At cover screw removal, various implants were found to be not integrated in the alveolar 
bone. In one dog, even all implants failed. Early implant failures result from an inability to 
establish an intimate bone-to-implant contact (Quirynen et al . 2002). It is widely accepted 
that surgical trauma is one of the most commonly suspected etiologies for early implant 
failure (for review see: Oh et al. 2002). Also bacterial contamination during implant surgery 
along with subsequent infection might lead to early implant failures (Quirynen et al . 2002). 
Despite the fact that animal surgery was performed with the utmost caution, surgical trauma 
as well as direct bacterial contamination cannot completely be ruled out and might at least 
partially explain our early failures. As it is well known that implant geometry, bone quantity 
as well as quality are associated with early implant failures in humans (Alsaadi et al. 2007), 
another possible reason for the lack of osseointegration could be the small width of the 
alveolar ridge in our dog model as compared with the implant diameter. In this respect, there 
is some indication by a study of Qahash et al. (Qahash, et al. 2008), who showed in a 
mandibular dog model that crestal resorption 8 weeks following endosseous implant 
installation is dependent on the width of the alveolar bone. They reported also that the closer 
implants were placed to the buccal plate of the alveolar ridge, the greater was the likelihood 
for bone resorption. A non-linear relationship between ridge width and buccal resorption was 
found with more pronounced resorption when the implants were placed within 2 mm of the 
crestal plate. This resorption pattern is corroborated by others (Araüjo, et al. 2005, Botticelli, 
et al. 2004, Covani, et al. 2004). Furthermore, as in the present study, crestal bone resorption 
clustered within individual animals (Qahash, et al. 2008). However, this thought remains 
speculative as no tooth loss was observed in the study of Qahash et al. (Qahash, et al. 2008).
In the present study, mean bone apposition data after three months of submerged healing for 
conventional- as well as MPS CaP coatings did not differ significantly from each other, which is 
in agreement with other studies of CaP coated implants in mandibular dog models (Ong, et al. 
2004, Schliephake, et al. 2009, Xiropaidis, et al. 2004). Also, our measured bone data are in 
agreement with earlier reports (Schliephake, et al. 2009, Xiropaidis, et al. 2005).
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After 12 weeks of healing, the non-coated implants yielded in a mean bone apposition of 
about 82%, which is high compared to other studies in mandibular dog models (Abrahamsson, 
et al. 2004, Jeon, et al. 2008, Moon, et al. 2008, Ong, et al. 2004, Schliephake, et al. 2009, 
Xiropaidis, et al. 2005, Yoon, et al. 2008). This discrepancy might be explained by dissimilarity 
in bone quality between different breeds, animal age and healing periods before 
implantation. It can be assumed that our implants were primarily placed in dense (type 1 or 2) 
bone (Lekholm and Zarb 1985), whereas other results might have included bone apposition in 
less dense (type 3 or 4) bone. This suggestion is further supported by reduced bone volume 
density in the vicinity of the implant surface in the studies of Xiropaidis et al. (Xiropaidis, et al. 
2005) and Schliephake et al. (Schliephake, et al. 2009).
In the present experiment, functional loading of conventionally and micro plasma-sprayed 
CaP coatings resulted in a similar implant-to-bone response. Still, it cannot be ruled out that 
this similarity might be attributed to the moderate number of implants as available for 
statistical analysis. Unfortunately, as the present study is one of the few studies were 
functional load was applied, comparable dog studies evaluating CaP coatings are to the best 
knowledge of the authors not available. Surprisingly, for both coating types functional load 
was associated with enhanced bone-to-implant contact and amount of bone. Although, the 
level of significance was not reached. It should be mentioned that a similar observation was 
reported by Mouzin et al. (Mouzin, et al. 2001) in a femoral condyle Labrador dog model. 
Four weeks after functional loading a significantly increased percentage of bone-to-implant 
contact was seen for CaP coated titanium implants.
Such a loading effect for CaP coatings stands out against non-coated titanium implants. In the 
current study, functional loading of non-coated implants resulted in nearly forty-five percent 
less bone-to-implant contact on the coronal half of the implant surface as compared to the 
non- loaded situation. This difference reached almost significance (p=0.058). This lack of 
significance can again be due to the low number of implants as available for statistical 
analysis. This suggestion is supported by the observation that two out of four loaded, non­
coated implants demonstrated less than twenty percent bone-to-implant contact onto the 
coronal implant half, while such an incidence of low coronal bone-to-implant contact was not 
found for other implant surfaces. Moreover, this finding is along the lines of a recent 
publication (Lee, et al. 2009). In a comparable mandibular beagle dog model, Lee et al. (2009) 
found that functional loading was for some implants associated with marginal bone loss, 
whereas for non functional loaded implants such a change in marginal bone level was not 
discernible. However, it should be highlighted that in contrast to the present study Lee et al. 
(2009) used blasted titanium implants in an immediate loading protocol for a period of eight 
weeks, whereas in the current investigation acid etched implants in a delayed protocol for a 
loading phase of six weeks were used.
While the promising effect of calcium phosphate coatings on the bone-to-implant response 
are known for decades (Jansen, et al. 1999, Van Blitterswijk, et al. 1993), the clinical 
performance of calcium phosphate coatings remains controversial (Lee, et al. 2000, Schwartz- 
Arad, et al. 2005). Especially, as it is suggested that coating degradation is related to
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supplementary crestal bone loss. Therefore, we decided to include implants that were only 
provided at their apical part with a CaP coating. This approach combines the positive calcium 
phosphate effects as faster and more bone apposition along with elevated interfacial 
mechanical strength (Bloebaum, et al. 1991, Cooley, et al. 1992, Rivero, et al. 1988, Thomas 
and Cook 1985), while avoiding a possible disadvantage as crestal bone resorption. However, 
in the current experimental design functional loading of apically coated implants was 
associated with a decrease in bone-to-implant contact onto the coronal, not-coated half of 
the implant surface as compared to the non-loaded condition. This compares very well with 
our results for non-coated implants and with a recent report (Lee, et al. 2009). In contrast, 
functional loading of completely microplasma and conventionally plasma spray coated 
implants resulted in more bone apposition onto the coronal half of the implant surface as 
compared to the non-loaded condition.
In an earlier goat study (Junker, et al. 2010), using similar types of CaP coatings a non­
uniform degradation of the coatings was found, which agreed with other studies dealing with 
calcium phosphate coatings (Caulier, et al. 1995, Caulier, et al. 1997, Caulier, et al. 1997, 
Caulier, et al. 1997, Dhert, et al. 1991, Jansen, et al. 1993, Klein, et al. 1994, Vercaigne, et al. 
1998). As already discussed in these previous publications (Caulier, et al. 1995, Caulier, et al. 
1997, Jansen, et al. 1999, Junker, et al. 2010), the reason and consequences of this coating 
loss are still not completely understood. Most likely coating degradation is due to the 
dissolution of the amorphous phase between the crystalline coating particles (Dhert, et al. 
1991, Dhert, et al. 1993, Jansen, et al. 1993, Van Blitterswijk, et al. 1993). Our coating 
degradation analysis indicated that evidently functional loading of conventionally plasma- 
sprayed coatings enhances their degradation pattern. Despite the physicochemical similarity 
between conventionally and microplasma-sprayed coatings, such an increase was not 
observed for the latter, which cannot be explained. Nevertheless, coating degradation or CaP 
particles embedded in bone by no means could be associated with osteolysis. Furthermore no 
presence of inflammatory cells was observed. Also, Piatelli et al. (Piatelli, et al. 1998) and Ong 
et al. (Ong, et al. 2002) reported that degradation of CaP coatings was not detrimental to peri- 
implant bone reaction, while Yamamoto et al. (Yamamoto, et al. 2006) even demonstrated 
that coating degradation was associated with enhanced osteoconductivity and increased 
bone-to-implant contact.
In the present study a mandibular beagle dog model with habitual functional loading (e.g. 
chewing) of dental implants was used. It should be emphasized that the current experiment 
is one of the few in which such a loading protocol was used (Lee, et al. 2009, Ong, et al. 
2004). According to international standards, dogs are suitable for the testing of oral implants 
(International Standard ISO 1093-6, 1994) and are the most frequently used large animal 
model for musculoskeletal and dental research (Pearce, et al. 2007). This is because canine 
bone closely approximates human bone composition and density (Aerssens, et al. 1998). 
However, bone microstructure, mineral density (Wang, et al. 1998) and remodeling rate 
(Bloebaum, et al. 1991, Bloebaum, et al. 1993) differ from humans. Therefore, extrapolation 
of dog data to the human situation should be done with caution. Nevertheless, the present
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data warrant the performance of a long-term dog study, in which the loaded condition is 
maintained for a longer time (i.e. 6-12 months). In view of this, it should also be noticed that 
in the current study standard abutments were used to mimic tooth crowns in order to apply 
functional load to dental implant. Obviously, as disadvantages neither for the animal nor for 
the experiment were found, custom-made anatomical crowns with adjusted occlusion are not 
needed to create a loaded condition in a dog model.
Conclusion
This study presented data about bone apposition and amount of bone around conventional as 
well as microplasma sprayed CaP coated titanium implants, which were subjected to 
functional loading during 6 weeks. In addition, apical CaP coated implants and non-coated, 
acid-etched implants were included in the study design. Within the limits of the experiment, 
we conclude that functional loading of MPS CaP coatings evokes a favorable bone response 
and moreover that the bone response, irrespective of the loading condition, does not differ 
with conventional plasma sprayed CaP coatings. On the other hand, functional loading of 
HACAM as well as MPS CaP coatings might be associated with more crestal bone apposition 
as compared to non-coated implants. These findings warrant the performance of a long-term 
dog study.
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Appendix
Figure 1: Study design
Week: 0
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Y
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Illustration 1: Measurement landmarks at the 1st, 4th and 8th thread
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Figure 1: The X-ray diffraction patterns of (a) conventionally plasma sprayed coating (HACAM), showing a oriented 
amorphous/crystalline structure, (b) microplasma sprayed coating (MPS-A), showing a oriented 
amorphous/crystalline coating, (c) microplasma sprayed coating (MPS-B), showing a preferential (001) oriented 
amorphous crystalline coating.
Picture 2: MPS coated non-loaded implant surrounded by dense bone (Objective 10x)
Picture 3: MPS coated functionally loaded implant surrounded by dense bone (Objective 10x)
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Picture 4: MPS coated non-loaded implant showing tentacle-like appearance in trabecular bone (Objective 10x)
Picture 5: HACAM coated functionally loaded implant showing tentacle-like appearance in trabecular bone (Objective 
10x)
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Picture 6-1: MPS coated non-loaded implant showing non-uniform coating thickness (Objective 10x)
Picture 6-2: MPS coated non-loaded implant showing non-uniform coating thickness (Objective 20x)
Picture 6-3: MPS coated non-loaded implant showing CaP particle surrounded by bone (Objective 40x)
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Picture 7: MPS coated functionally loaded implant showing non-uniform coating thickness and arrows showing CaP 
particles embedded in bone (Objective 40x)
Picture 8-1: HACAM coated non-loaded implant showing non-uniform coating thickness (Objective 10x
Picture 8-2: HACAM coated non-loaded implant showing non-uniform coating thickness (Objective 20x)
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Picture 8-3: HACAM coated non-loaded implant; arrow showing CaP particle surrounded by bone (Objective 40x)
Picture 9: Non-coated unloaded implant surrounded by dense bone (Objective 10x)
Picture 10: Non-coated functionally loaded implant showing reduced bone apposition onto the coronal part of the 
implant surface (Objective 10x)
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+%BIC Not loaded Loaded T-test
(between 
not loaded/ 
loaded)
N [number] 
(Implants/ 
animals)
Mean
[%]
SD
[%]
Sig. N [number] 
(Implants/ 
animals)
Mean
[%]
SD
[%]
Sig. Sig.
p-value
[95%CI]
Coronal non-coated 3 82.2 6.5 4 37.6 30.6 0.058
[-2.615,
9.798]
HACAM 3 61.4 42.8 4 62.6 26.9 0.967
[-68.939,
65.393]
MPS 3 75.3 28.1 3 90.3 12.5 0.445
[-64.212,
34.212]
aMPS 3 83.9 12.0 3 53.7 26.4 0.145
[-16.223,
76.756]
ANOVA
(between
groups) 0.726 0.124
Apical non-coated 3 81.7 9.4 4 65.0 29.9 0.402
[-30.279,
63.729]
HACAM 3 58.8 37.7 4 72.9 16.6 0.526
[-67.376,
39.126]
MPS 3 82.3 22.4 3 84.0 23.6 0.934
[-53.847,
50.514]
aMPS 3 82.9 12.5 3 83.8 9.2 0.925
[-25.781,
23.981]
ANOVA
(between
groups) 0.544 0.617
Entire
length
non-coated 3 81.9 7.7 4 52.5 25.0 0.112
[-9.819,
68.735]
HACAM 3 59.4 39.9 4 68.8 16.5 0.681
[-64.939,
46.122]
MPS 3 78.8 25.1 3 87.2 18.0 0.665
[-57.893,
41.223]
aMPS 3 83.4 12.2 3 68.7 17.8 0.303
[-19.862,
49.262]
ANOVA
(between
groups) 0.624 0.223
Table 1-1: Bone apposition data in the areas of interest at the different types of implant surfaces and loading 
conditions. In cases that equality o f variance could not be assumed (significance of Levene's Test for Equality of 
Variances <0.05) the relevant significance is given.
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%BIC
aMPS
coronal apical T-test
(between not 
loaded/loaded)
N Mean SD N Mean SD Sig.
[number] [%] [%] [number] [%] [%] p-value
(Implant/ (Implants/animal [95%CI]
animals) s)
Not loaded 3 83.9 12.0 3 82.9 12.5 0.923
[-28.861, 26.794]
Loaded 3 53.7 26.4 3 83.8 9.2 0.135
[-14.644, 74.911]
Table 1-2: Bone apposition data coronal versus apical at aMPS implant surfaces. In cases that equality of variance 
could not be assumed (significance of Levene's Test for Equality of Variances <0.05) the relevant significance is given.
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T-test
(between 
not loaded/ 
loaded)
N [number] 
(Implants/ 
animals)
N [number] 
(Implants/ 
animals)
Sig.
[95%CI]
Non-coated 500 0.26
[-27.070, 77.687]
0.324
[-25.592, 63.542]
Non-coated
1500
0.616
[-28.477, 43.443]
HACAM 500 0.284
[-49.866, 18.133]
0.502
[-21.177, 37.777]
HACAM1500 0.185
[-104.562, 28.162]
0.264
[58.259, -21.126]
0.633
[-43.002, 30.735]
0.062
[-47.319, 1.786]
0.721
[-24.993, 18.926]
0.652
[-23.900, 16.766]
0.770
[-23.653, 29.653]
ANOVA
(between
groups)
Non-coated 500 0.578
[-27.628, 43.028]
Non-coated
1000
0.412
[-31.320, 15.787]
0.665
[-16.461, 11.727]
HACAM 500 0.700
[-61.189, 4-
0.284
[-83.514, 30.364]
HACAM1500 0.260
[-91.919, 32.919]
0.561
[-52.403, 32.936]
0.360
[-48.794, 22.327]
0.145
[-72.840, 17.340]
0.319
[-13.884, 27.684]
0.085
[-22.331, 2.197]
0.083
[-38.316, 3.583]
ANOVA
(between
groups)
Non-coated 500 0.292
[-28.555, 76.788]
Non-coated
1000
0.581
[-33.298, 53.156]
Non-coated
1500
0.601
[-20.440, 31.790]
0.495
[-54.558, 30.299]
HACAM 1000 0.295
[-78.237, 29.295]
0.246
[-92.994, 25.294]
0.378
[-53.835, 25.535]
0.236
[-49.874, 16.574]
0.151
[-63.560, 15.777]
0.648
[-18.764, 27.631]
0.178
[-16.366, 2.533]
ANOVA
(between
groups)
0.382
[-27.489, 13.123]
Amount of Not loaded
SD SD
Non-coated
1000
0.338
Non-coated
1500
0580
HACAM 500
Table 2: Amount of bone data in the regions of interest at the different types of implant surfaces and loading 
conditions. In cases that equality o f variance could not be assumed (significance of Levene's Test for Equality of 
Variances <0.05) the relevant significance is given.
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Amount of bone 
aMPS 500
coronal apical T-test
(between 
not loaded/ 
loaded)
N [number] Mean SD N [number] Mean SD Sig.
(Implant/ animals) [%] [%] (Implants/
animals)
[%] [%] p-value
[95%CI]
Not loaded 3 74.2 3.8 3 73.4 3.3 0.7904
[-8.973,
7.306]
Loaded 3 77.3 13.2 3 61.5 15.7 0.2538
[-48.636, 17.103]
Table 2-2: Amount of bone (roi 500) data coronal versus apical at aMPS implant surfaces. In cases that equality of 
variance could not be assumed (significance of Levene's Test for Equality o f Variances <0.05) the relevant significance 
is given.
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%coating degra-
(between not
loaded/
loaded)
N [number] 
(Implants/ 
animals) [95%
N [number] 
(Implants/
I 95% I 95%CI]
0.064
[-100.77, 6.6031
0.522
[-78.473, 131.54]
T-test
(between 
groups; HACAM, 
MPS)
0479
[-95.825, 53.825]
0.214
[-73.570, 1
HACAM 0.003
[-62.174,-22.359]
0.657
[-79.834, 113.10]
0.239
[-63.885, 144.22]
ANOVA
(between 
groups; HACAM, 
MPS, aMPS)
Post hoc test 
(Tukey)
HACAM versus aMPS 
0.037
[-129.24, -4.70]
0.037
[-83.465
0.578
[-77.410, 120.58]
T-test
(between 
groups; HACAM, 
MPS)
0.499
[-77.472, 44.739]
0.229
[-76.310, 177.02]
Not loaded T-
SD SD
Table 3-1: Comparison of coating-to-implant contact data at distinct implant surfaces regarding load. In cases that 
equality of variance could not be assumed (significance of Levene's Test for Equality of Variances <0.05) the relevant 
significance is given
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%coating degradation coronal a pical T-test
(between 
not loaded/ 
loaded)
N [number]
(Implants/anim
als)
Mean
[%]
SD
[%]
N [number]
(Implants
/animals)
Mean
[%]
SD
[%]
Sig.
p-value
[95%CI]
HACAM 
Not loaded
3 49.4 21.5 3 50.7 13.0 0.9363
[-38.991, 41.458]
HACAM Loaded 4 2.4 2.8 4 8.4 7.7 0.1888
[-3.938,16.038]
MPS
Not loaded
3 28.4 41.5 3 38.9 32.1 0.7461
[-73.523, 94.523]
MPS
Loaded
3 55.0 50.7 3 55.6 50.9 0.9892
[-114.61,115.81]
Table 3-2: Comparison of coating-to-implant contact data for coronal versus apical at HACAM and MPS implant 
surfaces. In cases that equality of variance could not be assumed (significance of Levene's Test for Equality of 
Variances <0.05) the relevant significance is given.
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Introduction
As implant stability is one of the most important factors for successful osseointegration 
(Johansson and Albrektsson, 1987), calcium phosphate (CaP) coatings have been used to 
enhance implant stabilization and to maximize bone formation (Bloebaum et al., 1991; Cooley 
et al., 1992; Rivero et al., 1988; Thomas and Cook, 1985). Currently, plasma spraying (PS) is 
the most common method used to apply CaP coatings. However, relevant limitations still 
persist in PS CaP coatings. To overcome these, microplasma spraying (MPS) equipment -  with 
a low heat power to diminish overheating of powder particles and substrate, a small laminar 
plasma jet to achieve high spray efficiency by spraying for dental implants as well as low level 
of noise (25-50 dB) and hardly any dust that makes it possible to operate it under normal 
workroom conditions - has been developed (Borisov et al., 2002; Yushchenko et al., 1995). An 
animal experiment confirmed that MPS produces CaP coatings comparable to PS in terms of 
bone biocompatibility. Moreover, bone apposition and mechanical stability were significantly 
increased as compared with non-coated implants (Junker et al., 2010a). Likewise, in a short­
term trial in a mandibular dog model MPS coatings evoked a favorable bone response that 
was similar to PS coatings (Junker et al., 2010b).Yet, long-term data are lacking.
Therefore, the present study aimed to investigate long-term effects of functional loading on 
bone remodeling and coating behavior. It was hypothesized that long-term functional load of 
MPS and PS CaP coatings would result in comparable effects at the bone-implant interface 
and that the performance of MPS and PS CaP coating would be similar.
Materials and Methods
Implants
Fifty-six screw type titanium implants (diameter: 3.3 mm, length: 10 mm ; manufacturer: BTI, 
Vitoria, Spain) with four different surfaces were used (acid etched [Ra: 0.29 ^m], 
conventionally plasma sprayed CaP-coated [PS/HACAM: crystallinity 65%, Ra: 4.37 ^m, 
adhesion strength > 55 MPa], micro plasma sprayed CaP-coated [MPS: crystallinity 67%, Ra: 
4.78 ^m, adhesion strength 13 MPa] and only on the apical half MPS CaP-coated). 
Physicochemical analysis was performed by using X-ray diffraction (XRD, Philips, Eindhoven, 
The Netherlands). Implants were sterilized by autoclaving (15 minutes / 121 ° C ).
Animal model and implantation procedure
Seven healthy 4-5 year old Beagle dogs weighing about 10 kg were used. The study was 
conform national guidelines for care and use of laboratory animals and approved by the 
ethical committee for animal research of The Radboud University Nijmegen Medical Center.
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The animals were premedicated (Droperidol® [Prostrakan, Galahiels, UK], Fentanyl® [Hameln 
Pharmaceutical GmbH, Hameln, Germany] [0.2 ml/kg]), anaesthetized (intra-venous injection 
of 30 mg/kg Thiopental® [Hospira Enterprises B.V., Hoofddorp, The Netherlands]), intubated 
and maintained (Isoflurane® [Rhodia Organique Fine Limited, Avonmouth, Bristol, England]). 
Oral mucosa and dentition were cleaned with chlorhexidine digluconate 1%. Local 
anaeasthesia was given (Lidocaine® [Fresenius Kabi, Den Bosch, The Netherlands]). After 
surgery the animals were medicated (1 ml Albipen® 15% [Intervet BV, Boxmeer, The 
Netherlands], 2nd and 4th day postoperatively 1 ml Albipen® LA [Intervet BV, Boxmeer, The 
Netherlands]). The dogs received a normal diet. For weekly cleaning (oral hygiene) the dogs 
were sedated (Ketamine® [Eurovet, Bladel, The Netherlands], Xylazine® [Astra Zenica, 
Zoetermeer, The Netherlands]).
At week 0 all 2nd, 3rd and 4th mandibular premolars were extracted (Figure 1). By week 12 full 
thickness flaps were raised and four implant sites per mandibular half prepared. According to 
a randomization scheme self-tapping implants representing the four different surfaces were 
inserted ensuring that the implant shoulder was placed at the level of the marginal portion of 
the buccal plate. Primary closure was achieved by resorbable sutures.
At week 18, alternating the left or right side, implants were provided with gold standard 
structures to allow occlusal loading (Picture 1). The contra lateral side served as control. For 
transmucosal healing the flaps were adjusted, repositioned and sutured with resorbable 
material. Subsequently, the animals were allowed to chew. The implants were brushed twice 
weekly (Hibitane® [Regent Medical, Irlam, United Kingdom] 0.2% chlorhexidine gel). By week 
70 (52 weeks after loading) the dogs were sacrificed (premedication: Droperidol® [Prostrakan, 
Galahiels, United Kingdom], Fentanyl® [Hameln Pharmaceutical GmbH, Hameln, Germany]), 
general anesthesia: 30 mg/kg Thiopental® [Hospira Enterprises B.V., Hoofddorp, The 
Netherlands], lethal dose of intravenously injected Thiopental® [Hospira Enterprises B.V., 
Hoofddorp, The Netherlands]). The vascular system was perfused with physiologic saline, 
followed by 4% neutral formaldehyde as a fixative.
Histological procedures and histomorphometrical evaluation
Mandibles were dissected, immersed (4% neutral formaldehyde / 2 weeks) and sectioned. 
Each block contained one implant with surrounding bone. The specimens were dehydrated in 
ethanol, embedded and polymerized in MMA. With a diamond blade sawing microtome 
(Leica, SP1600, Nussboch, Germany) three thin (10 |am) non-decalcified sections in bucco- 
lingual direction parallel to the longitudinal axis of the implant were prepared. All sections 
were stained with basic fuchsin and methylene blue and examined by light microscope (Zeiss - 
Axio Imager Z1 automated microscope with AxioCam MRc5 digital camera and AxioVision 
V6.3.2. acquisition software, Göttingen, Germany). Moreover, for histomorphometry digital 
image analysis software (Leica Qwin Pro, Leica Microsystems Imaging Solutions, Cambridge, 
UK) was used.
Parameters assessed:
A. Percentage of mineralized bone contact at the interface
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B. Amount of mineralized bone in the proximity (0-1500 ^m) of the implant surface 
Measurements were performed:
1. coronal half (middle of the top of the most coronal, first implant thread to the 
middle of the top of the 4th thread);
2. apical half (middle of the top of the 4th implant thread to the middle of the top of the 
8th thread);
3. entire length (middle of the top of the most coronal, first implant thread to the 
middle of the top of the 8th thread);
Amount of bone contact was defined as percentage of implant length at which there was 
direct bone-to-implant contact without intervening soft tissue layers.
C. Coating thickness reduction
Coating thickness reduction was analyzed by measuring the length of the implant surface 
areas that were not covered with CaP coating any more. Finally, coating thickness 
reduction for the various areas of interest (i.e. coronal, apical, entire implant length) was 
expressed as the percentage of the corresponding implant surface that was no longer 
covered with CaP coating.
All quantitative measurements were performed for 3 different sections per implant, at both 
implant sides. Results were presented based on the average of these measurements. All 
parameters were scored separately by two independent researchers.
Statistical analysis
SPSS 16.0 (SPSS Inc., Chicago, USA) was used. For surface type effects on bone healing and for 
coating thickness reduction One-Way ANOVA with Tukey Post Hoc Multiple Comparison Test 
and Independent-Samples T-test (significance level: 0.05) were used. Differences between 
non-loaded and loaded were analyzed using Independent-Samples T-test (significance level: 
0.05).
Results
Physicochemical analysis
Physicochemical analysis is detailed in the appendix. Briefly, XRD patterns for MPS and 
PS/HACAM are comparable and indicative for the presence of an amorphous/crystalline 
phase.
Macroscopic evaluation
At cover screw removal several implants were not osseointegrated (Table 1 lists finally 
included implants). During loading no implants were lost. All maintained implants showed a 
clinically healthy gingiva and at sacrifice no macroscopic signs of inflammation or adverse 
reaction.
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Light microscopic evaluation
For all implants healing without signs of inflammatory response was confirmed. 
Conventionally- and micro plasma spray coated implants
For PS and MPS intimate cortical and trabecular bone contact without intervening soft tissue 
layer was found. Loading did not affect the bone apposition pattern.
Generally, PS and MPS were surrounded by dense bone (Pictures 2, 3, 4). Trabecular bone 
present at the implant surface had a tentacle-like appearance (Picture 5 and 6). CaP coating 
appearance was not uniform. For MPS hardly any coating was left. PS coatings appeared to 
maintain their thickness in some areas, while at others only a thin layer or no coating at all 
was left. Coating thickness reduction did never interfere with bone-to-implant contact. CaP 
particles were found embedded in bone in the implant surface vicinity. No multinucleated 
cells were observed in their proximity (Pictures 7-1, 7-2, 7-3, 8-1, 8-2, 8-3).
Apically micro plasma spray coated and non-coated implants
Non-coated and aMPS implants showed no adverse bone reaction. However, in about 25% of 
the specimen (one non-coated, two aMPS), loading appeared to reduce bone apposition onto 
the coronal part of both types (Pictures 9 and 10). Similar to PS and MPS, aMPS and non­
coated implants were surrounded by dense bone (Picture 9 and 11).
Bone contact percentage
Bone-to-implant contact was measured for distinct areas of interest (Table 1). Irrespective of 
surface type and loading no significant differences were found (ANOVA, T-test; p>0.05, Table 
1). Additionally, for aMPS supplementary analysis (not shown) revealed no significant 
different bone apposition onto the apical coated compared to the non-coated coronal part (T- 
test, p>0.8 [non-loaded], p>0.1 [loaded]).
Amount of bone
Amount of bone data were measured for distinct areas and regions of interest (Table 3). 
Oneway-ANOVA revealed significant differences between the different surfaces. Tukey Post 
Hoc Multiple Comparison Test demonstrated that these differences were in preponderance 
related to the low apical aMPS 1500 values.
Coating thickness reduction
Coating thickness reduction data are given in Table 2. Irrespective of loading, significant more 
thickness reduction was found for MPS versus PS ( p<0.05, Table 2). Loading was not 
associated with an altered coating thickness reduction pattern (p>0.05, Table 2). Additionally, 
for PS and MPS supplementary statistical analysis (analysis not shown) revealed no different
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coating thickness reduction at the apical compared to the coronal part (T-test, PS: p>0.1 [non­
loaded], p>0.1 [loaded], MPS: p>0.6 [non-loaded], p>0.9 [loaded]).
Discussion
Long-term loading effects of PS and MPS CaP coatings on bone remodeling and coating 
behavior were investigated. It was hypothesized that both coatings would result in 
comparable effects at the bone-implant interface and that coating performance would be 
similar. Hence, the null hypothesis as to bone remodeling is not rejected, whereas the null 
hypothesis concerning coating performance is rejected.
Some implants in all groups were not osseointegrated at cover screw removal. We suppose 
that this lack of osseointegration is not related to surface composition, but surgical trauma, 
bacterial infection or the limited alveolar ridge width (Junker et al., 2010b).
Non-loaded and loaded implants showed a similar implant-to-bone response for all four 
surface groups. However, the current results do not agree with our earlier studies in which HA 
plasma-spray coated and non-coated implants were placed in the maxillae of goats (Caulier et 
al., 1997a, 1997b). Always a stronger bone response to the HA-coated implants was observed 
compared with various types of machined and roughened titanium implants. A possible 
explanation for this discrepancy can be the acid etching treatment as presently used. Nano- 
roughening as created by acid-etching is known to have a favorable effect on the implant- 
bone response. Several studies confirm a higher percentage of bone-contact achieved with 
etched surfaces compared to machined and are reviewed elsewhere (Le Guéhennec et al., 
2007). It is supposed that adhesion and differentiation of osteogenic cells is enhanced by a 
nanotextured implant surface (Brett et al., 2004; Mendonça et al., 2008). Another explanation 
can be the local bone conditions. The maxillary bone of the goat has low density (Type 3-4), 
while bone in the dog mandible is much denser (Type 1-2). Also, implants in the mandible of a 
dog are installed in between the buccal and lingual cortical wall, which will increase the initial 
implant stability. Both local bone conditions and implant stability are known to have an effect 
on the implant-bone response (Brunski et al., 2009; Johansson and Albrektsson, 1987; 
Mendonça et al., 2008; Moy et al., 2009) . Apparently, the advantages of a CaP coating 
become only evident under more severe implantation conditions.
Promising effects of CaP coatings are known for decades (Jansen et al., 1999; Van Blitterswijk 
et al., 1993), but clinical performance remains controversial (Lee et al., 2000; Schwartz-Arad 
et al., 2005). Particularly, coating degradation is related to supplementary crestal bone loss. 
Therefore, we decided to include implants with an apical coating and assumed to combine 
positive biological effects of calcium phosphate ceramic, while avoiding possible 
disadvantages as crestal bone resorption. One year after loading aMPS and non-coated 
implants induced a similar bone-implant response. However, loading was for two aMPS 
implants associated with a decrease in bone-to-implant contact onto the coronal, not-coated 
part of the implants as compared to the non-loaded condition and the completely coated 
implants. This crestal bone loss agrees with observations by others (Block et al., 2000; Junker 
et al., 2010b; Lee et al., 2009). In our study (Junker et al., 2010b), this bone loss was already
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present after 12 weeks of loading. Therefore, we assume that it is related to the initial bone 
response. The deposition of a CaP coating appears to overcome the initial effect of occlusal 
loading on the bone healing response.
The significant differences found for bone volumes are biologically hardly explicable (Brunski, 
1999; Garetto et al., 1995) and might be related to placement of some implants into the 
mandibular canal (Novaes et al., 2002) and the moderate number of implants analyzed. 
Similar to earlier studies, a non-uniform reduction in thickness of plasma-sprayed coatings 
was found (Caulier et al., 1995; Dhert et al., 1991; Jansen et al., 1993; Junker et al., 2009a; 
Junker et al., 2010b). It has to be noticed that no thickness measurements of the coating as 
left were determined, as this assumes an accuracy that cannot be guaranteed. Accurate 
measurements can only be performed when the histological sections are made 100% parallel 
to the longitudinal axis of the implant, which is almost impossible in the used histological 
sectioning technique. For this reason, the coating thickness reduction, as assessed, is only 
referring to complete absence of CaP coating. The reason and consequences of the observed 
coating thickness reduction are still not completely understood. Most likely coating thickness 
reduction is due to dissolution of the amorphous phase between the crystalline coating 
particles. Presently, load was neither for PS nor for MPS associated with enhanced coating 
thickness reduction. Conversely, despite the physicochemical similarity between PS and MPS, 
significantly more coating thickness reduction was observed for the latter and cannot be 
explained. We emphasize that coating thickness reduction and release of CaP particles, which 
subsequently became embedded in bone tissue, could never be associated with osteolysis or 
inflammatory cells. This corroborates with others, like Piatelli et al. (Piatelli et al., 1998) and 
Ong et al. (Ong et al., 2002), who reported that degradation of CaP coatings was not 
detrimental to peri-implant bone reaction. Yamamoto et al. (Yamamoto et al., 2006) even 
demonstrated that coating degradation was associated with enhanced osteoconductivity and 
increased bone-to-implant contact.
We conclude that functional loading of MPS CaP coated implants evokes a favorable bone 
response and that this response - irrespective of loading - does not differ from PS coatings. 
However, functional loading of PS and MPS coated implants might be associated with 
increased crestal bone maintenance as compared to non-coated implants.
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Appendix
Figure 1: Study design
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Figure 1: The X-ray diffraction patterns of (a) conventionally plasma sprayed coating (HACAM), showing a oriented 
amorphous/crystalline structure, (b) microplasma sprayed coating (MPS-A), showing a oriented 
amorphous/crystalline coating, (c) microplasma sprayed coating (MPS-B), showing a preferential (001) oriented 
amorphous crystalline coating.
137
Picture 2: MPS coated non-loaded implant surrounded by dense bone (Objective 10x)
Picture 3: MPS coated functionally loaded implant surrounded by dense bone (Objective 10x)
Picture 4: PS coated functionally loaded implant surrounded by dense bone (Objective 10x)
Picture 5: MPS coated functionally loaded implant showing tentacle-like appearance in trabecular bone (Objective 
10x)
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Picture 6: PS coated functionally loaded implant showing tentacle-like appearance in trabecular bone (Objective 10x)
Picture 7-1: MPS coated functionally loaded implant showing non-uniform coating thickness (Objective 10x)
Picture 7-2: MPS coated functionally loaded implant showing non-uniform coating thickness (Objective 20x)
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Picture 7-3: MPS coated functionally loaded implant showing non-uniform coating thickness and CaP particle 
surrounded by bone (arrows) (Objective 40x)
Picture 8-1: PS coated functionally loaded implant showing non-uniform coating thickness (Objective 10x)
Picture 8-2: PS coated functionally loaded implant showing non-uniform coating thickness (Objective 20x)
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Picture 8-3: PS coated functionally loaded implant showing non-uniform coating thickness and CaP particle 
surrounded by bone (arrows) (Objective 40x)
Picture 9: Non-coated functionally loaded implant showing reduced bone apposition onto the coronal part of the 
implant surface (Objective 10x)
Picture 10: aMPS coated functionally loaded implant showing reduced bone apposition onto the coronal part of the 
implant surface (Objective 10x)
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Picture 11: Non-coated non-loaded im plant surrounded by dense bone (Objective 10x)
N on- loaded
Mean (SD ) [%]
Lo ad ed
Mean (S D ) [%]
Coronal non-coated (n=6) non-coated (n=7) ns
79.6 (12.9) 85.5 (6.6)
P S  (n=3) P S  (n=6) ns
94.7 (6.6) 83.7 (21.7)
M PS (n=6) M PS (n=6) ns
84.0 (13.5) 74.3 (16.6)
aM P S (n=5) aM P S (n=6)
89.4 (11.4) 72.2 (21.4) ns
ns ns
Apical non-coated (n=6) non-coated (n=7) ns
87.3 (12.0) 90.4 (4.6)
P S  (n=3) P S  (n=6) ns
97.7 (0.6) 95.0 (3.1)
M PS (n=6) M PS (n=6) ns
88.4 (6.8) 89.9 (5.6)
aM P S (n=5) aM P S (n=6)
88.2 (10.7) 88.1 (4.5) ns
ns ns
Entire length non-coated (n=6) non-coated (n=7) ns
83.8 (9.6) 87.9 (4.84)
P S  (n=3) P S  (n=6) ns
96.3 (3.4) 90.9 (9.3)
M PS (n=6) M PS (n=6) ns
86.1 (9.8) 82.9 (8.2)
aM P S (n=5) aM P S (n=6)
88.5 (11.1) 81.3 (10.8) ns
ns ns
ns: not significant different (p>0.05); * significant different (p<0.05)
Table 1: Bone apposition data in the areas of interest at the different types of implant surfaces and loading 
conditions.
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N o n - lo a d e d
M ean (S D )  [%]
L o a d e d
M ean (S D )  [%]
Coro n al P S  (n=3) P S  (n=6) ns
6 1 .4  (8 .9) 4 1.0  (19.4)
M P S  (n=6) M P S  (n=6) ns
1.3 (3 .1) 4.7  (4 .5)
* *
A p ica l P S  (n=3) P S  (n=6) ns
7 4.7  (7 .0) 5 8.8  (23.3)
M P S  (n=6) M P S  (n=6) ns
2 .2  (3 .4) 4 .4  (6 .0)
a M P S  (n=5) a M P S  (n=6) ns
11.8 (21.7) 2.2  (4 .5)
* *
Post hoc test Post hoc test
P S  vs . M P S  * P S  vs . M P S  *
P S  vs . a M P S  * P S  v s . a M P S  *
M P S  v s . a M P S  ns M P S  v s . a M P S  ns
Entire length P S  (n=3) P S  (n=6) ns
68.1 (7 .2) 4 9.9  (20.5)
M P S  (n=6) M P S  (n=6) ns
1.7 (2 .8) 4.5  (4 .5)
* *
ns: not significant different (p>0.05); * significant different (p<0.05)
Table 2: Comparison of coating-to-implant contact data at distinct implant surfaces regarding load.
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Am ount o f  
bone
Non- loaded
Mean (SD) [%]
Loaded
Mean (SD) [%]
C oro n al N on-coated  5 0 0  (n=6) 
86 .3  (6 .8)
N on-coated 5 00  (n=7) 
8 8 .4  (5.4)
ns
N on-coated  1000 (n=6) 
8 3 .9  (6 .9)
N on-coated 1000 (n=7) 
8 4 .6  (7.6)
ns
N on-coated  1500 (n=6) 
8 0 .4  (11 .2)
N on-coated 1500 (n=6) 
8 6 .2  (8.1)
ns
PS 500 (n=3) 
8 8 .8  (6 .3)
PS 500 (n=6) 
8 3 .6  (14.6)
ns
PS 1000 (n=3) 
8 5 .6  (8 .4)
PS 1000 (n=6) 
7 8 .3  (10.7)
ns
PS 1500 (n=3) 
6 2 .7  (44.8)
PS 1500 (n=5) 
9 0 .0  (7.8)
ns
MPS 500 (n=6) 
8 9 .9  (7 .3)
MPS 500 (n=7) 
8 5 .3  (13.4)
ns
MPS 1000 (n=6) 
86.1 (8 .6)
MPS 1000 (n=7) 
8 0 .3  (10.6)
ns
MPS 1500 (n=6) 
8 1 .6  (8 .5)
MPS 1500 (n=6) 
8 5 .5  (8.1)
ns
aM PS 500 (n=5) 
95.1 (3 .1)
aM PS 500 (n=6) 
8 4 .3  (14.0)
ns
aM PS 1000 (n=5) 
8 8 .6  (4 .9)
aM PS 1000 (n=6) 
7 8 .5  (14.1)
ns
aM PS 1500 (n=5) 
8 3 .4  (9 .9)
aM PS 1500 (n=6) 
6 8 .5  (16.9)
ns
ns ns
A p ica l Non-coated 500 (n=6) 
86.2 (5.8)
Non-coated 500 (n=7) 85.0 (5.8) ns
Non-coated 1000 (n=6) 
79.2 (11.7)
Non-coated 1000 (n=7) 
79.6 (8.5)
ns
Non-coated 1500 (n=6) 
78.7 (11.7)
Non-coated 1500 (n=7) 86.1 (12.0) ns
PS 500 (n=3) 
85.7 (9.2)
PS 500 (n=6) 
90.6 (4.3)
ns
PS 1000 (n=3) 
78.2 (11.7)
PS 1000 (n=6) 
79.2 (12.8)
ns
PS 1500 (n=3) 
70.5 (3.4)
PS 1500 (n=5) 
87.0 (7.4)
*
MPS 500 (n=6) 
89.2 (3.9)
MPS 500 (n=7) 
88.7 (4.7)
ns
MPS 1000 (n=6) 
81.7 (9.0)
MPS 1000 (n=7) 
82.4 (7.8)
ns
MPS 1500 (n=6) 
70.3 (18.7)
MPS 1500 (n=7) 
89.2 (10.2)
*
aM PS 500 (n=5) 
91.8 (5.4)
aM PS 500 (n=6) 
86.3 (6.3)
ns
aM PS 1000 (n=5) 
78.0 (10.6)
aM PS 1000 (n=6) 
73.9 (14.2)
ns
aM PS 1500 (n=5) 
61.9 (16.1)
aM PS 1500 (n=6) 
65.1 (21.8)
ns
* *
Post hoc test Post hoc test
Non-coated 500 vs. 
aM PS 1500 *
Non-coated 500 vs. 
aM PS 1500 ns
aM PS 500 vs. 
aM PS 1500 *
Non-coated 1500 vs. 
aM PS 1500 *
P S  500 vs.
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aM PS 1500 *
M PS 500 vs. 
aM PS 1500 *
M PS 1500 vs. 
aM PS 1500 *
aM PS 500 vs. 
aM PS 1500 ns
Entire length Non-coated 500 (n=6) 
86.3 (3.7)
Non-coated 500 (n=7) 
86.7 (5.2)
ns
Non-coated 1000 (n=6) 
81.5 (7.9)
Non-coated 1000 (n=7) 82.1 (7.4) ns
Non-coated 1500 (n=6) 
79.5 (10.8)
Non-coated 1500 (n=6) 
85.0 (5.6)
ns
PS 500 (n=3) 
87.3 (7.7)
PS 500 (n=6) 
87.1 (7.3)
ns
PS 1000 (n=3) 
81.9 (9.8)
PS 1000 (n=6) 
78.8 (9.6)
ns
PS 1500 (n=3) 
66.6 (23.2)
PS 1500 (n=5) 
88.5 (4.4)
ns
MPS 500 (n=6) 
89.6 (4.2)
MPS 500 (n=7) 
87.0 (7.3)
ns
MPS 1000 (n=6) 
83.9 (8.6)
MPS 1000 (n=7) 
81.3 (7.3)
ns
MPS 1500 (n=6) 
76.0 (12.7)
MPS 1500 (n=6) 
86.5 (8.1)
ns
aM PS 500 (n=5) 
93.5 (4.1)
aM PS 500 (n=6) 
85.3 (4.9)
*
aM PS 1000 (n=5) 
83.3 (7.2)
aM PS 1000 (n=6) 
76.2 (6.8)
ns
aM PS 1500 (n=5) 
72.6 (11.9)
aM PS 1500 (n=6) 
66.8 (18.0)
ns
* *
Post hoc test Post hoc test
P S  1500 vs. 
aM PS 500 *
Non-coated 500 vs. 
aM PS 1500 *
aM PS 500 vs. 
aM PS 1500 ns
Non-coated 1500 vs. 
aM PS 1500 *
P S  500 vs. 
aM PS 1500 *
P S  1500 vs. 
aM PS 1500 *
M PS 500 vs. 
aM PS 1500 *
M PS 1500 vs. 
aM PS 1500 *
aM PS 500 vs. 
aM PS 1500 *
ns: not significant different (p>0.05); * significant different (p<0.05)
Table 3: Sig. differences for amount of bone data in the regions of interest at the different types of implant 
surfaces and loading conditions.
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Chapter 6:
Bone reaction adjacent to microplasma sprayed CaP-coated oral implants subjected to 
occlusal load; an experimental study in the dog. Part III: Marginal bone and soft tissue 
healing-long term results
Introduction
During the last two decades, due to positive long-term results with implant supported 
overdentures and fixed partial dentures, implant borne single tooth restorations became 
more popular. Hence, increasing attention has been given to study soft tissue adaptation and 
periimplant crestal bone changes (Hermann, et al. 2001).
Implant supported restorations necessarily penetrate the oral mucosa and thereby the 
ectodermal integrity of the human body, thus creating a link between the oral environment 
and underlying tissues. Consequently, the soft-tissue connection to the transmucosal implant 
part is of critical importance for periimplant tissue stability and prevention of periimplant 
infection with subsequent tissue destruction (Klinge and Meyle 2006). In a similar manner to 
dento-gingival tissues the interface comprises a gingival sulcus, junctional epithelium as well 
as connective tissue. The vertical dimension of this soft-tissue interface has been termed 
"biological width" (Berglundh and Lindhe 1996, Cochran, et al. 1997, Gargiulo, et al. 1961, 
Vacek, et al. 1994). Moreover, "biological width" is an anatomical concept describing the 
dimensions of the soft tissue barrier around implants. In principle, the epithelial portion 
measures between 1.5 mm and 2 mm and the connective tissue portion between 1 mm and 
1.5 mm (Berglundh, et al. 1991). Early formation and development of this soft tissue barrier 
around implants placed in a healed alveolar ridge have recently been reported by Berglundh 
et al. (Berglundh, et al. 2007). The overall dimensions of this barrier have been shown to be in 
principle independent from the implant surgical technique, i.e. submerged versus non­
submerged (Abrahamsson, et al. 1999, Ericsson, et al. 1996) and type of implant, i.e. one- or 
two-piece implants (Abrahamsson, et al. 1996). Consequently , it was suggested that 
"biological width" is a physiologically formed structural unit (Hermann, et al. 2000). However, 
recent studies do indicate dimensional differences evaluating implantation in healed alveolar 
ridges opposed to implantation immediately after tooth extraction (Rimondini, et al. 2005, 
Schultes and Gaggl 2001, Vignoletti, et al. 2009).
Besides, to the best of our knowledge, the effect of long-term functional loading on soft 
tissue remodeling has not been definitively addressed (Assenza, et al. 2003, Cochran, et al. 
1997, Heitz-Mayfield, et al. 2004, Hermann, et al. 2000).
Next to soft tissue, periimplant crestal bone stability gains more and more interest. Marginal 
bone loss around functionally loaded dental implants has been a common observation and 
has been reflected in criteria for implant success (Albrektsson, et al. 1986). Many different 
reasons and explanatory models for this phenomenon have been given and were recently 
reviewed in detail by Isidor (Isidor 2006). In principle, periosteum reflection, implant bed 
preparation, microgap level between abutment and implant body, bacterial invasion,
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establishment of a "biological width", configuration of the coronal implant part , occlusal load 
or overload as well as compromised healing/adaptation (Chvartszaid et al. 2008) have been 
discussed.
Functional load will, because the stiffness of titanium implants is several times greater than 
that of cortical bone, result in the highest stress in the most coronal portion of the supporting 
bone and might be, at least in part, an explanation for observed marginal bone loss.
As surface modifications of titanium implants may affect stress distribution in bone and 
thereby strain at the bone implant interface (French, et al. 1989, Rieger, et al. 1989), it might 
be possible that changing the chemical surface composition could have a positive effect on 
marginal bone stability under conditions of long-term functional load. Coating of dental 
titanium implants with calcium phosphate (CaP) ceramic is the most frequently used method 
for changing the chemical surface composition (Le Guéhennec, et al. 2007). However, 
especially because of observed crestal bone loss, short- and long term clinical predictability of 
CaP coated dental implants remain controversial. For example, it is hypothesized that coating 
resorption or degradation might lead to an exposed roughened implant surface, which 
induces bacterial infection in the pergingival area. Consequently, in susceptible individuals 
such an infection might lead to peri-implantitis. Furthermore, osteolysis induced by coating 
resorption or degradation as well as loosening of implants due to coating delamination are 
proposed to occur (Lee, et al. 2000, Schwartz-Arad, et al. 2005) Several techniques have been 
developed and are used to coat CaP ceramics onto titanium implant surfaces. Plasma spraying 
(PS) is still the most common method used. However, relevant limitations persist in 
conventionally PS CaP coatings. To overcome these, a novel microplasma spraying (MPS) 
equipment has been developed (Borisov, et al. 2002, Borisov, et al. 2008, Yushchenko, et al.
1995). Recently, an animal experiment confirmed that MPS produces CaP coatings 
comparable to conventional PS in terms of bone biocompatibility. Moreover, bone apposition 
and mechanical stability were significantly enhanced as compared with non-coated implants 
(Junker, et al. 2010a). Likewise, in a short-term as well as in a long-term experiment in a 
mandibular dog model MPS coatings evoked a favorable bone response that was similar to PS 
coatings. However, functional load was neither for MPS nor for PS coatings associated with on 
average more bone apposition onto the coronal implant part as compared to non-coated 
implants. Moreover, functional loading was not associated with statistically significant more 
coronal coating degradation (Junker, et al. 2010b, Junker, et al. 2010c).
Therefore, the present study aimed to investigate long-term effects of functional load on soft- 
tissue adaptation as well as crestal bone stability. Based on the assumption that "biological 
width" is a physiologically formed structural unit (Hermann, et al. 2000), it was hypothesized 
that long-term functional load will not affect "biological width" dimension.
Furthermore, because functional load was neither for MPS nor for PS coatings associated with 
on average less bone apposition onto the coronal implant part as compared to non-coated 
implants (Junker, et al. 2010b, Junker, et al. 2010c) it was hypothesized that long-term 
functional load of MPS or PS CaP coated dental implants is not associated with less marginal 
bone stability.
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Material and Methods
The experimental model used in this study has been recently described (Junker, et al. 2010c). 
Implants
In total fifty-six screw type titanium implants were used (diameter: 3.3 mm, length: 10 mm ; 
manufacturer: BTI, Vitoria, Spain). The implants were divided in four groups; non-coated, acid 
etched implants (Ra: 0.29 ^m, Rq: 0.41 ^m), conventionally plasma sprayed implants 
(PS/HACAM: crystallinity 65%, Ra: 4.37 ^m, Rq: 5.48 ^m, adhesion strength > 55 MPa), micro 
plasma sprayed implants (MPS: crystallinity 67%, Ra: 4.78 ^m, Rq: 5.97 ^m, adhesion strength 
12.98±1.66 MPa) and implants that were provided only for their lower apical half with a MPS
®
coating. A Universal Surface Tester (UST , Würzburg, Germany) was used to characterize the 
different surface topographies of the implants. Therefore, three screws from each group were 
selected at random and measured at the apical flat part of the implant. Physicochemical 
analysis was performed by using X-ray diffraction (XRD, Philips, Eindhoven, The Netherlands). 
The PS/HACAM and MPS coatings were found to be composed similar and consisted of 
amorphous/crystalline hydroxyapatite. Before use, all implants were sterilized by autoclaving 
(for 15 minutes at 121 ° C ).
Animal model and implantation procedure
This experiment was performed using 7 healthy 4-5 year old Beagle dogs weighing about 10 
kg. The study was conform national guidelines for care and use of laboratory animals and 
approved by the ethical committee for animal research of The Radboud University Nijmegen 
Medical Center. Prior to the surgical procedures, the animals were premedicated with a 
combination of Droperidol® (Prostrakan, Galahiels, United Kingdom) and Fentanyl® (Hameln 
Pharmaceutical GmbH, Hameln, Germany) (0.2 ml/kg). Subsequently, they were 
anaesthetized with an intra-venous injection of 30 mg/kg Thiopental® (Hospira Enterprises
B.V., Hoofddorp, The Netherlands). After intubation, anesthesia was maintained with 
Isoflurane® (Rhodia Organique Fine Limited, Avonmouth, Bristol, England).The oral mucosa 
and dentition was cleaned with chlorhexidine digluconate 1% in water. Thereafter, local 
anesthesia was given by injection of Lidocaine® (Fresenius Kabi, Den Bosch, The Netherlands). 
After surgery, the animals were medicated with 1 ml Albipen® 15% (Intervet BV, Boxmeer, 
The Netherlands) and a maintenance dose of 1 ml Albipen® (Intervet BV, Boxmeer, The 
Netherlands) LA the 2nd and 4th day postoperatively. The dogs received a normal diet after 
surgery. For weekly cleaning (oral hygiene), the dogs were sedated with a combination of 
Ketamine® (Eurovet, Bladel, The Netherlands) and Xylazine® (Astra Zenica, Zoetermeer, The 
Netherlands). In a first surgical session (week 0), the second, third and fourth mandibular 
premolars were extracted bilaterally in each dog. After a healing period of three months 
(week 12), an incision was made at the bone crest and a full thickness mucoperiostal flap was 
raised both to the buccal- and to the lingual side of the alveolar ridge. Using a low-speed drill, 
a graded series of burrs and continuous physiological saline irrigation, four implant sites per
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mandibular half were prepared. Self-tapping implants representing the four different surfaces 
were subsequently inserted in their designated positions ensuring that the implant shoulder 
was placed at the level of the marginal portion of the buccal plate. For randomization a 
scheme was used. Finally, the wound was closed using resorbable sutures. After a healing 
period of 6 weeks (week 18), a re-entry operation was performed at both sides of the jaw. 
Alternating the left or right side, the cover screws of the implants were removed and the 
implants were provided with gold standard structures, mimicking tooth crowns to allow 
occlusal loading of the implants (Figure 1). In each dog the contra lateral side served as 
control. After flap elevation, soft tissue was adjusted, flaps were repositioned and sutured 
with resorbable suture material in order to allow transmucosal healing. Subsequently, the 
animals were allowed to chew with the implants. The implants were brushed twice weekly 
with Hibitane® (Regent Medical, Irlam, United Kingdom) 0.2% chlorhexidine gel. Fifty-two 
weeks after loading (Week 70), the dogs were sacrificed. After premedication with a 
combination of Droperidol® (Prostrakan, Galahiels, United Kingdom)and Fentanyl® (Hameln 
Pharmaceutical GmbH, Hameln, Germany) they were brought under general anesthesia using 
30 mg/kg Thiopental® (Hospira Enterprises B.V., Hoofddorp, The Netherlands). After some 
minutes a lethal dose of Thiopental® (Hospira Enterprises B.V., Hoofddorp, The Netherlands) 
was injected intravenously. The vascular system was perfused with physiologic saline, 
followed by 4% neutral formaldehyde as a fixative.
Histological procedures and histomorphometrical evaluation
After perfusion, the mandibles of the dogs were dissected and following excess tissue 
removal immersed with 4% neutral formaldehyde for another 2 weeks. Then, using a 
diamond saw, the mandibles were sectioned in smaller blocks, suitable for histological 
processing. Finally, each block contained one implant with surrounding bone. Subsequently, 
the specimens for histological evaluation were dehydrated in ethanol and embedded in 
methylmethacrylate (MMA). After polymerization in MMA, thin (10 |am) non-decalcified 
sections were prepared in a bucco-lingual direction parallel to the long axis of the implant 
using a modified diamond blade sawing microtome technique (Leica, SP1600, Nussboch, 
Germany). All sections were stained with basic fuchsin and methylene blue and were 
examined with a light microscope (Zeiss - Axio Imager Z1 automated microscope with 
AxioCam MRc5 digital camera and AxioVision V6.3.2. acquisition software, Göttingen, 
Germany) and digital image analysis software (Leica Qwin Pro, Leica Microsystems Imaging 
Solutions, Cambridge, UK) was used for histomorphometrical measurements.
The following parameters were assessed:
C. Dimension of the soft-tissue
The following measurements [in mm] and calculations were performed for each 
implant (Figure 2):
1. Sulcus depth (SD): linear distance between the gingival margin (GM) and 
the most coronal point of the junctional epithelium (cJE)
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2. Junctional epithelium (JE): linear distance between cJE and the most 
apical point of the junctional epithelium (aJE)
3. Connective tissue (CT): linear distance between aJE and the first bone- 
to-implant contact
4. "Biological width" (BW): SD+JE+CT
D. Marginal bone level
The linear distance from middle of the top of the most coronal, first implant 
thread to the first bone-to- implant contact was measured [in mm] for each 
implant (Figure 3). If the first bone-to-implant was located coronal from the 
measurement landmark of the first implant thread this was indicated as a 
positive value (+), on the contrary, if located apical it was indicated as a negative 
value (-).
Statistical analysis
For statistical analysis SPSS 16.0 (SPSS Inc., Chicago, USA) was used. To evaluate effects of the 
different surface types on coronal bone apposition and soft tissue healing One-Way ANOVA 
with Tukey Post Hoc Multiple Comparison Test (significance level: 0.05) was used. Differences 
between non-loaded and functional loaded implants were analyzed using Independent- 
Samples T-test (significance level: 0.05).
Results
Macroscopic evaluation
All dogs remained in good health. However, during second stage surgery several implants 
were found to be not osseointegrated. Lost implants were equally distributed over all four 
implant groups. Finally, for sulcus depth measurements 5 non-loaded/non-coated implants 
(from dogs 3, 6, 7, 10 and 14), 3 non-loaded/PS implants (from dogs 3, 6 and 14), 6 non­
loaded/MPS implants (from dogs 3, 6, 7, 10, 13 and 14), 5 non-loaded/aMPS implants (from 
dogs 3, 6, 7, 13 and 14), 5 loaded/non-coated implants (from dogs 3, 6, 7, 10 and 14), 4 
loaded/PS implants (dogs 1, 10, 13 and 14), 7 loaded/MPS implants (from dogs 1, 3, 6, 7, 10, 
13 and 14) and 6 loaded/aMPS implants (from dogs 1, 3, 6, 7, 13 and 14) could be included in 
the study. Furthermore, for measurements of the junctional epithelium, connective tissue as 
well as "biological width" 6 non-loaded/non-coated implants (from dogs 1, 3, 6, 7, 10 and 14), 
3 non-loaded/PS implants (from dogs 3, 6 and 14), 6 non-loaded/MPS implants (from dogs 3, 
6, 7, 10, 13 and 14), 5 non-loaded/aMPS implants (from dogs 3, 6, 7, 13 and 14), 7 
loaded/non-coated implants (from dogs 1, 3, 6, 7, 10, 13 and 14), 4 loaded/PS implants (dogs
1, 10, 13 and 14), 7 loaded/MPS implants (from dogs 1, 3, 6, 7, 10, 13 and 14) and 6 
loaded/aMPS implants (from dogs 1, 3, 6, 7, 13 and 14) could be included. Moreover, for 
marginal bone level measurements 6 non-loaded/non-coated implants (from dogs 1, 3, 6, 7, 
10 and 14), 3 non-loaded/PS implants (from dogs 3, 6 and 14), 6 non-loaded/MPS implants
(from dogs 3, 6, 7, 10, 13 and 14), 5 non-loaded/aMPS implants (from dogs 3, 6, 7, 13 and 14),
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7 loaded/non-coated implants (from dogs 1, 3, 6, 7, 10, 13 and 14), 5 loaded/PS implants 
(dogs 1, 6, 10, 13 and 14), 7 loaded/MPS implants (from dogs 1, 3, 6, 7, 10, 13 and 14) and 6 
loaded/aMPS implants (from dogs 1, 3, 6, 7, 13 and 14) could be included in the study. Table 1 
lists the number of implants finally included for the histomorphometrical assessment. During 
loading no additional implants were lost. All maintained implants showed clinically a healthy 
gingiva without signs of pocket formation, recession or bone resorption. Furthermore, at 
sacrifice, no macroscopic signs of inflammation or adverse tissue reaction were noticeable.
Light microscopic evaluation
For all harvested implants light microscopic evaluation confirmed an uneventful healing 
without any signs of an inflammatory response, as characterized by the absence of infiltration 
by inflammatory cells.. For loaded and non-loaded implants an intimate bone contact without 
intervening soft tissue layer was found. Bone healing as well as coating behavior are detailed 
in an earlier publication (Junker, et al. 2010c).
Irrespective of implant type and loading condition, the barrier epithelium appeared mature 
and was in contact to the surface of the implant (Fig. 4). In some sites, the epithelium 
extended close to the marginal bone level (Fig. 5). In most of the specimens, the marginal 
bone level, i.e. the first bone-to-implant contact was located at the first coronal screw thread.
Histomorphometrical evaluation
The results from the histomorphometric measurements (mm) are listed in Table 1.
Sulcus depth
For non-loaded implants, statistical testing (ANOVA) of the sulcus depth data revealed no 
significant difference (p=0.098) between the distinct implant surfaces.
For loaded implants, statistical testing (ANOVA) of the sulcus depth data revealed no 
significant difference (p=0.078) between the distinct implant surfaces.
Furthermore, no significant differences were found for functional loading as compared to the 
non-loaded condition (Independent-Samples T-test; non-coated: p=0.230, PS: p=0.268, MPS: 
p=0.314, and aMPS: p=0.092).
Junctional epithelium
For non-loaded implants, statistical testing (ANOVA) of the length of the junctional epithelium 
data revealed a significant difference (p=0.026) between the distinct implant surfaces. Tukey 
Post Hoc Multiple Comparison Test proved significant less junctional epithelium length for PS 
compared to non-coated implants (p=0.037), PS compared to MPS implants (p=0.041), as well 
as for PS compared to aMPS implants (p=0.028).
For loaded implants statistical testing (ANOVA) revealed no significant difference (p=0.615) in 
junctional epithelium length between the distinct implant surfaces.
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Furthermore, no significant differences were found for functional loading as compared to the 
non-loaded condition (Independent-Samples T-test; non-coated: p=0.915, PS: p=0.388, MPS: 
p=0.913, and aMPS: p=0.386).
Connective tissue (CT)
For non-loaded implants, statistical testing (ANOVA) revealed a significant difference 
(p=0.019) in connective tissue thickness between the distinct implant surfaces. Tukey Post 
Hoc Multiple Comparison Test proved significant more connective tissue for non-coated 
compared to aMPS implants (p=0.020).
For loaded implants, statistical testing (ANOVA) revealed no significant difference (p=0.765) in 
connective tissue thickness between the distinct implant surfaces.
Furthermore, no significant differences were found for functional loading as compared to the 
non-loaded condition (Independent-Samples T-test; non-coated: p=0.082, PS: p=0.581, MPS: 
p=0.269, and aMPS: p=0.122).
"Biological width"
For non-loaded implants, statistical testing (ANOVA) of the biological width data revealed a 
significant difference (p=0.049) between the distinct implant surfaces. Tukey Post Hoc 
Multiple Comparison Test proved significant more "biological width" for non-coated implants 
compared to PS implants (p=0.031).
For loaded implants, statistical testing (ANOVA) revealed no significant difference (p=0.640) in 
biological width between the distinct implant surfaces.
Furthermore, no significant differences were found for functional loading as compared to the 
non-loaded condition (Independent-Samples T-test; non-coated: p=0.391, PS: p=0.442, MPS: 
p=0.474, and aMPS: p=0.829).
Marginal bone level
For non-loaded implants, statistical testing (ANOVA) revealed a significant difference 
(p=0.014) in marginal bone between the distinct implant surfaces. Tukey Post Hoc Multiple 
Comparison Test proved significant higher bone level for aMPS implants compared to non­
coated implants (p=0.044) as well as for aMPS implants compared to MPS implants (p=0.012). 
For loaded implants, statistical testing (ANOVA) revealed no significant difference (p=0.651) in 
marginal bone level between the distinct surfaces.
Furthermore, for non-coated, PS, and MPS implants no significant differences were found for 
functional loading as compared to the non-loaded condition (Independent-Samples T-test; 
non-coated: p=0.779, PS: p=0.190, MPS: p=0.759). However, for aMPS implants a significant 
difference was found (p=0.020).
Discussion
The present study investigated the long-term effect of functional loading on soft-tissue 
adaptation as well as marginal bone level in relation to implant surface composition. The null
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hypothesis that long-term functional loading will not affect "biological width" dimension is 
not rejected. Furthermore, the null hypothesis that long-term functional loading of MPS or PS 
CaP coated dental implants is not associated with less marginal bone stability is not rejected. 
Regrettably, a few implants were found to be not osseointegrated at second stage surgery. 
This lack of osseointegration occurred in all implant groups. Therefore, we suppose that it is 
not related to the implant surface composition, but due to surgical trauma, bacterial 
contamination with subsequent infection or the limited width of the alveolar ridge as 
compared with the implant diameter (Junker, et al. 2010b).
"Biological width" is an anatomical concept that describes soft tissue barrier dimensions 
around teeth and implants (Berglundh, et al. 1991, Berglundh and Lindhe 1996, Cochran, et 
al. 1997, Gargiulo, et al. 1961, Vacek, et al. 1994). Investigations in dogs demonstrated that 
mucosal attachment to implants parallels that at teeth. In principle, mucosal attachment 
comprises an epithelial (about 1.5-2 mm) and a connective tissue portion (about 1-1.5mm) 
(Berglundh, et al. 1991, Buser, et al. 1992, Cochran, et al. 1997, Hermann, et al. 2001).
In the present study, for non-loaded implants mean sulcus depths ranged from 0.1 to 0.3 mm, 
mean junctional epithelium from 0.9 to 1.8 mm, mean connective tissue from 0.4 to 1.1 mm, 
and mean "biological width" from 1.5 to 2.9 mm. Similar long-term experiments have not 
been done frequently. Nonetheless, our data differ from those of Assenza et al. (Assenza, et 
al. 2003). In a mandibular Beagle dog model Assenza et al. (Assenza, et al. 2003) found after 
12 months of unloaded healing a mean sulcus depth of 1.2 mm, a mean junctional epithelium 
height of 1.1 mm, and a mean connective tissue height of 1.2 mm, which indicates a mean 
"biological width" of 3.5 mm. Unfortunately, in the study of Assenza et al. (Assenza, et al. 
2003) clear measurement landmarks and/or a measurement description as well as standard 
deviations are lacking. Therefore, a proper comparison with our results is rather difficult. On 
the other hand, our data are in the range of a study of Hermann et al. (Hermann, et al. 2000). 
In a mandibular foxhound model, they found after 3 months of non-loaded, trans-mucosal 
healing a mean sulcus depth of 0.49 mm (SD: 0.32 mm), a mean junctional epithelium height 
of 1.16 mm (SD: 0.47 mm), a mean connective tissue height of 1.36 mm (SD: 0.74 mm), and a 
mean "biological width" of 3.01 mm (SD: 0.74 mm). Additionally, it should be noticed that 
"biological width" measurements of unloaded implants differ within the literature 
(Abrahamsson, et al. 1996, Abrahamsson, et al. 1999, Berglundh, et al. 1991, Ericsson, et al.
1996). Further, we observed that a difference existed in soft-tissue height between the 
various implant surfaces as used in the current study. These differences do also not 
corroborate with other studies (Abrahamsson, et al. 1996, Cochran, et al. 1997) and are hard 
to explain. There are a lot of additionally unknown parameters, which can all affect the 
gingival response, like differences between animal species, loading condition, oral hygiene 
regime, etc.
In the present study, for loaded implants mean sulcus depths ranged from 0.1 to 0.2 mm, 
mean junctional epithelium from 1.3 to 1.7 mm, mean connective tissue from 0.6 to 0.8 mm, 
and mean "biological width" from 2.0 to 2.8 mm. Comparable long-term experimentation has 
not been done very often (Assenza, et al. 2003, Cochran, et al. 1997, Hermann, et al. 2000).
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Our results compare with those of Cochran et al. and Hermann et al. (Cochran, et al. 1997, 
Hermann, et al. 2000), but are again in contrast to Assenza et al. (Assenza, et al. 2003), who 
found in a mandibular Beagle dog model after 12 months of loading a larger sulcus depth (1.1 
mm), smaller junctional epithelium (0.9 mm), as well as a larger connective tissue (1.2 mm). 
Also, after loading, no differences in soft-tissue height were found between the used different 
implant surfaces, which corroborates with Cochran et al. (Cochran, et al. 1997).
Marginal bone loss around oral implants during the first year of function has been a common 
clinical observation (Isidor 2006). The cause of this phenomenon can be occlusal 
load/overload. It is presumed that functional load results in stress transfer with the highest 
stress level in the most coronal part of the supporting bone (Kitamura, et al. 2004, Misch, et 
al. 2005). It has been described (Hansson 1999, Hansson 2000) that the stress state in the 
interfacial bone can be characterized by von Mises stresse, normal interfacial stresses ad 
interfacial shear stress. Especially, high inter facial shear stresses are held responsible for the 
failure of bone implant systems and the occurrence of marginal bone loss. In the present 
study, mean bone level ranged from 0.3 to 1.8 mm for unloaded and from 0.2 to 0.7 mm for 
loaded implants. For non-coated, PS and MPS functional loading could not be associated with 
significant marginal bone level changes. Apparently, the applied load in the present 
experiment did not result in strain at the marginal bone-implant interface leading to bone 
fatigue failure (Isidor 2006). Similar findings are reported by others in comparable dog models 
(Assenza, et al. 2003, Berglundh, et al. 2005, Heitz-Mayfield, et al. 2004). However, it should 
be kept in mind that Assenza et al. (Assenza, et al. 2003) and Berglundh et al. (Berglundh, et 
al. 2005) used anatomical crowns with adjusted occlusion and only Mayfield et al. (Heitz- 
Mayfield, et al. 2004) used an occlusal loading approach that might be compared with the 
load as applied on the implants in the current experiment, which consisted in the use of 
healing abutment-like crowns with a supra-occlusal contact pattern.
Remarkably, for the aMPS implants functional loading resulted in a significantly different 
marginal bone response. Although, the first implant-bone contact was still above the first 
screw-thread, it was at a lower level compared with the non-coated, PS and MPS implants. 
Still, all implants were provided with the same surface roughness in their neck portion, which 
has been claimed to be favorable from a biomechanical point of view, as surface roughness 
can reduce the peak interfacial shear stress (Hansson 1999, Hansson 2000). An explanation 
for this phenomenon can only be given by doing a complete biomechanical analysis of the 
used implant systems as well as of the applied loading condition. Nevertheless, it can be 
hypothesized that partial coating of an implant surface with CaP ceramic result in a different 
axial stiffness of the implants. This hypothesis is supported by our earlier observations that 
the transfer of loading forces for a CaP coated implant differs compared with a non-coated 
implant (Corten, et al. 1997). A change in axial stiffness of the implant can have an effect on 
the implant interfacial shear stress (Hansson 1999).
Overall, the peri-implant bone levels were not affected by surface composition and long-term 
functional load, which corroborates with others (Heitz-Mayfield, et al. 2004). The current 
findings suggest also that irrespective of loading similar marginal bone levels are paralleled by
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alike soft-tissue height which is in agreement with other experimental animal studies (Heitz- 
Mayfield, et al. 2004, Hermann, et al. 2000) as well as clinical observations (Buser, et al. 
1999).
Conclusion
This study presented data on soft-tissue adaptation as well as crestal bone level around PS 
and MPS CaP coated titanium implants, which were subjected to functional loading during 
one year. In addition, apical CaP coated implants and non-coated, acid-etched implants were 
included in the study design.
Within the limits of the experiment, we conclude that, in comparison, functional loading does 
not affect the marginal soft-tissue response to MPS CaP coated implants. However, in 
comparison, functional loading might affect marginal bone response to MPS CaP coated 
implants.
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Appendix
Fig u re l: Standard structure fo r  occlusal loading in situ
QM
Figure 2: Soft-tissue measurements
Figure 3: M easurement landm ark at the 1st thread
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Figure 4: M ature barrier epithelium in contact with the implant surface
Figure 5: Epithelium extended close to the marginal bone level
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Marginal hard and soft tissue
N [number] 
(I/animals)
M
E
D
I
A
M
E
A
p-value
[95%CI]*
N [number] 
(I/animals)
M
E
D
I
A
M
E
A
p-value
[95%CI]‘
T-test
( not loaded
/loaded)___
Sig.
p-value
[95%CI]‘
0.388 
[-14, 0.7]
Post hoc test (Tukey) 0.037 
[0 0 ,1 6 ]
0.581 
[-0.6, 0.4]
Post hoc test (Tukey) 0.020 
[0.1,13]
Post hoc test (Tukey)
0.190 
[-0.5,1.8]
Post hoc test (Tukey) 0.044 
[-2.4, -0.0]
Non- loaded
non-coateds D U.2 J.3 0.2 0.2 0.2 0.1
PS 0.2 0.2 0.1 0.1 0.1
0.1 0.2 0.1 0.314 
[-0.1 0.0]
0.2 0.2 0.1 0.1 0.1
non-coatedJE 1.7 1.7 0.3 1.8 1.7 0.6
PS 0.9 0.4 1.2 1.3 0.6
1.6 1.7 0.5 1.9 1.7 0.7 0.913 
[-08, 0.8]
1.8 1.8 0.3 1.4 1.5 0.7
PS
PS 0.041 
[-1.6, - 0 0
PS 0.028 
[ 1 ,  -011
non-coatedCl 1.0 0.6 0.6 0.6 0.3 0.082 
[ -0 1 1 0 1
PS 0.6 0.5 0.2 0.7 0.6 0.3
0.5 0.5 0.2 0.6 0.8 0.7 0.269 
[-10, 0.3]
0.5 0.4 0.2 0.6 0.6 0.3
0.033
3W non-coated 3.0 2.9 0.8 2.2 2.5 0.8 0.391 
[-0 6,1.3]
PS 1.7 1.5 0.5 2.0 2.0 0.9
2.4 0.6 2.8 1.2 0.474 
[-16, 0.8]
2.5 2.3 0.5 1.8 2.2 0.9 0.829 
[-10,121
0.049
0.031 
[0.1, 2.6]
non-coated 0.5 0.8 0.779 
[-10, 0.8]
PS 0.4 0.7
0.6 0.9 0.759 
[-08,1.1]
0.9 0.9
0.011 0.651
0.012 
[-2.6, -03]
Table 1: Soft tissue dimension and marginal bone level. In cases that equality o f variance could not be assumed  
(significance o f  Levene's Test fo r  Equality o f  Variances <0.05) the relevant significance is given.
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Chapter 7:
Bone healing of SLActive® and Nanotite™ Implants: a histological and histomorphometric 
study in dogs
Introduction
The replacement of missing teeth by means of endosseous titanium implants has been proven 
to be a successful treatment modality for both completely and partially edentulous patients 
(Buser and Tonetti 1997, Lambrecht et al. 2003). This concept is based on the phenomenon 
of osseointegration, which involves the establishment of a direct bone-to-implant contact 
(BIC) without the inter-position of connective tissue (Brânemark et al. 1969, Schwartz et al. 
2007b).
Osseointegration of oral implants is determined by the surgical trauma during implant 
installation as well as the healing dynamics of the receiving bone bed. Considering the healing 
dynamics, the implant design as well as the surface condition of the implant is of major 
importance.
Once an implant is inserted in a bone site, a cascade of biological events is initiated. Initially, 
osteoconduction occurs, which implies the recruitment and migration of osteogenic cells to 
the implant surface. Secondly, new bone formation takes place, which results in the 
formation of a mineralized interfacial matrix, followed by a bone-remodeling process (Davies 
1998 and 2003b). This phenomenon is influenced by the microtopography of the implant 
surface. Surface roughness is one of the parameters, which is considered of importance in the 
cellular cascade of the bone healing process. As a rule, roughened surfaces increase BIC 
during the initial bone-healing process (Misch 2008).
Besides implant surface topography, chemical surface modifications have been investigated 
to improve the osseointegration of titanium implants (Albrektsson 1983; De Maeztu et al. 
2007, Kieswetter et al. 1996, Oates et al. 2007, Orsini et al. 2007).
In terms of surface roughness and chemical surface modification, two implant systems attract 
attention as they are supposed to possess an enhanced "osteogenicity", i.e. SLActive® (ITI, 
Institute Straumann, Waldenburg, Switzerland) and NanoTite™ (3i Implant Innovations, Palm 
Beach Gardens, FL, USA).
The SLActive surface is created by coarse grit-blasting followed by acid etching. This results in 
a surface with a moderate roughness with a roughness value (Ra) between 1.2 to 3.99 ^m. 
(Albrekstsson et al. 2004, Boyan et al. 1998, Rupp et al. 2006, Zhao et al. 2005). The implant 
surface is composed of TiO2 with some TiO and Ti2O3 (Rupp et al. 2006, Zhao et al. 2005). 
Following the etching procedure, the surface is conditioned in nitrogen to prevent exposure 
to air and then stored in a sealed tube containing an isotonic NaCl solution (Zhao et al. 2005). 
The SLActive® surface is described to be very hydrophilic with an average contact angle of 0° 
(Rupp et al. 2006).
The NanoTite™ surface is created by dual acid etching of titanium followed by a sol-gel 
deposition method using discrete crystalline deposition (DCD) of CaP (nominal crystal size 20­
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100 nm; Mendes et al. 2008) with a surface coverage of approximately 50% (Lin et al. 2009; 
Mendes et al. 2008). The suggested nano-feature size of the tightly adherent adsorbed 
CaP/DCD crystal is 20-100 nm (Mendes et al. 2008). The created nanostructure increases the 
surface area by up to 40% compared with the acid-etched surface with microtopography 
(Ogawa et al. 2008). The surface has been characterized as hydrophobic with a contact angel 
of 121.9° (Lin et al. 2009).
Several animal studies have already been performed with both implants (Ferguson et al. 
2006, Buser et al. 2004, Schwartz et al. 2007a, 2007b , and 2007c, Bornstein et al. 2008, 
Mendes et al. 2007 and 2008). Overall, these studies revealed that both surfaces promoted 
bone apposition during the early stages of bone regeneration. However, till now no studies 
have been performed in which both implant surfaces were compared with each other in order 
to determine whether the surface roughness or surface chemical composition is a 
predominant factor in the bone deposition process. In these studies both initial and late bone 
response was investigated.
The objective of the present study was to evaluate and compare two types of implants, i.e. 
grit-blasted and acid etched implants (SLActive®) with nano-meter-scale hydroxyapatite 
surface modified implants (NanoTite™). Therefore, two, four and eight weeks after their 
installation in the mandibles of dogs, the implants with their surrounding tissues were 
harvested and the clinical stability as well as bone response were assessed.
With this study we intended to accept or reject the following hypothesis:
H0: The clinical stability, bone volume percentage, and bone-to-implant contact of the grit­
blasted and acid etched treated implants (SLActive®) and the nano-meter-scale 
hydroxyapatite modified implants (NanoTite™) are the same at different healing time periods. 
H1: The clinical stability, bone volume percentage, and the bone-to-implant contact of the 
grit-blasted and acid etched treated implants (SLActive®) and the nano-meter-scale 
hydroxyapatite modified implants (NanoTite™) differ at different healing time periods.
Material and methods
Implants
Two different types of implants were used for the study:
1. 22 SLActive® implants (Institute Straumann, Waldenburg, Switzerland). The implants 
had a diameter of 3.3 mm and length of 8 mm.
2. 22 Nanotite™ implants (3i Implant Innovations, Palm Beach Gardens, Fl, USA). The 
implants had a diameter of 3.25 mm and length of 8.5 mm.
All implants were provided sterile by the manufacturers.
Experimental Animals
This study was performed at the College of Dentistry, King Saud University Riyadh, Kingdom of 
Saudi Arabia. The study was approved by the Animal Ethic Committee, College of Dentistry,
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Riyadh. The animal research facility attached to the King Khalid University Hospital was used 
for the study.
Eleven male Beagle dogs were used in this study. The dogs were one to two years old (mean 
age of 18 months) and weighed 10 to 15 kg. An adoption period of four weeks was given to 
the Beagle dogs to adjust with the animal housing environment. They were vaccinated during 
the first week of housing and were fed once per day with soft food diet and water.
Animals were divided in three groups according the specified healing time as planned in the 
study:
• Group A: 2 weeks healing period
• Group B: 4 weeks healing period (1 month)
• Group C: 8 weeks healing period (2 months)
Group A included 3 dogs, whereas group B and C included 4 Beagle dogs.
Surgical procedure
All surgical procedures were done under aseptic conditions by the same surgical team. Prior 
to surgery, the dogs were always sedated with an intravenous injection of a 2.5% Thiopental 
Sodium (20 mg/kg; AstraZeneca, London, UK). After intubation, anaesthesia was maintained 
with Isoflurane. The oral mucosa and dentition were cleaned with chlorhexidine digluconate 
1% in water. Thereafter, local anesthesia was given (2% xylocain and 1:80.000 epinephrine) to 
reduce bleeding.
Phase I (Extraction phase): After anesthesia, three premolars (P2, P3, and P4) in the right side 
of the mandible (unilaterial) were extracted atraumatically with special care. Reflection of full 
thickness mucoperiosteal flaps and root separation was performed using diamond burrs in a 
high-speed hand-piece with saline coolant. Thin elevators were used to luxate the separated 
roots, which were extracted using forceps with a rotary movement to avoid any trauma of the 
alveolar ridge and labial bone. Wound closure was performed by means of resorbable 
sutures (vicryle 4/0 sutures) using a simple interrupted technique. Prophylactic administration 
of clindamycine (11.0mg/kg body weight) was performed intra and postoperatively for 10 
days. Four months were allowed to complete the healing of the extraction sockets.
Phase II (Implantation phase): Each animal received randomly four implants unilaterally in the 
lower jaw (two of each implant type). In total 44 implants were installed; 22 SLActive® and 22 
NanoTite™ implants.
For implant installation, a midcrestal incision was made on the healed alveolar ridge to 
expose the respective sites for implant insertion and a full thickness mucoperiosteal flap was 
reflected.
Surgical implant preparation was accomplished according to the manufacturers' guidelines for 
both implant types, using a low trauma drilling technique under copious irrigation with sterile
0.9% physiological saline.
All implants were installed with their permucosal part penetrating through the gingiva. After 
this non-submerged implant installation, the flaps were closed with simple interrupted 
techniques using resorbable (4/0 vicryl) sutures, and primary soft tissue closure was achieved
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without any additional procedure. A broad spectrum antibiotic (Gentamycin 4 mg/kg body 
weight) was administered intramuscularly for 7 days. The dogs were kept on a soft diet during 
the study period. None of the implants in the study were loaded. Periodic clinical examination 
was recorded at 2, 4, and 8 weeks.
Resonance frequency analysis (RFA)
Clinical evaluation of implant stability at the end of the respective implantation times was 
performed by Resonance Frequency Analysis (RFA) using the Osstell device (Osstell; 
Integration Diagnostics, Savedalen, Sweden). RFA produces an implant stability quotient (ISQ), 
which was measured for each implant at their buccolingual and mesiodistal side after 
attaching the specified SmartPegs for the specified implant type. All measurements were 
done twice separately for accuracy. RFA was recorded at baseline, 2, 4, and 8 weeks following 
the surgical implant placement. Then the mean of the recorded readings was taken for 
analysis.
Harvesting of tissue specimens
Three dogs were sacrificed at two weeks (group A), four dogs at four weeks (group B), and 
four dogs at eight weeks (group C) of non-submerged healing. Euthanasia was performed with 
an overdose of sodium pentobarbital-3%. The jaws were dissected, and blocks containing the 
experimental specimens were obtained. Subsequently, the harvested tissue blocks were fixed 
in 4% phosphate-buffered formaldehyde solution (pH=7.4) for seven days.
Micro CT
After fixation in phosphate-buffered formaldehyde solution (pH=7.4) and dehydration in 
ethanol 70%, three-dimensional micro-computed tomography (^CT) images were made to 
analyze the bone volume of the implant surrounding bone mass. The specimens were
®
wrapped in Parafilm M (Pechiney Plastic Packaging, Chicago, USA) to prevent drying during 
scanning. Then, all samples were scanned at an energy of 101 kV and intensity of 96 ^A with a 
resolution of 37.41 ^m pixel using an aluminum filter (1mm) (Skyscan-1072 X-ray
®
microtomograph, TomoNT version 3N.5, Skyscan , Belgium). Cone-Beam reconstruction
®
(version 2.15, Skyscan ) was performed. All scan and reconstruction parameters applied were 
identical for all specimens and calibration rods. Prior to analysis, all implants were digitally 
filled using ImageJ (ImageJ 1.38x, National Institutes of Health, Bethesda, Maryland, USA) 
software in order to exclude the interior of the implants. Subsequently, the data were
®
analyzed by CT Analyser (version 1.4, Skyscan ). The region of interest (ROI) was specified as 
an annular area with a diameter of 1.5 mm surrounding the implants over a length of 3 mm. 
In this area bone volume (BV mm3) was determined and expressed as a percentage of the 
total ROI volume.
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Histological and histomorphometric analysis
After micro-CT imaging and further dehydration, all specimens were embedded in 
methylmethacrylate. After polymerization, three 10 ^m thick sections of the implants and 
surrounding tissues were prepared using a modified diamond blade sawing microtome 
technique (Leica, SP1600, Nussboch, Germany). The sections were made in a bucco-lingual 
direction. All sections were stained with basic fuchsin and methylene blue and were examined 
with a light microscope (Zeiss - Axio Imager Z1 automated microscope with AxioCam MRc5 
digital camera and AxioVision V6.3.2. acquisition software, Göttingen, Germany). In addition, 
digital image analysis software (Leica Qwin Pro, Leica Microsystems Imaging Solutions, 
Cambridge, UK) was used for histomorphometrical measurements.
The following parameters were assessed:
D. Amount of bone in the proximity (0-1500 ^m) of the implant surface. Measurements 
were along the entire length of the implant.
E. Percentage of bone contact at the interface (BIC): The amount of bone contact was 
defined as the percentage of implant length at which there was direct bone-to- 
implant contact without intervening soft tissue layer. Measurements for bone-to- 
implant contact were performed along the implant interface from the most coronal 
bone contact till the apex of the implant.
Statistical Analysis
The statistical analysis was performed using a commercially available software program (SPSS 
17.0, SPSS, Chicago, IL). Mean values (±SD) of RFA, BV, and BIC were calculated for each 
group. The data were examined for normal distribution. For the statistical evaluation of the 
changes within groups over time, the paired t test was used. For comparison between the 
different implant surfaces as well as between histomorphometry and micro CT, independent 
t-test and for comparison between groups, One-way Analysis of Variance (ANOVA) was used. 
P values <0.05 were considered significant.
Results
Clinical findings
Twelve Beagle dogs were initially included in the study, but one dog died during the first 
surgical phase due to unknown reasons.
In total 44 implants were placed during the second surgical phase. Finally, forty implants were 
analyzed, as four implants, present in four different animals, could not be assessed. Three of 
those implants were found to be not integrated at the time of harvesting and one implant 
was missing at retrieval.
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Resonance Frequency Analysis (RFA)
To assess the variation of RF values of the tested implants, two parameters were defined in 
this study. The initial RF (IRF) values of the implants were defined as the measured values 
immediately after implantation, and the final RF (FRF) values was defined as the measured 
values according to the healing periods before sample retrieval. The RFA was measured as 
implant stability quotient (ISQ).
Initial Resonance Frequency (IRF); Table 1 lists the mean IRF values for the 2, 4 and 8 weeks 
implantation times of both implant groups. IRF values varied between 62-68 ISQ.
Statistical testing revealed that no differences in additional stability existed between both 
implant types for all scheduled implantation times (Table 1).
Final Resonance Frequency (FRF): Table 2 lists the mean FRF values for both implant types and 
all implantation times. Compared with the IRF, the mean ISQ for NanoTite™ implants after 2 
weeks of implantation decreased to 55.50, while the mean ISQ after 4 and 8 weeks of
®
implantation increased to 66.75 and 68.19 respectively. For SLActive implants the mean ISO 
decreased also after two weeks of implantation, but now to 59.33, while the FRF increased 
after 4 and 8 weeks of implantation to 67.71 and 72.25 respectively.
Statistical analysis (Table 2, 3 and 4) showed that:
1. FRF values increased significantly during implantation (4 and 8 weeks compared with 
2 weeks) for both implant types.
2. FRF values at 2 weeks were significantly lower compared with the IRF values for both 
implant types.
3. FRF values at 4 and 8 weeks of implantation were significantly higher compared with 
FRF values at 2 weeks of implantation.
®
4. Only for 8 weeks of implantation the FRF value for SLActive implants was 
significantly higher compared with NanoTite™ implants.
Histological Evaluation
Two weeks of implantation
No gross differences could be observed in bone response to the NanoTite™ and SLActive® 
implants. Around all implants bone resorption had occurred at the crestal level. The coronal 
2-3 screw threads became exposed and were covered with connective tissue (Figure 1). The 
connective tissue did not show an inflammatory response, as characterized by the lack of an 
immense infiltration of inflammatory cells. At the apical part of the implants, a tight 
connection between the implant surface and surrounding bone was seen. At the crestal side 
of the implants, a small gap existed between the implant and bone surface. This gap was filled 
with fibrous tissue. Occasionally, the original drill margins were still recognized (Figure 2).
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Four weeks of implantation
Again, the light microscopically analysis showed no differences between NanoTite™ and 
SLActive® implants. For most of the implants, the two most crestal screw threads were still 
not covered with bone tissue (Figure 3a). Adaptation of the gingival tissue to the implant neck 
had occurred without any sign of severe inflammatory response. The bone close to the 
implant surface had remodeled and osteoid was deposited (Figure 4). In areas were bone was 
present, a tight contact between the bone and implant surface was seen without the 
presence of an intervening fibrous tissue layer (Figure 3b). For two NanoTite™ implants, still a 
gap existed at the crestal site between the implant and bone surface (Figure 5). This gap was 
filled with non-inflamed connective tissue. At the bone as well as implant surface, signs of 
bone remodeling and osteoid deposition were seen. For two SLActive® implants, the original 
drill wall was still partly visible (Figure 6). However, for one of those implants, new bone 
formation with a cancellous appearance had occurred in the crestal gap between implant and 
bone surface (Figure 6).
Eight weeks of implantation
Subjectively, bone response to NanoTite™ and SLActive® implants was similar. Remodeling of 
the bone close to the implant had proceeded and all implants were surrounded by dense, 
very compact bone (Figure 7, 8, and 9). At the interface, a close contact existed between the 
bone and implant surface without intervening connective tissue layer. For about half of the 
implants, only one screw-thread was still not covered with bone (Figure 7). About the other 
half of the implants were almost completely surrounded by bone form their apex to the 
crestal side and for these implants no screw-threads were exposed to connective tissue 
(Figure 8 and 9). The increase in crestal bone height was associated with periosteal bone 
formation. The newly formed bone had a compact-cancellous structure.
Bone volume percentage (BVP) measured by Micro-CT
The BVP's as measured by micro-CT for both implant types are listed in Table 5. The data 
show that BVP increased for both implant types from 2 to 4 weeks of implantation, while no 
further increase was observed at 8 weeks of implantation. Statistical analysis revealed that 
this increase was significant. Further, the data showed that BVP was similar for both 
NanoTite™ and SLActive® implants at the various implantation times. This was confirmed by 
statistical testing.
Bone volume percentage (BVP) measured by histomorphometry
Table 6 lists the BVP percentages of the NanoTite™ implants at the various implantation 
times. At 4 weeks of implantation, BVP was found to be significantly higher compared with 
both 2 and 8 weeks of implantation.
Table 6 lists also the BVP's for SLActive® implants at the various implantation times. No 
significant differences were observed.
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Although, the data suggested that BVP for SLActive® implants was higher at all implantation 
times compared with NanoTite™ implants, statistical analysis could not confirm that these 
differences were significant.
Comparison of BVP micro-CT vs. BVP histomorphometry
In Table 7 and 8, the BVP data, as determined by both micro-CT and histomorphometry, are 
compared with each other. The results indicated that by using histomorphometry 
continuously higher BVPs were found than by using micro-CT. Statistical analysis confirmed 
that indeed for NanoTite™ as well as SLActive® implants, the BVP's were significantly higher 
as determined by histomorphometry at 4 and 8 weeks of implantation. Such a significant 
difference did not exist after 2 weeks of implantation.
Bone-to-Implant Contact (BIC) Percentage
The results for the bone-to-implant contact percentages for both implant systems and the 
various implantation times are listed in Table 9.
The data show that the BIC% increased during implantation time for both SLActive® and 
NanoTite™ implants. Statistical testing confirmed that the increase in BIC was significant 
between 2 and 4 weeks of implantation and 2 and 8 weeks of implantation for both implant 
systems. The additional increase in BIC form 4 to 8 weeks of implantation was only significant 
for the NanoTite™ implants (P<0.05). Statitistical analysis revealed also that no significant 
differences in BIC existed between SLActive® and NanoTite™ implants at all the respective 
implantation times.
Discussion
The objective of the present study was to evaluate and compare two types of dental implants 
provided with two different surfaces, i.e. grit-blasted and acid etched implants (SLActive®) 
and nano-meter-scale hydroxyapatite modified implants (NanoTite™). In addition, as most of 
the currently applied implant surface modifications focus on an enhancement of the early 
stages of bone healing, the study was designed to analyze the performance of these two 
implant types after two, four and eight weeks of installation. The evaluation parameters 
included stability of the implants as measured by RFA as well as bone response indicators 
using micro-CT and histology.
Initial (primary) implant stability was defined as implant stability at the time of implant 
placement. The increase in stability resulting from regeneration and remodeling at the 
implant-bone interface after installation was regarded as final (secondary) implant stability 
(Meredith 1998). The efficacy to determine the healing status and stability of titanium in 
animal studies has already been confirmed in an earlier study of Rasmusson et al. (1999). 
They showed that RFA measures the stability of an implant during bending and represents the 
stiffness of the bone close to the implant surface. Besides, they proved that a relation exists 
between RFA data and histomorphometrical bone-implant contact analysis. The efficacy of
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RFA analysis to determine the healing status and stability of dental implants was confirmed 
again in our study. Previous studies indicated also the existence of a correlation between the 
exposed implant height above the marginal bone and the measured implant stability 
(Meredith et al. 1996, Meredith et al. 1997a). Therefore, this length has been kept as constant 
as possible in the present study by the fixation of so-called Smart-Pegs to the implants at the 
time of evaluation.
Analysis of our RFA data revealed that at baseline (time of implant installation), no differences 
existed in implant stability between both implant systems and various implant groups. After 
two weeks of implantation, ISO values had decreased for both SLActive® and NanoTite 
implants™, which is in agreement with earlier studies (Barewal et al. 2003, Oates et al. 2007). 
At prolonged implantation times, the ISQ values showed again a slight increase. For both 
implant systems, RFA stability at 8 weeks of implantation was significantly higher compared 
with the initial reading at baseline. Again, these findings corroborated with various other 
studies as performed in experimental animals as well as humans. The observed changes in ISQ 
values are most likely due to the bone healing process in the implant-bone interface. Directly 
after installation, a dental implant is surrounded by a zone of necrotic bone (Roberts 1993). 
During the initial stages of bone healing, this devitalized bone is removed by osteoclastic 
activity. Subsequently, new bone is deposited by osteoblasts originating from the bony 
environment. This novice bone matures during time, which results in the formation of a 
strong compact bone interface that can resists the forces of mastication. Bone remodeling 
around a dental implant has been shown to take place in a zone of 0.5-1.0 mm around the 
implant during the first 8-12 weeks of implantation (Roberts 1993).
Further, RFA data showed that only at 8 weeks of implantation the ISQ value of the SLActive® 
implants was significantly higher compared with the NanoTite™ implants. It has to be 
emphasized that the difference in measured stability was very limited. In view of this, the 
clinical relevance of this observation is questionable.
Micro-CT analysis showed an increase in BV for both implant types from 2 to 4 weeks of 
implantation, while no further increase was observed at 8 weeks of implantation, this 
increase was significant. Furthermore, the BV was similar for both NanoTite™ and SLAactive® 
implants at the various implantation times. Also, no difference in BV was measured between 
the NanoTite™ and SLActive® implants.
The BV, as determined by histomorphometry, showed the same trend compared with the BV, 
as determined by micro-CT, i.e. an increase in between 2 to 4 weeks of implantation. 
However, in contrast to the micro-CT data, the BV appeared now to increase again for both 
implant systems at 8 weeks of implantation. Further comparison of the micro-CT and 
histomorphometrical measurements learned also that the BV as measured by 
histomorphometry resulted always in higher amounts. Two explanations can be given for this 
occurrence. First, the histomorphometrical measurements are based on the evaluation of 
three histological sections, which are taken mainly of the middle part of the implant. In 
addition, it is assumed that the three selected sections are representative for the entire 
specimen (Schouten et al. 2009). As a consequence, over estimation of the bone formation
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can occur. Second, micro-CT provides a three-dimensional reconstruction of the implant with 
the surrounding bone at a significant resolution for quantification of parameters relevant to 
characterize bone formation (Hedberg et al. 2005). Also, no loss of tissue and information 
occurs due to the histological sectioning process. Therefore, micro-CT reconstructions are a 
more reliable representation of the real bone structure than two-dimensional histology. 
Nevertheless, the tissue characterization by micro-CT is inferior compared with histology. 
Histological analysis visualizes tissue structures at a resolution of 1-2 ^m's, while micro-CT 
depicts usually at a resolution of 10-20 ^m.
This consequent mismatch in absolute values can be extra enhanced by the required 
definition of a threshold procedure for micro-CT analysis as well as the presence of a thin 
layer of noise around the whole implant. This noise is caused by the geometry of the implants 
and the scattering of titanium (Schouten et al. 2009). Finally, it has to be noticed that the 
observed decrease in BV around the implant at the histological level corroborates with earlier 
studies Trombelli et al. 2008: Ferrus et al. 2010: Tomasi et al. 2010), who reported that bone 
tissue alterations continue to occur up to 6 months after bone wounding as well as implant 
installation.
Evaluation of the bone-to-implant contact percentages demonstrated no significant findings 
between both implant systems. At four and eight weeks of implantation the amount of bone- 
to-implant contact was always higher compared with the two weeks implants. Bone 
formation at the implant surface appeared to increase continuously. However, at 8 weeks of 
implantation no significant difference existed compared with the four week situation. 
Nevertheless, it has to be noticed that the bone-to implant contact percentages at 2 and 4 
weeks are somewhat overestimated compared with the eight weeks implants. The bone-to- 
implant contact was measured form the most coronal (first point of) bone contact till the 
apical end of the implants. As observed, at 2 and 4 weeks, the first two-three screw threads 
were not covered with bone tissue. At 8 weeks of implantation, for half of the implants only 
one screw-thread was exposed, while the other half of the implants were completely covered 
with bone. The non-covered implant areas were excluded from the measurements. 
Nevertheless, the amount of measured bone contact agrees with a lot of other studies in 
which similar implant systems were used (Junker et al. 2009). A striking observation was also 
the increase of bone in the crestal area during prolonged implantation. The newly formed 
bone seemed to have a periosteal origin. An explanation for this phenomenon is difficult to 
give, but is certainly not due to loading of the implants as the implants were left in marginally 
exposed oral condition. Evidently, the results prove that both implant surfaces evoke a bone 
compatible behavior and are able to stimulate crestal bone formation. The data could not 
confirm that the difference in wettability between the SLActive® and NanoTite™ implant 
surface did result in a different bone response. On the other hand, the histological sections 
show that the implant bed was composed of bone of high quality and quantity. The 
histological appearance of the bone around the implants can even be enhanced by the used 
direction of histological sectioning, i.e. in a bucco-lingual direction. In view of this, 
extrapolation of the current animal study to the human situation has to be done with care.
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Conclusion
In conclusion, this study showed that SLActive® and NanoTite™ implants evoke a similar bone 
response after implantation for 2, 4 and 8 weeks in a non-submerged position in the mandible 
of dogs. In addition, the data confirmed that RFA is a reliable method to determine dental 
implant stability and to follow non-invasively the bone formation process.
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Appendix
Fig. 1: A fter two weeks o f implantation no gross difference in bone response was observed fo r  NanoTite™ and 
SLActive® implants. Around all implants bone resorption had occurred at the crestal level. The coronal 2-3 screw  
threads became exposed and were covered with connective tissue.
Fig. 2: Occasionally, after two weeks o f implantation the original drill margins were still recognized.
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Fig. 3a: A fter fo u r weeks o f implantation light m icroscopically analysis showed no differences between NanoTite™ and 
SLActive® implants. For m ost o f the implants, the two m ost crestal screw threads were still not covered with bone 
tissue.
Fig. 3b: A fter fo u r weeks o f implantation, in areas were bone was present, a tight contact between the bone and 
im plant surface was seen without the presence o f an intervening fibrous tissue layer.
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Fig. 4: A fter fo u r weeks o f implantation the bone close to the im plant surface had remodeled and osteoid was 
deposited.
Fig. 5: A fter fo u r weeks o f implantation fo r  two NanoTite™ implants, still a gap existed at the crestal site between the 
im plant and bone surface. This gap was filled  with non-inflamed connective tissue. A t  the bone as well as im plant 
surface, signs o f bone remodeling and osteoid deposition were seen.
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Fig. 6: A fter fo u r weeks o f implantation fo r  two SLActive® implants, the original drill wall was still partly visible. For 
one o f those implants, new bone form ation with a cancellous appearance had occurred in the crestal gap between 
im plant and bone surface.
Fig. 7: A fter eight weeks o f implantation bone response to NanoTite™ and SLActive® implants was similar. Remodeling 
o f the bone close to the im plant had proceeded and all implants were surrounded by dense, very com pact bone. A t  the 
interface, a close contact existed between the bone and im plant surface without intervening connective tissue layer. 
For about half o f the implants, only one screw-thread was still not covered with bone.
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Fig. 8: A fter eight weeks o f implantation bone response to NanoTite™ and SLActive® implants was similar. About one 
half o f the im plants were alm ost com pletely surrounded by bone form  their apex to the crestal side and fo r  these 
implants no screw-threads were exposed to connective tissue.
Fig. 9: A fter eight weeks o f implantation bone response to NanoTite™ and SLActive® implants was similar. About one 
half o f the im plants were alm ost com pletely surrounded by bone form  their apex to the crestal side and fo r  these 
implants no screw-threads were exposed to connective tissue.
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Table 1: Resonance frequency analysis initial reading (IRF)
Groups
Initial Resonance Frequency Reading 
ISQ
Independent t- test 
value and 
p- value
NanoTite Dental 
Implant
SLActive Dental 
Implant
Mean S.D Mean S.D
Group A 62.58 8.47 64.67 5.12 t = 0.515, 
P=0.618 (N.S.)
Group B 62.25 8.43 67.13 2.70 t = 1.559, 
P=0.141 (N.S.)
Group C 64.37 3.24 67.63 4.87 t = 1.572, 
P=0.138 (N.S.)
ANOVA Test 
F -  value 
P value
F= 0.208 
P = 0.814 (N.S.)
F= 0.901 
P = 0.423 (N.S.)
Note: N.S. -  Not Significant
Table 2: Resonance Frequency Analysis final reading (FRF)
Groups
Final Resonance Frequency Reading 
ISQ
Independent t- test 
value and 
p- value
Nanotite Dental 
Implant
SLActive Dental 
Implant
Mean S.D Mean S.D
Group A 55.50 8.77 59.33 8.25 t = 0.746, 
P=0.475 (N.S.)
Group B 66.75 3.36 67.71 6.57 t = 0.323, 
P=0.752 (N.S.)
Group C 68.19 2.03 72.25 3.37 t = 2.919, 
P=0.011 *
ANOVA Test 
F -  value 
P value
F= 11.063 
P = 0.001***
F= 7.641 
P = 0.004 **
Note: * P<0.05, ** P<0.01, *** P<0.001 Level o f Significance, N.S. -  N ot Significant
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Table 3: Changes in Resonance Frequency for NanoTite Implants
Groups
NanoTite Dental Implant Paired t- test 
value and 
p- valueInitial Reading Final Reading Changes Reading
Mean S.D Mean S.D Mean S.D
Group A 62.58 8.47 55.50 8.77 -6.60 13.31 t = 1.109, 
P=0.330 
(N.S.)
Group B 62.25 8.43 66.75 3.36 3.67 3.83 t = 2.345, 
P=0.066 
(N.S.)
Group C 64.37 3.24 68.19 2.03 3.81 3.03 t = 3.553, 
P=0.009 **
ANOVA Test 
F -  value 
P value
F= 0.208 
P = 0.814 (N.S.)
F= 11.063 
P = 0.001***
Note: ** P<0.01, *** P<0.001 Level o f Significance, N.S. -  Not Significant
Table 4: Changes in Resonance Frequency for SLAactive Implants
Groups
SLActive Dental Implant Paired t- test 
value and 
p- valueInitial Reading Final Reading Changes Reading
Mean S.D Mean S.D Mean S.D
Group A 64.67 5.12 59.33 8.25 5.33 3.44 t = 3.792, 
P=0.013 *
Group B 67.13 2.70 67.71 6.57 0.71 6.47 t = 0.292, 
P=0.780 (N.S.)
Group C 67.63 4.87 72.25 3.37 4.62 3.42 t = 3.825, 
P=0.006 **
ANOVA Test 
F -  value 
P value
F= 0.901 
P = 0.423 (N.S.)
F= 7.641 
P = 0.004 **
Note: * P<0.05, ** P<0.01 Level o f Significance, N.S. -  Not Significant
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Table 5: Bone Volume Percentage (BVP) measured by Micro-CT
Groups
Bone Volume Percentage Independent t- test 
value and 
p- value
NanoTite Dental 
Implant
SLActive Dental 
Implant
Mean S.D Mean S.D
Group A 42.42 3.38 45.28 5.13 t = 1.143, 
P=0.280 (N.S.)
Group B 52.75 5.53 53.70 5.27 t = 0.276, 
P=0.788 (N.S.)
Group C 50.79 4.31 54.24 3.98 t = 1.379, 
P=0.191 (N.S.)
ANOVA Test 
F -  value 
P value
F= 9.229 
P = 0.002 **
F= 6.265 
P = 0.010 **
Note: ** P<0.0.1 Level o f Significance, N.S. -  Not Significant
Table 6: Bone Volume Percentage measured by histomorphometry
Groups
Bone Volume Percentage Independent t- test 
value and 
p- value
Nanotite Dental 
Implant
SLActive Dental 
Implant
Mean S.D Mean S.D
Group A 54.58 19.35 62.46 24.40 t = 0.598, 
P=0.564 (N.S.)
Group B 78.39 9.93 79.13 9.91 t = 0.139, 
P=0.892 (N.S)
Group C 62.02 13.71 72.51 13.00 t = 1.461, 
P=0.170 (N.S.)
ANOVA Test 
F -  value 
P value
F= 5.102 
P = 0.018 *
F= 1.504 
P = 0.252 (N.S.)
Note: * P<0.05 Level o f Significance, N.S. -  Not Significant
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Table 7: Comparison of BVP's for NanoTite implants
Groups
NanoTite Independent t- test 
value and 
p- value
Histomorphometry Micro CT
Mean S.D Mean S.D
Group A 54.58 19.35 42.42 3.38 t = 1.517, 
P = 0.160 (N.S.)
Group B 78.39 9.93 52.75 5.53 t = 5.201, 
P = 0.001 ***
Group C 62.02 13.71 50.79 4.31 t = 2.202, 
P = 0.048 *
Note: * P<0.05, *** P<0.001 Level o f Significance, N.S. -  Not Significant
Table 8: Comparison of BVP's for SLActive implants
Groups
SLActive Independent t- test 
value and 
p- value
Histomorphometry Micro CT
Mean S.D Mean S.D
Group A 62.46 24.40 45.28 5.13 t = 1.698, 
P = 0.124 (N.S.)
Group B 79.13 9.91 53.70 5.27 t = 5.231, 
P = 0.001 ***
Group C 72.51 13.00 54.24 3.98 t = 3.801, 
P = 0.002 **
Note: ** P<0.01, *** P<0.001 Level o f Significance, N.S. -  Not Significant
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Table 9: Bone-to-Implant Contact percentages for SLActive and NanoTite implants
Groups
Bone Volume Percentage Independent t- test 
value and 
p- value
NanoTite Dental 
Implant
SLActive Dental 
Implant
Mean S.D Mean S.D
Group A 53.9 13.1 59.6 11.3 t = 0.7737 
P= 0.4589 (N.S.)
Group B 71.6 11.3 78.3 9.0 t = 1.191 
P= 0.2588 (N.S.)
Group C 85.9 6.1 89.6 5.7 t = 1.268 
P= 0.2254 (N.S.)
ANOVA Test 
F -  value 
P value
F= 15.681 
P = 0.0001***
F= 20.519 
P = 0.00001***
Note: * P<0.05, ** P<0.01, *** P<0.001 Level o f Significance, N.S. -  N ot Significant
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Chapter 8:
1. Summary and address to the objectives
In a recent systematic review (Esposito, et al. 2007), mainly because of relative short follow- 
up periods, few patients and high risk of bias, no evidence was found that there are particular 
implant materials, shapes or surface modifications that are superior with respect to the 
clinical performance of oral implants. Nevertheless, there is evidence for the improvement of 
implant-bone integration by surface modification (Albrektsson and Wennerberg 2004, 
Albrektsson and Wennerberg 2004, Wennerberg and Albrektsson 2009). Consequently, 
optimization of implant surfaces, is still a dynamic field in experimental as well as clinical 
Implant Dent (Esposito, et al. 2007, Montes, et al. 2007). In principle, surface modifications 
are accomplished by roughening or by altering the chemical composition.
Plasma spraying (PS) of dental titanium implants with calcium phosphate ceramic (CaP) is one 
of the used methods for changing the chemical surface composition (Le Guéhennec, et al. 
2007). However, relevant limitations still persist in conventionally PS CaP coatings. To 
overcome these, a novel microplasma spraying (MPS) equipment was developed (Borisov, et 
al. 2002, Yushchenko, et al. 1995). Prior to clinical studies, well-designed preclinical 
experiments are needed to characterize novel coatings. Therefore, the central objective of 
this thesis was to carry out appropriate animal experiments to study coating behavior, 
biocompatibility, osteoconductivity, mechanical stability as well as bone and gingival response 
under functional load of MPS CaP-coated titanium implants.
Beside plasma spraying other methods have been developed and are used to coat CaP 
ceramics onto titanium implant surfaces. Currently, the Nanotite surface ( 3i Implant 
Innovations, Palm Beach Gardens, USA) with a sol-gel deposited calcium phosphate nano 
particle modification of a minimally rough titanium alloy implant surface, is available for 
clinical use. Animal (Mendes et al. 2007, 2008) and human (Goené et al. 2007, Orsini et al. 
2007) data indicate, but do not finally proof an advantage of the surface composition of the 
Nanotite surface during osseointegration
Effects of implant surface coatings and composition on bone integration: A review of the 
literature
Objective of chapter 2 was to review systematically the evidence of surface modification on 
bone integration. Hence, two reviews, one for "recently developed and marketed implant 
surfaces" ( e.g.: OsseoSpeed® (Astra Tech), SLActive® (Straumann), TiUnite® (NobelBiocare), 
Nanotite® ( 3i) and Friadent plus® (DENTSPLY Friadent) as well as another one for 
experimental surface alterations were prepared . A systematic search strategy for studies 
(with outcome variables related to bone-to-implant contact on the basis of histological 
analysis or mechanical stability testing) revealed 3212 publications of potential interest for 
"recently developed and marketed implant surfaces". Twenty-nine articles were eventually
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selected for inclusion in a first review. While 32 out of 357 titles formed the basis for a second 
review on experimental surface alterations.
These reviews yielded the conclusions that:
• Surface modifications that alter the topography of the currently marketed implant 
types will inevitably also effect the surface composition. Hence, either surface 
characteristic may have contributed to the observed improved bone integration, and 
it may be difficult to attribute beneficial effects to either topography or composition 
alone.
• For four (OsseoSpeed®, SLActive®, TiUnite® and Nanotite®) of the five most widely 
marketed implant types in Europe alterations in the surface composition improved 
bone integration compared with their predecessors. For one implant type (Friadent 
Plus®) such evidence is lacking. For two (TiUnite®, Nanotite®) of the five implant 
types, confirmative human histological data are available.
• Implants with thin calcium phosphate coatings demonstrated improved bone 
integration compared with uncoated implants. However, confirmative human studies 
are lacking.
• Coating of implants with peptide sequences (e.g. RGD) has not consistently resulted 
in improved bone integration.
• Coating of implants with growth factors (e.g. BMP-2) does not enhance bone 
integration. In fact, BMP-2 coatings may even reduce bone integration.
Bone-supportive behavior of microplasma-sprayed CaP-coated implants: mechanical and 
histological outcome in the goat
Biological properties (biocompatibility, osteoconductivity and mechanical stability) of 
different MPS CaP coatings were investigated in the third chapter. Therefore, in total forty- 
eight screw type titanium implants were inserted into the femoral condyles of twelve goats. 
The implants were divided in four groups; non-coated, acid etched standard BTI implants, 
conventionally PS coated , as well as two experimental MPS coated implants. Six and twelve 
weeks after implantation the animals were sacrificed and bone-to-implant contact, amount of 
bone, as well as mechanical bone fixation were evaluated. For bone-to-implant contact no 
statically significant difference was found between the different CaP coatings. However, 
statically significant differences were found between non-coated, acid etched titanium 
implants and CaP coated implants after six and twelve weeks of healing. Amount of bone 
values were not statistically significant different between the different CaP coatings at six and 
twelve weeks. Furthermore, CaP ceramic coated implants showed statistically significant 
higher torque values compared to the non-coated implants after six and at twelve weeks of 
healing. No significant differences existed between the various types of CaP coatings. On the 
basis of these observations, it was concluded that conventionally PS CaP ceramic coated 
implants, as well as MPS coated implants have a comparable effect on adjacent bone 
response.
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Bone reaction adjacent to microplasma sprayed CaP-coated oral implants subjected to 
occlusal load; an experimental study in the dog. Part I: Short-term results
Purpose of chapter 4 was to investigate in a mandibular dog model bone biological properties 
and occlusal loading effects of titanium implants provided with MPS CaP coatings. Thus, for 
histomorphometrical evaluation forty-eight screw type titanium implants were inserted in the 
mandibles of six adult Beagle dogs. The implants were either acid etched without additional 
coating, coated with conventionally PS CaP ceramic, coated with MPS CaP ceramic, or with a 
MPS coating at the apical part only (aMPS). To assess the effect of occlusal loading a split 
mouth design was used. Six weeks after implantation, the implants in one half of the 
mandible of each dog were functionally loaded while the contra lateral implants served as 
control. Six weeks after loading the animals were sacrificed and bone-to-implant contact as 
well as the amount of bone around the implants were assessed. Irrespective of surface and 
functional load, neither for bone-to-implant contact nor amount of bone statistically 
significant differences were found between the various implant surfaces. Conversely, 
functional loading of the non-coated implants was associated with a tendency of crestal bone 
loss. Within the limits of the experiment, it was concluded that functional loading of MPS CaP 
coatings evokes a favorable bone response and moreover that the bone response, 
irrespective of the loading condition, does not differ with conventional plasma sprayed CaP 
coatings.
Bone reaction adjacent to microplasma sprayed CaP-coated oral implants subjected to 
occlusal load; an experimental study in the dog. Part II: Long-term results
Long-term effects of functional loading on bone remodeling and coating behavior in a 
mandibular dog model were investigated in chapter 5. In total fifty-six screw type titanium 
implants were inserted in the mandibles of seven adult Beagle dogs. The implants were either 
acid etched, conventionally PS, MPS, or at the apical part only MPS coated. After six weeks of 
healing, implants in one half of the mandible were subjected to occlusal load while the contra 
lateral implants served as control. Fifty-two weeks after loading the animals were sacrificed. 
Irrespective of loading, bone healing was comparable for all surfaces tested. It was concluded 
that functional loading of MPS CaP coated implants evokes a favorable bone response and 
moreover that the bone response, irrespective of the loading condition, does not differ from 
PS CaP coated implants. On the other hand, functional loading of PS as well as MPS CaP 
coated implants might be associated with increased crestal bone maintenance as compared 
to non-coated implants.
Bone reaction adjacent to microplasma sprayed CaP-coated oral implants subjected to 
occlusal load; an experimental study in the dog. Part III: Marginal bone and soft tissue 
healing-long term results
Objective of chapter 6 was to investigate in a mandibular dog model long-term effects of 
functional loading on crestal bone level changes as well as soft-tissue adaptation around
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titanium implants provided with MPS CaP coatings. The experimental model is described in 
chapter 5.Histometric analysis of undecalcified histologic sections included the evaluation of 
the sulcus depth, the dimension of the junctional epithelium and the connective tissue as well 
as the first bone-to-implant contact. For MPS surfaced implants functional loading was 
associated with - compared to the non-loaded state -  unchanged soft-tissue dimension. 
Furthermore, soft-tissue dimension did not differ from the dimensions around non-coated, PS 
and aMPS implants. Moreover, the first bone-to-implant contact was not significantly altered 
by functional loading and comparable non-coated, PS and aMPS implants. Within the limits of 
the experiment, it was concluded that, in comparison, functional loading does not affect the 
marginal bone and soft-tissue response to MPS CaP coated implants
Bone healing of SLActive® and Nanotite™ Implants: a histological and histomorphometric 
study in dogs
The purpose of chapter 7 was to evaluate and compare two types of dental implants provided 
with two different surfaces, i.e. grit-blasted and acid etched implants (SLActive®) and nano­
meter-scale hydroxyapatite modified implants (NanoTite™). For clinical and 
histomorphometrical evaluation 22 SLActive® and 22 Nanotite™ implants were inserted in 
eleven Beagle dogs. Animals were divided in three groups (group A: 2 weeks of healing; group 
B: 4 weeks of healing; group C: 8 weeks of healing). Resonance frequency analysis (RFA) was 
assessed immediately after implantation and after 2, 4 and 8 weeks of healing. Two, 4 and 8 
weeks after implantation the animals were sacrificed and bone-to-implant contact as well as 
amount of bone surrounding the implants were assessed. For SLActive® and Nanotite™ 
implants RFA-values decreased after 2 weeks and increased after 4 and 8 weeks of 
implantation. Only after 8 weeks mean RFA-value for SLActive® was significantly higher 
compared to Nanotite™. Furthermore, for both SLActive® and Nanotite™ implants bone-to- 
implant contact percentage increased significantly over time. No differences in bone-to- 
implant contact was found between SLActive® and Nanotite™ at all the respective 
implantation times. Moreover, for the different healing periods no significant differences for 
bone volume percentage between SLActive® and Nanotite™ implants was found. The present 
study showed that SLActive® and NanoTite™ implants evoke a similar bone response after 
implantation for 2, 4 and 8 weeks in a non-submerged position in the mandible of dogs. In 
addition, the data confirmed that RFA is a reliable method to determine dental implant 
stability and to follow non-invasively the bone formation process.
2. Closing remarks and future perspectives
In the present thesis biological properties, coating behavior as well as effects of functional 
loading on bone remodeling, crestal bone level changes and soft-tissue adaptation of MPS 
CaP coated titanium implants were studied. The null hypothesis that MPS CaP coated 
implants evoke to PS CaP coated implants comparable in vivo effects was not rejected. 
Therefore, it is assumed that microplasma spraying might be an appropriate method to coat
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CaP ceramics onto titanium implants. Conversely, despite the physicochemical similarity 
between MPS and PS CaP coatings, the null hypothesis that both coatings will perform similar 
was rejected. In chapter 4 functional loading of PS coatings enhanced their degradation, 
whereas in chapter 5 load was neither for MPS nor for PS coatings associated with increased 
coating degradation. In contrast, irrespective of the loading condition, significantly more MPS 
coating loss was observed in chapter 5. Furthermore, the H1-hypothesis that surface chemical 
composition (e.g.: CaP coating) is a predominant factor in the bone deposition process cannot 
be rejected. In chapter 2 and 3 increased implant stability and bone-to-implant contact for 
chemically modified implant surfaces (CaP coating) were observed. However, such a 
difference was not found in chapter 4, 5, 6 and 7, which questions the advantages of CaP 
coatings in the current experimental conditions. These results might be related to local bone 
conditions and initial implant stability as achieved in the used dog animal model. Bone in the 
dog mandible is dense (Type 1-2) and implants are installed in between the buccal and lingual 
cortical wall, both increasing initial implant stability. Probably, the advantages of CaP coatings 
become only evident under more severe implantation conditions. In this respect, it has to be 
noticed that there is an increasing trend to install oral implants in more challenging clinical 
cases, especially in elderly patients with poor wound healing due to e.g. diabetes, other 
metabolic malconditions, osteoporosis, radiation therapy, et cetera. Calcium phosphate 
coatings which are known to enhance initial implant stabilization and to maximize bone 
formation might lead to a predictive implant-to-bone response in such situations. However, 
this is speculative and cannot be extrapolated from the current experiments. As mentioned 
earlier, in the local bone conditions of the presently used 1-5 year old, healthy Beagle dogs an 
advantage of CaP coatings was not found. Therefore, the next logical step would be to 
investigate bone-healing effects of CaP-coated implants in animal models resembling more 
challenging clinical situations as metabolic malconditions (e.g. diabetes), osteoporosis, and 
radiation therapy. On the other hand, the clinical performance of calcium phosphate coatings 
remains controversial because it is suggested that coating degradation might be related to 
foreign body response, third-body wear with associated osteolysis as well as supplementary 
crestal bone loss. In the current experiments, displaced CaP particles were found embedded 
in bone in the vicinity of the implant surface. However, these particles were not related to 
foreign body reaction or osteolysis (Chapter 3, 4 and 5). Furthermore, long-term marginal 
bone stability under functional load was not affected by coating degradation (Chapter 6). 
Beside dentistry, microplasma spraying of CaP coatings might be a useful tool in orthopedics. 
Within this field of medicine, the use of biological or cement less fixation using CaP coatings 
has been proposed as an alternative to cemented fixation of load-bearing orthopedic 
implants. Actually, CaP coating have been reported to enhance clinical success with failure 
rates as low as 2% (Ong et al. 2009). However, despite the successful application of plasma- 
sprayed CaP coatings on orthopedic and dental implants, controversies and concerns hamper 
their widespread use. Therefore, new coating techniques to deposit well characterized thin 
CaP layers are currently being developed. These thin CaP coatings may be, because of their 
improved properties (e.g.: better adhesion to a variety of substrates, uniformity in
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composition and structure as well as greater stability in the biological environment) the 
successor of the current thick plasma-sprayed coatings and render them superfluous.
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Chapter 9:
1. Samenvatting en aangeven van de doelen
In een recente systematische review (Esposito, et al. 2007) werd geen bewijs gevonden dat er 
een specifiek implantaat materiaal, vorm of oppervlakte aanpassing superieur is wat betreft 
klinische prestaties van orale implantaten. Dit is voornamelijk het gevolg van korte follow-up 
periodes, weinig patiënten en een hoog risico op bias. Er is echter wel bewijs gevonden voor 
een betere inheling van implantaten in botweefsel na aanpassing van de oppervlakte- 
eigenschappen van het implantaat (Albrektsson and Wennerberg 2004; Albrektsson and 
Wennerberg 2004; Wennerberg and Albrektsson 2009). Dit rechtvaardigt de bestaande 
interesse in potentiële technieken voor de oppervlaktemodificatie van orale implantaten 
(Esposito, et al. 2007; Montes, et al. 2007). Oppervlakte modificatie wordt hoofdzakelijk 
bewerkstelligd door gebruik te maken van verruwing van het implantaatoppervlak of door 
verandering van de chemische samenstelling van het oppervlak.
Eén van de gebruikte methodes voor het veranderen van de chemische oppervlakte 
samenstelling is door het titanium implantaat te bedekken met een laag calcium fosfaat 
keramiek (CaP) door middel van de plasma-spuit (PS) techniek (Le Guéhennec, et al. 2007). Er 
kleven echter een aantal beperkingen aan de toepassing van conventionele PS CaP coatings. 
Daarom werd nieuwe microsplasma spuit (MPS) apparatuur ontwikkeld (Borisov, et al. 2002; 
Yushchenko, et al. 1995). Naast plasma-spuiten zijn inmiddels ook andere methodes 
ontwikkeld om titanium implantaten te bedekken met CaP keramiek. Momenteel is 
bijvoorbeeld het Nanotite (3i Implant Innovations, Palm Beach Gardens, USA) beschikbaar: 
een oppervlakte verandering middels het neerslaan van kristallijne CaP nano-deeltjes op een 
opgeruwd titanium implantaat. Recente proefdier- (Mendes et al. 2007, 2008) en humane 
studies (Goené et al. 2007; Orsini et al. 2007) suggereren, maar bewijzen niet met zekerheid, 
een voordelig effect van dit Nanotite oppervlak tijdens de botinhelings-fase. Voordat klinische 
studies uitgevoerd kunnen worden, dienen goed ontworpen preklinische experimenten 
uitgevoerd te worden om der gelijke nieuwe coatings te karakteriseren. Het primaire doel van 
dit proefschrift was daarom proefdierstudies uit te voeren, waarin zowel het botgedrag van 
de CaP coatings en de stabiliteit van de bot en gingiva reactie onderzocht werden onder 
functionele belasting.
Effect van implantaatoppervlakte structuur en samenstelling op osseointegratie: een 
overzicht van de literatuur.
Het doel van hoofdstuk 2 was op basis van een systematische literatuur review bewijs te 
vinden voor het effect van implantaat oppervlakte modificatie op osseointegratie. Er werden 
daartoe 2 reviews uitgevoerd; één voor “recent ontwikkelde en op de markt gebrachte 
implantaatoppervlaktes"; OsseoSpeed® (Astra Tech), SLActive® (Straumann), TiUnite® 
(NobelBiocare), Nanotite® (3i) en Friadent plus® (DENTSPLY Friadent), en één voor 
experimentele oppervlakte modificaties. Een systematische zoekstrategie (artikelen waarin
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gegevens over het histologische bot-implantaat contact en mechanische stabiliteitstesten 
werden gepresenteerd) leverde 3212 publicaties op die mogelijk interessant waren voor het 
eerste review (“recent ontwikkelde en op de markt gebrachte oppervlaktes"). Uiteindelijk 
werden 29 artikels in dit review opgenomen. Daarnaast werden 32 van in totaal 357 artikelen 
gebruikt voor het review over experimentele oppervlakte aanpassingen.
De conclusies van de reviews waren:
• Oppervlaktemodificaties die de topografie van de momenteel op de markt zijnde 
implantaattypes veranderen zullen onvermijdelijk ook effect hebben op de 
oppervlakte compositie. Hierdoor is het niet goed mogelijk om een gunstig effect 
daadwerkelijk aan óf de topografie óf de oppervlakte samenstelling toe te wijzen.
• Bij vier (OsseoSpeed®, SLActive®, TiUnite® and Nanotite®) van de vijf in Europa het 
meest gepromote implantaat types verbeterde de oppervlakte samenstelling de 
osseointegratie in vergelijking met hun voorgangers. Voor één (Friadent Plus®) 
implantaattype ontbrak dergelijk bewijs. Bij twee (TiUnite®, Nanotite®) van de vijf is 
bevestigend humaan histologisch bewijs beschikbaar.
• Implantaten voorzien van een dunne CaP coating toonden een betere 
osseointegratie in vergelijking met niet-gecoate implantaten. Er zijn echter geen 
humane studies beschikbaar die dit effect bevestigen.
• Het coaten van implantaten met peptide sequenties (bijv. RGD) resulteert niet 
consequent in een verbeterde osseointegratie.
• Het coaten van implantaten met groeifactoren (bijv. BMP-2) verbetert de 
osseointegratie niet. BMP-2 coatings kunnen de osseointegratie zelfs verminderen.
Botgenezing bevorderende eigenschappen van microplasma gespoten CaP gecoate 
implantaten: mechanische en histologische resultaten in geiten.
De biologische eigenschappen (biocompatibiliteit, osteoconductiviteit en mechanische 
stabiliteit) van verschillende MPS CaP coatings werden onderzocht in het derde hoofdstuk. 
Hiervoor werden in totaal 48 titanium implantaten geplaatst in de femorale condyle van 12 
geiten. De implantaten waren verdeeld in vier groepen; niet gecoat, geëtste standaard 
implantaten (acid etched standard BTI implants), conventioneel PS gecoat en twee 
experimenteel MPS gecoate implantaten. Zes en twaalf weken na implantatie werden de 
dieren geofferd en werd het bot -  implantaat contact, hoeveelheid bot en mechanische bot 
fixatie geëvalueerd. Voor het bot -  implantaat contact werd geen statistisch significant 
verschil gevonden tussen de verschillende CaP coatings. Er werden echter wel statistisch 
significante verschillen gevonden in bot-implantaat contact tussen niet-gecoate, geëtste en 
CaP gecoate implantaten na zes en twaalf weken genezing. De hoeveelheid bot tussen de 
verschillende CaP coatings na zes en twaalf weken inheling was gelijk. Bovendien lieten de 
CaP gecoate implantaten na zes en twaalf weken genezing significant hogere mechanische 
fixatie waardes zien in vergelijking met de niet-gecoate implantaten. Er waren geen statistisch 
significante verschillen tussen de verschillende types CaP coatings. Op basis hiervan werd
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geconcludeerd dat conventioneel PS CaP gecoate implantaten en MPS gecoate implantaten 
een vergelijkbaar effect hebben op naburig bot.
Botreactie t.o.v. occlusaal belaste microplasma CaP gecoate orale im plantaten;een 
experimentele studie in honden. Deel I: korte termijn resultaten
In hoofdstuk 4 is een onderzoek beschreven, waarin 48 implantaten geplaatst werden in de 
onderkaak van Beagle honden. De implantaten werden occlusaal belast, waarna histologisch 
onderzoek werd verricht naar de bot-implantaat reactie. De implantaten waren óf geëtst 
zonder additionele coating, gecoat met conventionele PS CaP keramiek, gecoat met MPS CaP 
keramiek óf er was uitsluitend in het apicale gedeelte een MPS CaP coating aangebracht 
(aMPS). De implantaten werden gerandomiseerd geplaatst (split mouth ontwerp). Zes weken 
na implantatie werden de implantaten in één helft van de onderkaak functioneel belast. De 
implantaten aan de contralaterale zijde dienden als controle. Na zes weken belasting werden 
de dieren geofferd en werden zowel bot -  implantaat contact als de hoeveelheid bot 
gemeten.
Implantaatoppervlak modificatie en functionele belasting vertoonden beide geen effect op 
bot -  implantaatcontact en hoeveelheid bot. Er werd daarentegen wel een tendens gezien 
tussen functionele belasting en verlies van crestaal bot bij de niet-gecoate implantaten. 
Binnen de grenzen van het onderzoek werd geconcludeerd dat functionele belasting van MPS 
CaP coatings geen negatief effect had op de botreactie. De botreactie is onder alle 
toegepaste omstandigheden vergelijkbaar met die t.o.v. conventioneel plasma gespoten CaP 
coatings.
Botreactie t.o.v. occlusaal belaste microplasma CaP gecoate orale implantaten. Deel II: 
lange termijn resultaten
De lange termijn effecten van occlusale belasting op bot en coating zijn beschreven in 
hoofdstuk 5. De gebruikte implantaten en procedures waren gelijk aan die van hoofdstuk 4. 
De implantaten bleven nu echter 1 jaar zitten, waarna de dieren werden geofferd. Ondanks 
de occlusale belasting was de botreactie vergelijkbaar voor alle geteste oppervlakte 
modificaties van de implantaten. Er werd dan ook geconcludeerd dat de functionele belasting 
van MPS CaP gecoate implantaten een gunstige botreactie opriep en dat deze reactie niet 
verschilt van PS CaP gecoate implantaten. Tevens werd vastgesteld dat de functionele 
belasting van zowel PS als MPS CaP gecoate implantaten lijkt te resulteren in het behoud van 
het crestale bot.
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Botreactie t.o.v. occlusaal belaste microplasma CaP gecoate orale implantaten. Deel III: 
Marginaal bot en weke delen genezing -  lange termijn resultaten
Doel van hoofdstuk 6 was om het lange termijn effect van functionele belasting op zowel 
crestaal botniveau als op de gingivale reactie rondom MPS CaP gecoate implantaten te 
onderzoeken.
Het experimentele model is reeds beschreven in hoofdstuk 4 en 5. Met behulp van 
histologische coupes werd de gingivale sulcus diepte, de hoogte van het aanhechtingsepitheel 
en het initieel bot -  implantaat contact bepaald. Voor de MPS gecoate implantaten bleek 
functionele belasting geen effect op de zacht weefseldimensies te hebben. Bovendien 
verschilden deze dimensies niet t.o.v. niet-gecoate, PS en aMPS gecoate implantaten. 
Functionele belasting had ook geen effect op het initiële bot -  implantaatcontact en was 
vergelijkbaar met niet-gecoate, PS en MPS gecoate implantaten. Binnen de grenzen van het 
experiment werd derhalve geconcludeerd dat functionele belasting van MPS CaP gecoate 
implantaten geen effect heeft op marginaal bot en zacht weefsel reactie.
Bot genezing b ijS L A c t iv e ®  en Nanotite™ implantaten: een histologische en 
histomorfometrische studie in honden.
In hoofdstuk 7 werd de botreactie t.o.v. twee types commercieel verkrijgbare orale 
implantaten vergeleken, namelijk gestraalde en geëtste SLActive®- en nano-hydroxyapatiet 
gecoate NanoTite™ implantaten. In totaal werden werden 22 SLActive® and 22 Nanotite™ 
implantaten geplaatst in elf Beagle honden. De dieren werden onderverdeeld in 3 groepen 
(groep A: 2 weken genezing, groep B: 4 weken genezing, groep C: 8 weken genezing). Twee, 
vier en acht weken na implantatie werden de dieren geofferd en het bot -  implantaatcontact 
en hoeveel bot rondom de implantaten gemeten. Voor zowel SLActive® als Nanotite™ 
implantaten nam het bot -  implantaat contact percentage significant toe gedurende de 
implantatietijd. Er werden geen verschillen gevonden voor bot -  implantaat contact en 
bothoeveelheid tussen SLActive® en Nanotite™ implantaten op de diverse implantatietijden. 
De studie toonde aan dat SLActive® en Nanotite™ implantaten na 2, 4 en 8 weken implantatie 
in de onderkaak van honden een gelijke botreactie oproepen.
2. Afsluitende opmerkingen toekomstperspectieven
In het voorliggende proefschrift werden de biologische eigenschappen, coating gedrag 
alsmede de effecten van functionele belasting op bot remodelering, crestaal botniveau en 
gingiva aanhechting t.o.v. MPS CaP gecoate implantaten onderzocht. De nulhypothese dat 
MPS CaP gecoate implantaten met PS CaP gecoate implantaten vergelijkbare in vivo 
resultaten opleveren werd niet verworpen.
Microplasma spuiten is dan ook een geschikte methode om titanium implantaten te coaten 
met CaP keramiek. Omgekeerd werd de nulhypothese dat MPS en PS CaP coatings 
vergelijkbaar presteren verworpen. In hoofdstuk vier werd namelijk aangetoond dat de 
initiële functionele belasting de degradatie van PS coatings bevorderde, terwijl in hoofdstuk
208
vijf geen relatie tussen langdurige belasting en de degradatie van PS en MPS coatings werd 
gezien. Daarentegen kan de H1-hypothese dat chemische samenstelling van het oppervlakte 
(CaP coating) een bepalende factor is voor de botreactie niet verworpen worden. In 
hoofdstuk 2 en 3 werden een toename in implantaat stabiliteit en bot -  implantaat contact 
gevonden voor de CaP gecoate implantaten. Een dergelijk verschil werd echter niet gevonden 
in hoofdstuk 4, 5, 6 en 7. Dit stelt de uiteindelijke voordelen van een CaP coating ter discussie. 
Er dient echter benadrukt te worden dat de behaalde resultaten beïnvloed kunnen zijn door 
de locale botcondities en de initiële implantaatstabiliteit in het gebruikte hondenmodel. Het 
bot in de mandibula van een hond is zeer compact (Type 1 -2). Bovendien werden de 
implantaten geplaatst tussen de buccale en linguale corticale wand. Dit verhoogt de initiële 
stabiliteit. De voordelen van CaP coatings worden waarschijnlijk dan ook alleen zichtbaar 
onder moeilijkere (gecompromitteerde) condities. Hierbij kan opgemerkt worden dat er een 
trend is om orale implantaten te plaatsen in meer uitdagende klinische situaties. Dit betreft 
bijvoorbeeld oudere patiënten met een verminderde wondgenezing als gevolg van diabetes 
of andere metabole aandoeningen, osteoporose, bestraling, etc. Calcium fosfaat coatings, die 
er juist om bekend staan de initiële implantaatstabiliteit te verhogen en bot formatie te 
maximaliseren, kunnen dan wellicht wel leiden tot voorspelbare bot -  implantaat reactie. Dit 
is echter nog speculatief en kan niet zonder meer geconcludeerd worden uit de 
experimentele resultaten van voorliggend proefschrift. Zoals eerder aangegeven, onder de 
locale botcondities zoals die gevonden worden bij de gebruikte 1 -  5 jaar oude, gezonde 
Beagle honden, werd geen groot voordeel voor het gebruik van CaP coatings gevonden. Een 
logische volgende stap is dan ook om het bot genezing bevorderende effect van CaP gecoate 
implantaten te onderzoeken in diermodellen die moeilijkere condities (diabetes, osteoporose 
en bestraling) nabootsen.
In de literatuur wordt beschreven dat calcium fosfaat coatings degraderen en dat als gevolg 
daarvan een ontstekingsreactie kan optreden welke gepaard gaat met botafbraak. In de 
huidige experimenten werd een dergelijk verschijnsel niet waargenomen. Weliswaar werden 
in de nabijheid van het implantaatoppervlak CaP deeltje gevonden, maar deze waren volledig 
ingebed in bot en konden niet gerelateerd worden aan een ontstekingsreactie of botafbraak 
(hoofdstuk 3, 4 en 5). Bovendien werd het crestale botverlies ook in het geheel niet beïnvloed 
door coating degradatie (hoofdstuk 6).
Microplasma spuiten zou naast de tandheelkunde ook in de orthopedie een nuttige 
toepassing kunnen vinden. Binnen de orthopedie is het gebruik van biologische of niet- 
gecementeerde CaP gecoate implantaten voorgesteld als alternatief voor de gecementeerde 
fixatie van knie- en heupprotheses. CaP coatings zouden het klinisch gedrag van dergelijke 
implantaten kunnen verbeteren (Ong et al. 2009). Desalniettemin blijft het een feit dat er 
voortdurend controverses en discussies ontstaan rondom de veilige toepassing van plasma 
gespoten CaP coatings. Daarom worden er momenteel nieuwe technieken ontwikkeld om 
goed gekarakteriseerde dunne CaP coatings op implantaten aan te brengen. Deze dunne 
lagen kunnen, dankzij hun verbeterde eigenschappen (zoals een betere hechting aan het 
implantaatoppervlak, uniformere samenstelling en structuur, maar ook een betere stabiliteit
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in de biologische omgeving), de opvolgers zijn van momenteel toegepaste "dikke" plasma 
gespoten coatings zijn.
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